<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">102287</article-id><article-id pub-id-type="doi">10.7554/eLife.102287</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.102287.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Decapping activators Edc3 and Scd6 act redundantly with Dhh1 in post-transcriptional repression of starvation-induced pathways</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Kumar</surname><given-names>Rakesh</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0003-0349-0914</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Fan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Niphadkar</surname><given-names>Shreyas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0002-4028-395X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Onu</surname><given-names>Chisom</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3338-5141</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Vijjamarri</surname><given-names>Anil Kumar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Greenberg</surname><given-names>Miriam L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7724-5426</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Laxman</surname><given-names>Sunil</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hinnebusch</surname><given-names>Alan G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1627-8395</contrib-id><email>ahinnebusch@nih.gov</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>Division of Molecular and Cellular Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007wpch15</institution-id><institution>Institute for Stem Cell Science and Regenerative Medicine (DBT-inStem)</institution></institution-wrap><addr-line><named-content content-type="city">Bengaluru</named-content></addr-line><country>India</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01070mq45</institution-id><institution>Department of Biological Sciences, Wayne State University</institution></institution-wrap><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Topisirovic</surname><given-names>Ivan</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Hauf</surname><given-names>Silke</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02smfhw86</institution-id><institution>Virginia Tech</institution></institution-wrap><addr-line><named-content content-type="city">Blacksburg</named-content></addr-line><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>25</day><month>11</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP102287</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-08-28"><day>28</day><month>08</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-08-28"><day>28</day><month>08</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.08.28.610059"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-12-09"><day>09</day><month>12</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.102287.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-10-10"><day>10</day><month>10</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.102287.2"/></event></pub-history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-102287-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-102287-figures-v1.pdf"/><abstract><p>Degradation of many yeast mRNAs involves decapping by the Dcp1:Dcp2 complex. Previous studies on decapping activators Edc3 and Scd6 suggested their limited roles in mRNA decay. RNA-seq analysis of mutants lacking one or both proteins revealed that Scd6 and Edc3 have largely redundant activities in targeting numerous mRNAs for degradation that are masked in the single mutants. These transcripts are frequently targeted by decapping activators Dhh1 and Pat1, and the collective evidence suggests that Scd6/Edc3 act interchangeably to recruit Dhh1 to Dcp2. Ribosome profiling shows that redundancy between Scd6 and Edc3 and their functional interactions with Dhh1 and Pat1 extend to translational repression of particular transcripts, including a cohort of poorly translated mRNAs displaying interdependent regulation by all four factors. Scd6/Edc3 also participate with Dhh1/Pat1 in post-transcriptional repression of proteins required for respiration and catabolism of alternative carbon sources, which are normally expressed only in limiting glucose. Simultaneously eliminating Scd6/Edc3 increases mitochondrial membrane potential and elevates metabolites of the tricarboxylic acid and glyoxylate cycles typically observed only during growth in low glucose. Thus, Scd6/Edc3 acts redundantly, in parallel with Dhh1 and in cooperation with Pat1, to adjust gene expression to nutrient availability by controlling mRNA decapping and decay.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Scd6</kwd><kwd>Edc3</kwd><kwd>Dhh1</kwd><kwd>decapping</kwd><kwd>mRNA degradation</kwd><kwd>respiration</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HD008899-06</award-id><principal-award-recipient><name><surname>Kumar</surname><given-names>Rakesh</given-names></name><name><surname>Zhang</surname><given-names>Fan</given-names></name><name><surname>Vijjamarri</surname><given-names>Anil Kumar</given-names></name><name><surname>Hinnebusch</surname><given-names>Alan G</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q48ey07</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01 HL117880</award-id><principal-award-recipient><name><surname>Onu</surname><given-names>Chisom</given-names></name><name><surname>Greenberg</surname><given-names>Miriam L</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q48ey07</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35 GM149271</award-id><principal-award-recipient><name><surname>Onu</surname><given-names>Chisom</given-names></name><name><surname>Greenberg</surname><given-names>Miriam L</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04reqzt68</institution-id><institution>Wellcome Trust/DBT India Alliance</institution></institution-wrap></funding-source><award-id>Senior Fellowship IA/S/21/2/505922</award-id><principal-award-recipient><name><surname>Niphadkar</surname><given-names>Shreyas</given-names></name><name><surname>Laxman</surname><given-names>Sunil</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Multi-omics analyses reveal redundant functions of yeast mRNA decapping activators Scd6 and Edc3 in facilitating recruitment of helicase Dhh1 and accelerating degradation of transcripts required for respiration in glucose-replete cells.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Degradation of mRNA is a key aspect of gene expression that can be regulated in response to nutrient availability, cell stress, and developmental pathways in eukaryotic cells and further serves to eliminate defective mRNAs. A major pathway of cytoplasmic mRNA turnover involves truncating the poly(A) tail by the Ccr4/Not and Pan2/Pan3 complexes, followed by removal of the m<sup>7</sup>G cap by the Dcp1/Dcp2 decapping complex and 5’ to 3’ exonucleolytic degradation by Xrn1. The decapping complex is activated by factors that interact with low-complexity sequence motifs in the C-terminal tail (CTT) of the catalytic subunit Dcp2, including Edc3, Scd6, DEAD-box helicase Dhh1, and Pat1, which also interact with one another extensively. There is evidence that Pat1 is recruited to oligoadenylate tails remaining on mRNAs following partial deadenylation, in association with the Lsm1-Lsm7 complex, and activates decapping via interactions with other decapping activators and with the Dcp2 CTT itself (<xref ref-type="bibr" rid="bib36">Parker, 2012</xref>; <xref ref-type="bibr" rid="bib22">He and Jacobson, 2023</xref>).</p><p>Genome-wide analysis of mRNA abundance (RNA-seq) in yeast mutants lacking Dhh1, Pat1, or both factors revealed functional cooperation by Pat1 and Dhh1 (<xref ref-type="bibr" rid="bib20">He et al., 2018</xref>), with a large fraction being up-regulated only in the <italic>pat1∆dhh1∆</italic> double mutant (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). The majority of mRNAs up-regulated by <italic>dhh1∆</italic> or <italic>pat1∆</italic> mutations are likewise up-regulated in <italic>dcp2∆</italic> cells (<xref ref-type="bibr" rid="bib20">He et al., 2018</xref>) and exhibit greater than average proportions of decapped mRNAs in WT cells but not in <italic>dhh1∆</italic> or <italic>pat1∆</italic> cells (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>), consistent with Dhh1/Pat1 targeting mRNAs for degradation via decapping. While more than half of the mRNAs up-regulated by <italic>dcp2∆</italic> are up-regulated by <italic>dhh1∆</italic> and/or <italic>pat1∆,</italic> a large fraction are targeted primarily by the Upf factors instead, responsible for nonsense-mediated mRNA decay (NMD) (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>; <xref ref-type="bibr" rid="bib6">Celik et al., 2017</xref>).</p><p>The cumulative contributions of Dhh1 and Pat1 to mRNA decay is consistent with their independent interactions with distinct segments of the Dcp2 CTT (<xref ref-type="bibr" rid="bib20">He et al., 2018</xref>), which appears to be direct for Pat1 but bridged by Edc3 or Scd6 for Dhh1. There is also evidence for distinct decapping complexes containing either Dhh1 or Pat1 in addition to Xrn1, Edc3, or Scd6 (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>). However, Dhh1 occupancy (<xref ref-type="bibr" rid="bib30">Miller et al., 2018</xref>), tends to be elevated for mRNAs up-regulated by either <italic>dhh1∆</italic> (23) or <italic>pat1∆</italic> (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>), consistent with Dhh1 contributing to degradation of mRNAs targeted by Pat1. Moreover, Pat1 binding to the Dcp2 CTT was required for degradation of certain Dhh1-targeted mRNAs when Dhh1 recruitment to the CTT was compromised (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>).</p><p>There is evidence that Edc3 is a common constituent of decapping complexes containing Xrn1 and one or more of the decapping activators Dhh1, Pat1, Scd6, and Upf1 (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>). It is surprising, therefore, that Edc3 has been implicated in targeting only two transcripts for degradation, <italic>YRA1</italic> and <italic>RPS28B</italic> (<xref ref-type="bibr" rid="bib2">Badis et al., 2004</xref>; <xref ref-type="bibr" rid="bib11">Dong et al., 2007</xref>). Edc3 shares sequence similarity with decapping activator Scd6 and both proteins contain an FDF motif shown to interact competitively with the Dhh1 homolog in animal systems (<xref ref-type="bibr" rid="bib50">Tritschler et al., 2008</xref>; <xref ref-type="bibr" rid="bib51">Tritschler et al., 2009</xref>). Edc3 and Scd6 also share N-terminal LSm domains that compete for binding to helical-leucine-rich (HLM) motifs in the CTT of fission yeast Dcp2 (<xref ref-type="bibr" rid="bib13">Fromm et al., 2012</xref>). Analyzing effects of deleting the Edc3 interaction site in the <italic>S. cerevisiae</italic> Dcp2-CTT on levels of several Dhh1-repressed mRNAs suggested that recruitment of Dhh1 to Dcp2 can be mediated interchangeably by Edc3 or Scd6 bound to the same site in the Dcp2 CTT (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>). These findings, plus the fact that deleting <italic>S. cerevisiae SCD6</italic> and <italic>EDC3</italic> simultaneously confers a synthetic growth defect (<xref ref-type="bibr" rid="bib10">Decourty et al., 2008</xref>), suggest that yeast Scd6 and Edc3 function redundantly in targeting specific mRNAs for decapping and degradation.</p><p>Although tethering yeast Dhh1 or Scd6 enhances degradation of reporter mRNAs via Dcp1/Dcp2 (<xref ref-type="bibr" rid="bib5">Carroll et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Sweet et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>), it is not well understood how these factors are targeted to specific native mRNAs. Dhh1 has been implicated in accelerating degradation associated with non-optimal codons in yeast mRNAs (<xref ref-type="bibr" rid="bib38">Presnyak et al., 2015</xref>), being required for the rapid turnover conferred by suboptimal codons inserted in reporter mRNAs (<xref ref-type="bibr" rid="bib48">Sweet et al., 2012</xref>). A queue of slowly elongating ribosomes upstream from non-optimal codons can be recognized by Dhh1, and overexpressing or tethering Dhh1 evokes ribosome stalling at non-optimal codons. Moreover, Dhh1 association and Dhh1-dependent repression of mRNA abundance both correlate with codon non-optimality across the yeast transcriptome (<xref ref-type="bibr" rid="bib40">Radhakrishnan et al., 2016</xref>). However, the mRNAs most highly up-regulated in <italic>dhh1∆</italic> and <italic>pat1∆</italic> cells are not enriched for suboptimal codons, suggesting that other features are responsible for their preferential targeting by Dhh1 or Pat1 for decapping/decay (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>).</p><p>In addition to enhancing mRNA decay, there is evidence that Pat1, Dhh1, and Scd6 can repress translation. Tethering Dhh1 or Scd6 represses translation of reporter mRNAs in <italic>dcp2∆</italic> cells, where the tethered transcripts cannot be decapped and degraded (<xref ref-type="bibr" rid="bib5">Carroll et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Sweet et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>). Deletion of Dhh1 and Pat1 simultaneously eliminated loss of bulk polysomes evoked by nutrient starvation and also increased initiation rates of certain mRNAs (<xref ref-type="bibr" rid="bib23">Holmes et al., 2004</xref>; <xref ref-type="bibr" rid="bib9">Coller and Parker, 2005</xref>; <xref ref-type="bibr" rid="bib1">Arribere et al., 2011</xref>). Supporting a direct role in repressing translation, overexpressing Dhh1 or Pat1 in non-starved cells evoked polysome disassembly and reduced the initiation rate of specific mRNAs; and addition of Dhh1 (<xref ref-type="bibr" rid="bib9">Coller and Parker, 2005</xref>) or N-terminally truncated Pat1 (<xref ref-type="bibr" rid="bib34">Nissan et al., 2010</xref>) to yeast extracts inhibited bulk translation and 48 S preinitiation complex (PIC) assembly in vitro. Ribosome profiling studies of <italic>dhh1Δ, pat1Δ</italic> and <italic>pat1Δdhh1Δ</italic> mutants identified hundreds of genes whose transcripts are translationally down-regulated or activated by Dhh1 or Pat1 in nutrient-replete cells (<xref ref-type="bibr" rid="bib26">Jungfleisch et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Radhakrishnan et al., 2016</xref>; <xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>), which frequently involves cooperation between Dhh1 and Pat1 (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>).</p><p>Recently, we showed that Pat1 and Dhh1 function with the decapping enzyme in rich medium to repress the abundance or translation of numerous mRNAs encoding proteins required specifically in media containing an alternative carbon or nitrogen source (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>; <xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). These include mitochondrial proteins involved in oxidative phosphorylation (Ox. Phos.) and diverse other proteins known to be transcriptionally repressed by carbon or nitrogen catabolite repression in rich medium.</p><p>In this study, we used a multi-omics approach to determine whether Edc3 and Scd6 have largely redundant functions in targeting mRNAs for decapping and attendant degradation, and whether they functionally cooperate with Pat1 or Dhh1 in repressing the abundance or translation of specific mRNAs. We identified a large cohort of mRNAs that are up-regulated in an <italic>scd6Δedc3Δ</italic> double mutant but not in either single mutant lacking only Scd6 or Edc3, without a commensurate increase in transcription of the cognate genes. These transcripts display a strikingly similar pattern of up-regulation in the <italic>dhh1Δ</italic> mutant in the manner predicted if Edc3/Scd6 redundantly recruit Dhh1 to Dcp2 for activation of decapping (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>). We further observed functional redundancy between Scd6 and Edc3 and extensive cooperation with Dhh1/Pat1 in repressing translation of particular mRNAs, with evidence for interdependent repression by all four decapping factors. Importantly, Edc3/Scd6 contribute to post-transcriptional repression of proteins required for catabolism of non-preferred carbon or nitrogen sources on rich medium, acting collectively to enhance glucose repression, maintain low-level mitochondrial electron transport, and reduce levels of tricarboxylic acid (TCA) and glyoxylate cycle intermediates in glucose-replete cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Evidence that Scd6 and Edc3 functionally cooperate to control the abundance of many individual mRNAs</title><p>To determine whether Scd6 and Edc3 function redundantly in post-transcriptional control of gene expression, we constructed a <italic>scd6∆edc3∆</italic> double mutant isogenic to the <italic>scd6∆</italic> and <italic>edc3∆</italic> single mutants we examined previously (<xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>). Only the double mutant exhibits a marked slow-growth (Slg<sup>-</sup>) phenotype on synthetic complete medium (SC), which was largely complemented by introducing either <italic>SCD6</italic> or <italic>EDC3</italic> on a single copy plasmid (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Analysis of polysome assembly revealed a ~40% reduction in ratio of polysomes to monosomes (P/M) in the <italic>scd6∆edc3∆</italic> double mutant, whereas the single mutants showed little (<italic>scd6Δ</italic>) or no (<italic>edc3∆</italic>) reduction in bulk translation by this assay (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). These results suggest that Scd6 and Edc3 act redundantly to carry out one or more functions required for WT levels of bulk translation and cell growth in nutrient-replete cells.</p><p>To examine the effects of the <italic>scd6Δ, edc3Δ,</italic> and <italic>scd6Δedc3Δ</italic> mutations on the abundance and translation of individual mRNAs, we conducted RNA-Seq and ribosome profiling (Ribo-Seq) of the mutant and WT strains following growth in liquid rich medium (YPD) at 30°C (processed data compiled in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). Ribo-Seq entails deep-sequencing of ribosome-protected fragments (RPFs, or ribosome footprints), and cycloheximide was added to the lysates to arrest elongating ribosomes on the mRNA following cell breakage. The ratio of RPF sequencing reads summed over the coding sequences (CDS) to the total mRNA reads from RNA-Seq for the corresponding transcript provides a measure of translational efficiency (TE) for each mRNA (<xref ref-type="bibr" rid="bib24">Ingolia et al., 2009</xref>). The ribosome profiling and RNA-Seq results between two biological replicates for each strain were highly reproducible with Pearson correlation coefficients (r) ranging between 0.95–1.0 for different pairwise comparisons of replicates (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–B</xref>). We employed DESeq2 (<xref ref-type="bibr" rid="bib29">Love et al., 2014</xref>) to identify statistically significant differences in relative mRNA abundance, RPF abundance, or TE for all expressed mRNAs between WT and mutant strains (see Methods for details).</p><p>Analysis of the RNA-Seq results identified 81 mRNAs that were significantly up-regulated in the <italic>edc3Δ</italic> mutant vs. WT by &gt;1.5 fold at a false discovery rate (FDR) of &lt;0.05 (dubbed mRNA_up_e3 transcripts; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>), and 123 mRNAs reduced in abundance by <italic>edc3∆</italic> by the same criteria (dubbed mRNA_dn_e3, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). Only 14 mRNAs were up-regulated and only 34 down-regulated by the <italic>scd6Δ</italic> single mutation (respectively, mRNA_up_s6 and mRNA_dn_s6, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A–B</xref>). Importantly, many more mRNAs were dysregulated by the <italic>scd6Δedc3Δ</italic> double mutation: 741 in the mRNA_up_s6,e3 group and 793 in the mRNA_dn_s6,e3 group (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A–B</xref>), indicating that the two factors have highly redundant functions in controlling mRNA abundance.</p><p>Many yeast mutants with Slg<sup>-</sup> phenotypes, including <italic>pat1Δ, dhh1Δ,</italic> and <italic>dcp2∆</italic> deletion mutants, exhibit altered expression of most mRNAs belonging to the Environmental Stress Response (ESR) (<xref ref-type="bibr" rid="bib35">O’Duibhir et al., 2014</xref>), which includes ~300 induced (iESR) and ~600 down-regulated (rESR) mRNAs dysregulated in WT cells by various stresses (<xref ref-type="bibr" rid="bib14">Gasch et al., 2000</xref>). In keeping with its Slg<sup>-</sup> phenotype, the <italic>scd6Δedc3Δ</italic> mutation conferred a marked reduction in median expression of rESR mRNAs, and increased expression of the iESR mRNAs, which exceeded in magnitude the changes observed for the slowest growing yeast deletion mutants analyzed previously (<xref ref-type="bibr" rid="bib35">O’Duibhir et al., 2014</xref>; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C–D</xref>). The two single mutations, by contrast, conferred much smaller changes in ESR mRNAs (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C–D</xref>). (In all box plots, when notches do not overlap between adjacent boxes, their two medians differ with 95% confidence; and when notches do not overlap 0 in log<sub>2</sub> plots, the median differs significantly from that of all mRNAs, which is invariably close to 1.0.) Consistent with these results, the transcripts up-regulated in the double mutant are enriched for iESR mRNAs (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), suggesting that the 187 iESR transcripts up-regulated in this strain are responding indirectly to cell stress. The remaining 75% of mRNAs up-regulated in <italic>scd6Δedc3Δ</italic> cells are not iESR mRNAs however (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), suggesting that their increased abundance arises from eliminating Edc3/Scd6 functions in mRNA decay. Below, we excluded the ESR mRNAs from analyses of mRNA changes in an effort to focus on the transcripts controlled directly by Scd6 and Edc3.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Most mRNAs up-regulated in the <italic>scd6∆edc3∆</italic>mutant are not iESR transcripts and exhibit Scd6/Edc3 functional redundancy in repression of transcript abundance.</title><p>(<bold>A</bold>) Venn diagram of overlap between the 741 mRNAs up-regulated in the <italic>scd6Δedc3Δ</italic> mutant vs. wild-type (WT) (mRNA_up_s6,e3) and the 283 induced ESR (iESR) mRNAs, indicating fold-enrichment and p value of overlap determined by the hypergeometric distribution. (<bold>B</bold>) Venn diagram of overlaps involving all 591 non-iESR mRNAs up-regulated in abundance by <italic>scd6Δ</italic> (6 Non-iESR mRNA_up_s6 transcripts)<italic>, edc3Δ</italic> (64 mRNA_up_e3 transcripts), or <italic>scd6Δedc3Δ</italic> mutations (554 Non-iESR mRNA_up_s6,e3 transcripts). (<bold>C</bold>) Notched box-plot analyses of log<sub>2</sub> changes in mRNA abundance (log<sub>2</sub>∆mRNA) determined by DESeq2 analysis between the indicated mutants vs. WT for mRNAs belonging to the specified sectors of the Venn diagram in (<bold>B</bold>). The numbers of mRNAs in each group for which data were obtained are indicated immediately above the x-axis; unlogged median values are indicated for each column at the bottom. (<bold>D</bold>) Gene browser image for <italic>MDH2</italic> showing the mRNA (top 16 tracks) and ribosome-protected fragment (RPF) (bottom 16 tracks) reads measured by parallel RNA-Seq and ribosome profiling analyses for two biological replicates of WT and the indicated mutants with fold-changes in mRNA or RPFs between mutant and WT indicated to the right of each track. In panels <bold>A-D</bold>, results for the <italic>scd6∆, edc3∆,</italic> and <italic>scd6∆edc3∆</italic> mutations, abbreviated as <italic>∆s6, ∆e3,</italic> and <italic>∆s6,∆e3,</italic> are shown in gray, white or light gray, and cyan, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Combining <italic>scd6Δ</italic> and <italic>edc3∆</italic> mutations confers synthetic reductions in cell growth and polysome assembly.</title><p>(<bold>A</bold>) Serial dilutions of wild-type (WT) strain HFY114, <italic>edc3∆</italic> strain FZY862, <italic>scd6∆</italic> strain SYY2352, and <italic>scd6∆edc3∆</italic> strain FZY858 transformed with empty <italic>URA3 CEN</italic> vector YCplac33 or derivatives of this vector containing <italic>EDC3</italic> (pLfz614-7) or <italic>SCD6</italic> (pLfz615-5) were spotted on synthetic complete plates minus uracil (SC-Ura) and incubated at the indicated temperatures. (<bold>B</bold>) Polysome profiles of the strains in (<bold>A</bold>) but lacking plasmids cultured in YPD medium at 30 C to log-phase growth and treated with cycloheximide prior to harvesting to block run-off of elongating ribosomes during cell lysis. Cell extracts were resolved by sedimentation through 10–50% sucrose gradients, and gradients were scanned at 260 nm to yield the indicated tracings. Average polysome/monosome ratios (P/M) from two biological replicates are shown, with means +/- SEMs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Reproducibility among biological replicates of RNA-Seq, Ribo-Seq, External RNA Controls Consortium (ERCC)-normalized RNA-Seq, Rpb1 ChIP-seq, and TMT mass spectrometry (TMT-MS) data.</title><p>(<bold>A</bold>) Correlation matrix showing Spearman correlation coefficients calculated for pair-wise comparisons of numbers of RPKM-normalized RNA-Seq reads for all expressed genes among all eight RNA-Seq libraries generated for two biological replicates (_1,_2) of the indicated genotypes. The correlation coefficients between replicates are ≥0.98 and for all comparisons &gt;0.95 with p-values of ≈0. For this and all similar plots below, the eccentricity of the ellipses are scaled parametrically to the correlation value between the two samples. (<bold>B</bold>) Same as (<bold>A</bold>) but for Ribo-Seq data, with correlation coefficients between replicates &gt;0.995 and for all comparisons &gt;0.96 with p-values of ≈0. (<bold>C</bold>) Same as (<bold>A</bold>) but for ERCC-normalized RNA-Seq data, with correlation coefficients between replicates &gt;0.97 and for all comparisons &gt;0.94 with p-values of ≈0. (<bold>D</bold>) Same as (<bold>A</bold>) but for Rpb1 ChIP-Seq data comparing three normalized occupancies averaged across the coding sequences (CDS) of all 5770 expressed genes, with correlation coefficients between replicates &gt;0.98 and for all comparisons &gt;0.91 with p-values of ≈0. (<bold>E</bold>) Same as (<bold>A</bold>) but for TMT-MS data, comparing log<sub>2</sub> cyclic Loess-normalized exclusive MS1 intensities for all expressed proteins with correlation coefficients between replicates &gt;0.96 and for all comparisons &gt;0.95 with p-values of ≈0. (<bold>F</bold>) Correlation between changes in abundance of RNA vs. ribosome-protected fragments (RPFs) for 5835 expressed transcripts in the <italic>scd6Δedc3Δ</italic> double mutant compared to WT, calculated from RPKM-normalized RNA-Seq and Ribo-Seq reads obtained after combining data from biological replicates, with the Pearson correlation coefficient (r) and p-value of the correlation indicated.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Functional redundancy between Scd6 and Edc3 in controlling mRNA abundance and mobilizing the environmental stress response (ESR).</title><p>(<bold>A–B</bold>) Venn diagrams of overlaps between all mRNA_up (<bold>A</bold>) and all mRNA_dn (<bold>B</bold>) groups identified in <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> mutants vs. wild-type (WT), with fold-enrichments and p values from the hypergeometric distribution indicated for overlapping sets. (<bold>C–D</bold>) Notched box-plot analyses of log<sub>2</sub> changes in mRNA abundance in mutant vs. WT for 585 rESR (<bold>C</bold>) and 283 iESR (<bold>D</bold>) mRNAs conferred by <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> mutations and those observed for the slowest-growing yeast deletion mutants (M) analyzed previously (<xref ref-type="bibr" rid="bib35">O’Duibhir et al., 2014</xref>). Each box depicts the interquartile range containing 50% of the data, intersected by the median; the notch indicates a 95% confidence interval (CI) around the median. Median changes (unlogged) are shown at the bottom. (<bold>E</bold>) Ratios of capped to total mRNA abundance in transcript numbers per million reads (TPMs) (Relative C/T) in WT or <italic>dhh1∆</italic> cells plotted for all mRNAs, the 554 non-iESR mRNA_up_s6,e3, or 526 non-rESR mRNA_down_s6,e3 transcripts dysregulated in <italic>scd6Δedc3Δ</italic> vs. WT cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig1-figsupp3-v1.tif"/></fig></fig-group><p>Considering only mRNAs not governed by the ESR, we identified 591 non-iESR mRNAs significantly up-regulated in any of the three mutants (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; e.g., Non-iESR mRNA_up_s6,e3 designating the 554 mRNAs up-regulated in the double mutant). Examining the ∆RNA values for the majority fraction of the Non-iESR transcripts up-regulated only in the double mutant reveals little change in median abundance in each single mutant but strong up-regulation in the double mutant (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>, sectors (iii)), as expected for redundant repressive functions of Scd6 and Edc3. <italic>MDH2,</italic> encoding an enzyme of the glyoxylate cycle, exemplifies a non-iESR transcript up-regulated in both mRNA and RPF abundance exclusively in the double mutant (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The small fraction of 27 mRNAs significantly up-regulated in both the <italic>edc3Δ</italic> single mutant and double mutant exhibits only slightly elevated median abundance in the <italic>scd6Δ</italic> single mutant, and only slightly greater up-regulation in the double mutant vs. <italic>edc3Δ</italic> single mutant (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>, sectors (ii)), indicating a minimal repressive contribution by Scd6. Interestingly, the small set of 37 mRNAs significantly up-regulated only in the <italic>edc3Δ</italic> single mutant shows reduced rather than increased abundance in the <italic>scd6Δ</italic> single mutant, and lower up-regulation in the double mutant vs. the <italic>edc3Δ</italic> single mutant (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>, sectors (i)), suggesting that Scd6 enhances rather than represses these mRNAs, especially in <italic>edc3∆</italic> cells.</p></sec><sec id="s2-2"><title>Evidence that Dhh1 and Pat1 functionally cooperate with Scd6/Edc3 in repressing mRNA abundance</title><p>We recently identified a group of 1018 non-iESR mRNAs up-regulated by either <italic>pat1Δ, dhh1Δ,</italic> or <italic>pat1Δdhh1Δ</italic> mutations (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). Importantly, this group is highly enriched for the 591 mRNAs up-regulated by <italic>scd6Δ, edc3Δ,</italic> or <italic>scd6Δedc3Δ</italic> mutations (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Indeed, ~70% of the transcripts up-regulated by <italic>scd6Δ/edc3Δ</italic> are also up-regulated in one of the three <italic>pat1Δ/dhh1Δ</italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, sector (ii)), showing comparable up-regulation in the <italic>scd6Δedc3Δ, pat1Δ,</italic> and <italic>dhh1Δ</italic> mutants, but little change in the <italic>scd6Δ</italic> and <italic>edc3Δ</italic> single mutants (<xref ref-type="fig" rid="fig2">Figure 2B(ii)</xref>). These mRNAs generally exhibit the greatest up-regulation in the <italic>pat1Δdhh1Δ</italic> double mutant, indicating cumulative contributions of Dhh1 and Pat1 to their repression, in contrast to the largely redundant roles played by Scd6 and Edc3 in their repression. As expected, the smaller group of 180 mRNAs significantly up-regulated exclusively by <italic>scd6Δ/edc3Δ</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, sector (i)) shows strong up-regulation in the <italic>scd6Δedc3Δ</italic> double mutant and they are also appreciably up-regulated by <italic>dhh1Δ</italic> while being largely unaffected by <italic>pat1Δ</italic> (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, sector (i)). Finally, the majority group of 607 mRNAs significantly up-regulated by only <italic>pat1Δ</italic> or <italic>dhh1Δ</italic> displays the largest increases in the two mutants lacking Pat1, but smaller and similar increases in response to the <italic>scd6Δ/edc3Δ</italic> and <italic>dhh1Δ</italic> mutations (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>, sectors (iii)). Overall, these findings suggest that Dhh1 and Pat1 both contribute to repressing the majority of mRNAs repressed redundantly by Scd6 and Edc3, with Dhh1 contributing more extensively than Pat1.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Most mRNAs up-regulated in the <italic>scd6∆edc3∆</italic> mutant are also up-regulated by <italic>dhh1Δ</italic> and <italic>pat1Δ</italic>.</title><p>(<bold>A</bold>) Venn diagram of overlap between all 591 non-iESR mRNAs up-regulated in abundance by the <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> mutations (from <xref ref-type="fig" rid="fig1">Figure 1B</xref>) and 1018 non-iESR mRNAs up-regulated by the <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> mutations identified previously (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). Fold enrichments and p value from the hypergeometric distribution are indicated for the overlap. (<bold>B</bold>) Notched box plots of log<sub>2</sub>∆mRNA between the indicated mutants vs. wild-type (WT) for mRNAs in the three sectors specified in (<bold>A</bold>). (<bold>C</bold>) Hierarchical clustering analysis of log<sub>2</sub>∆mRNA values conferred by the indicated mutations vs. WT for 784 of the 794 mRNAs up- or down-regulated in <italic>dhh1Δ</italic> vs. WT cells for which RNA-Seq data was obtained in all four strains and with log<sub>2</sub>∆mRNA values &gt;-5 and &lt;5, conducted with R heatmap.2 function from R ‘gplots’ library, using default hclust hierarchical clustering algorithm. Spearman coefficients (ρ) and associated p values are given for the indicated correlation analyses. (<bold>D</bold>) Venn diagram of overlaps between the 591 non-iESR mRNAs up-regulated by the <italic>scd6Δ/edc3Δ</italic> mutations vs. WT (from <xref ref-type="fig" rid="fig1">Figure 1B</xref>) and the indicated 431 and 590 non-iESR mRNAs up-regulated by <italic>dhh1Δ</italic> or <italic>pat1Δ</italic> vs. WT, respectively, identified previously (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). The 220, 78, and 293 mRNAs found exclusively in only one of the three sets are indicated in the cyan, red-orange, and yellow sectors, respectively while the 127, 71, and 53 mRNAs shared by two of the three sets and the 173 mRNAs shared by all three sets are indicated in the corresponding regions of overlap. Fold enrichments and p values from the hypergeometric distribution are indicated for the overlaps. (<bold>E</bold>) Notched box plots of log<sub>2</sub>∆mRNA between the indicated mutants vs. WT for the 431 non-iESR mRNAs up-regulated by <italic>dhh1Δ</italic> vs. WT shown in panel (<bold>D</bold>). In panels <bold>A</bold>, <bold>B</bold>, <bold>D</bold>, and <bold>E</bold>, results for mRNAs up-regulated by the <italic>scd6∆, edc3∆,</italic> and <italic>scd6∆edc3∆</italic> mutations are shown in gray, white, and cyan, respectively, while those for mRNAs up-regulated by the <italic>pat1∆, dhh1∆,</italic> and <italic>pat1∆dhh1∆</italic> mutations are shown in yellow, orange, and red, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig2-v1.tif"/></fig><p>Further evidence for this last point comes from a k-means clustering analysis of mRNA changes in different mutants for the group of 431 non-iESR mRNAs up-regulated by <italic>dhh1Δ,</italic> which revealed a stronger correlation between the changes conferred by <italic>scd6Δ/edc3Δ</italic> and <italic>dhh1Δ</italic> (ρ=0.90) than between <italic>pat1Δ</italic> with either <italic>dhh1Δ</italic> (ρ=0.74) or <italic>scd6Δ/edc3Δ</italic> (ρ=0.71) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Consistent with this, the <italic>scd6Δ/edc3Δ</italic> mutations up-regulate a considerably larger proportion of the mRNAs significantly up-regulated by <italic>dhh1∆</italic> (~70%) vs. those up-regulated by <italic>pat1∆</italic> (~41%) (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Furthermore, the majority of mRNAs up-regulated by <italic>dhh1∆</italic> exhibit redundant repression by Scd6 and Edc3, showing marked up-regulation comparable to that given by <italic>dhh1Δ</italic> itself only in the <italic>scd6Δ/edc3Δ</italic> double mutant (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). These findings are consistent with the involvement of Edc3/Scd6 in the degradation of most mRNAs targeted by Dhh1, which are more variably and less extensively repressed by Pat1.</p></sec><sec id="s2-3"><title>Evidence that Scd6/Edc3 repress mRNA abundance by enhancing decapping/degradation and facilitating Dhh1 association with Dcp2</title><p>We next examined whether the mRNAs significantly down-regulated by Edc3/Scd6 are also regulated by the decapping enzyme Dcp1/Dcp2. Supporting this, cluster analysis of mRNA changes revealed that the majority of non-iESR mRNAs up-regulated in the <italic>scd6Δedc3Δ</italic> double mutant are also up-regulated by <italic>dcp2Δ</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, blue colors in cols. 1 &amp; 3), with a strong correlation between the abundance changes conferred by these mutations relative to WT (ρ=0.74). In addition, <italic>dcp2Δ</italic> increased the median abundance of this group of mRNAs similarly to that given by <italic>scd6Δedc3Δ</italic> (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, cols. 1 &amp; 4). These findings implicate decapping by Dcp1:Dcp2 as an important driver of the repression of mRNA levels directed by Scd6/Edc3. The cluster analysis in <xref ref-type="fig" rid="fig3">Figure 3A</xref> once again reveals greater similarity between the mRNA changes conferred by <italic>scd6Δedc3Δ</italic> and those given by <italic>dhh1Δ</italic> (ρ=0.90) versus <italic>pat1Δ</italic> (ρ=0.69); and <italic>pat1∆</italic> also confers a smaller median reduction than does <italic>dhh1∆</italic> for the Scd6/Edc3-down-regulated mRNAs (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Evidence that impaired decapping not increased transcription, drives changes in mRNA abundance in <italic>scd6Δedc3Δ</italic> cells and that Edc3/Scd6 redundantly promote Dhh1 association with Dcp2.</title><p>(<bold>A</bold>) Hierarchical clustering analysis of log<sub>2</sub>∆mRNA values conferred by the indicated mutations vs. wild-type (WT) for 741 of the 1052 mRNAs up- or down-regulated in <italic>scd6Δedc3Δ</italic> vs. WT cells for which RNA-Seq data was obtained in all five strains and with log<sub>2</sub>∆mRNA values &gt;-5 and &lt;5, conducted as in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, showing Spearman coefficients and p values for indicated correlations. (<bold>B</bold>) Notched box-plots of log<sub>2</sub>∆mRNA between the indicated mutants vs. WT for the 554 non-iESR mRNAs up-regulated by <italic>scd6Δedc3Δ</italic> vs. WT (shown in <xref ref-type="fig" rid="fig1">Figure 1B</xref>). (<bold>C</bold>) Ratios of capped to total mRNA abundance in transcript numbers per million reads (TPMs) (Relative C/T) in WT or <italic>scd6∆edc3∆</italic> cells plotted for all 5391 mRNAs, the 498 non-iESR mRNA_up_s6,e3, or 429 non-rESR mRNA_down_s6,e3 transcripts dysregulated by <italic>scd6Δedc3Δ</italic> vs. WT. (<bold>D</bold>) Notched box plots of the codon-protection index (CPI) for all mRNAs or for the sets of mRNAs up- or down-regulated by <italic>scd6Δedc3Δ</italic> vs. WT, including or excluding ESR transcripts, as indicated. (<bold>E</bold>) Notched box-plots showing log<sub>2</sub> changes in absolute mRNA abundance from External RNA Controls Consortium (ERCC) spike-in normalized RNA-Seq (left) or absolute Rpb1 occupancies averaged over the coding sequences (CDSs) from <italic>S. pombe</italic> chromatin spike-in normalized Rpb1 ChIP-Seq (right) in <italic>scd6Δedc3Δ</italic> vs. WT cells for all mRNAs or the 554 or 526 non-ESR mRNAs up- or down-regulated, respectively, by <italic>scd6Δedc3Δ</italic> vs. WT. (<bold>F</bold>) Co-immunoprecipitation analysis of Dhh1-Dcp2 association in yeast cell extracts. Transformants of <italic>DHH1-TAP</italic> strains H5695 (WT), H5696 (<italic>edc3Δ</italic>), H5697 (<italic>scd6Δ</italic>), and H5698 (<italic>edc3Δ scd6Δ</italic>) and the parental untagged strains all harboring single-copy plasmid pAK133 expressing HA-tagged Dcp2 were cultured in SC-Ura at 30°C and whole cell extracts were incubated with IgG sepharose beads to purify Dhh1-TAP and associated proteins. Washed beads were eluted by boiling in SDS loading buffer and eluates and input extracts were resolved in parallel by SDS-PAGE and subjected to immunoblot analysis to detect the tagged proteins. Immune complexes were visualized with enhanced chemiluminescence.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Relative and spike-in normalized Rpb1 occupancies from ChIP-seq analysis.</title><p>Sheets 1–2 labeled ‘Relative occs._replicates’ and ‘Relative occs._ Reps._averaged’ contain the processed data from ChIP-Seq analysis of Rpb1 in three biological replicates of wild-type (WT) and <italic>scd6∆edc3∆</italic> strains and the averaged data from combining the replicates, respectively, listing the relative occupancies averaged over the coding sequences for each expressed gene normalized to the average occupancy on each chromosome. Sheet ‘<italic>S. pombe</italic> norm. factor calcs,’ lists the calculations of normalization factors obtained from total numbers of reads aligned to the <italic>S. pombe</italic> genome for each chromatin sample spiked-in with equal aliquots of <italic>S. pombe</italic> chromatin prior to immunoprecipitation with Rpb1 antibodies. Factors are calculated for each individual replicate (col. E) or for the combined replicates for each strain (col. G). Sheets ‘Normalized occs._replicates’ and ‘Normalized occs._reps._avged’ list the spike-in normalized Rpb1 occupancies calculated for each replicate or the combined replicates for each strain, respectively, calculated using the respective normalization factors for individual or combined replicates determined in the previous two sheets.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>External RNA Controls Consortium (ERCC) spike-in normalized RNA-Seq data.</title><p>Sheet 1 lists the numbers of reads for each ERCC molecule identified in each RNA sample and calculations of the normalization factors for each sample. Sheet 2 lists the un-normalized reads for each yeast gene in each RNA sample, the ERCC-normalized reads for each sample, and the density of normalized reads for each gene calculated by normalizing for coding sequences (CDS) lengths. Sheets 2–4 list processed data from DESeq2, including log<sub>2</sub>Δ mRNA, p-value, and adj. p-value determined for each gene in the indicated mutant vs. wild-type (WT) strain, obtained by setting the size factor to unity.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig3-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Figures of the uncropped blots with the relevant bands labelled used to prepare <xref ref-type="fig" rid="fig3">Figure 3F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig3-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Original images of the full uncropped, unedited blots used to prepare <xref ref-type="fig" rid="fig3">Figure 3F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig3-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Supporting information for measurements of transcription and abundance of transcripts dysregulated in the <italic>scd6∆edc3∆</italic> double mutant.</title><p>(<bold>A</bold>) Reproducibility among biological replicates of Rpb1 ChIP-seq data. Log<sub>2</sub> values of relative Rpb1 occupancies averaged over the coding sequences (CDSs) for three replicates of wild-type (WT) or <italic>scd6Δedc3Δ</italic> cells for the mRNAs up- or down-regulated by <italic>scd6Δedc3Δ</italic> vs. WT, without excluding environmental stress response (ESR) transcripts. (<bold>B</bold>) Notched box-plots showing log<sub>2</sub> changes in absolute mRNA abundance from External RNA Controls Consortium (ERCC) spike-in normalized RNA-Seq (left) or relative mRNA abundance determined by DESeq2 analysis of RNA-Seq results (right) in <italic>scd6Δedc3Δ</italic> vs. WT cells for all mRNAs or the 554 or 526 non-ESR mRNAs up- or down-regulated, respectively, by <italic>scd6Δedc3Δ</italic> vs. WT.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Biological replicates of co-immunoprecipitation analysis of Dhh1-Dcp2 association in yeast cell extracts.</title><p>(<bold>i-ii</bold>) Results for two of three biological replicates of the experiment described in <xref ref-type="fig" rid="fig3">Figure 3F</xref>.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Figures of the uncropped blots with the relevant bands labelled used to prepare <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig3-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata2"><label>Figure 3—figure supplement 2—source data 2.</label><caption><title>Original images of the full uncropped, unedited blots used to prepare <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig3-figsupp2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Average median codon optimality scores and average median translational efficiency (TE) values in wild-type (WT) cells for mRNAs repressed in abundance by Scd6/Edc3 or Dhh1/Pat1.</title><p>(<bold>A</bold>) Notched box-plots of log<sub>2</sub>∆mRNA between <italic>scd6Δedc3Δ</italic> (left, cyan) or <italic>dhh1Δ</italic> (right, orange) vs. WT for six bins of all non-environmental stress response (ESR) mRNAs sorted according to stAI values, designated by the median stAI value for each bin, or for all non-ESR mRNAs (All). (<bold>B</bold>) tAI, stAI, and average CSC values for the 591 non-iESR mRNAs derepressed in abundance by the <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> mutations, the 1018 non-ESR mRNAs up-regulated by the <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> mutations, or all 5802 non-ESR mRNAs. (<bold>C</bold>) Log<sub>2</sub> values of TE determined in WT cells for the same groups of non-iESR mRNAs derepressed by the <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> mutations or by the <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> mutations analyzed in (<bold>A</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig3-figsupp3-v1.tif"/></fig></fig-group><p>Additional support that Scd6/Edc3 target mRNAs for decapping came from evidence that mRNAs up-regulated in the <italic>scd6Δedc3Δ</italic> mutant tend to accumulate in WT cells as decapped isoforms. Following decapping by Dcp1/Dcp2 mRNAs frequently undergo 5’ to 3’ decay co-translationally, with Xrn1 following behind the last translating ribosome loaded prior to decapping, and such decapped intermediates account for ~12% of all mRNAs in WT cells (<xref ref-type="bibr" rid="bib37">Pelechano et al., 2015</xref>). We reasoned that mRNAs preferentially targeted by Scd6/Edc3 for decapping and attendant degradation by Xrn1 should exhibit a greater than average proportion of decapped intermediates in WT cells. To test this, we conducted cap analysis of gene expression (CAGE) to quantify the abundances of all capped mRNA 5’ ends and compare them to total mRNA abundances determined by RNA-Seq conducted in parallel on biological replicates prepared from the WT and <italic>scd6∆edc3∆</italic> strains described above. Transcript numbers per million reads (TPMs) from CAGE (C) and RNA-Seq (T) were determined and C/T ratios calculated as a proxy for the proportion of capped molecules for each transcript (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>; <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). (Because the CAGE and RNA-Seq data were normalized separately, the C/T ratios are relative, not absolute, proportions of capped transcripts.) Importantly, the C/T ratios are lower in WT cells for the 498 non-iESR mRNAs up-regulated in the <italic>scd6Δedc3Δ</italic> double mutant compared to all expressed mRNAs (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, cols. 1 &amp; 5) in the manner expected for mRNAs preferentially targeted for decapping in WT cells. By contrast, the C/T ratios are higher than average for the non-rESR mRNAs that are down-regulated in relative abundance in <italic>scd6Δedc3Δ</italic> cells, as expected for an unusually low degree of decapping in WT (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, cols 3 &amp; 5). Importantly, these C/T ratios were elevated in <italic>scd6Δedc3Δ</italic> cells to nearly the same level for all three groups of mRNAs, which exceeds the ratios found in WT cells, in the manner expected from eliminating Scd6/Edc3-stimulated decapping (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, cf. cols. 2, 4, 6). Similar results were obtained for these same groups of dysregulated mRNAs by analyzing our previous CAGE data obtained for the <italic>dhh1∆</italic> mutant (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E</xref>). These findings are consistent with the notion that impaired decapping dependent on Scd6/Edc3 and Dhh1 is an important driver of increased mRNA abundance in the <italic>scd6Δedc3Δ</italic> mutant.</p><p>Independent evidence for this last conclusion was provided by analyzing the codon protection indices (CPI) of mRNAs up-regulated by <italic>scd6Δedc3Δ</italic>, an indicator of co-translational decay by Xrn1. Decapped degradation intermediates exhibit three-nucleotide periodicity generated by precise Xrn1 cleavage up to the last translating ribosome at the 5’ end of mRNA, and the CPI quantifies the prevalence of such intermediates for each mRNA (<xref ref-type="bibr" rid="bib37">Pelechano et al., 2015</xref>). Importantly, the mRNA_up_s6,e3 transcripts (whether including or excluding ESR mRNAs) exhibit higher than average median CPIs, indicating a greater than average involvement of decapping and co-translational degradation by Xrn1 in their decay, whereas mRNA_dn_s6,e3 transcripts exhibit lower than average CPI values, consistent with an alternative degradation pathway controlling their abundance <italic>scd6Δedc3Δ</italic> (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><p>To determine whether increased transcription contributes to increased abundance of mRNAs up-regulated by <italic>scd6∆edc3∆</italic>, we performed ChIP-Seq analysis of Rpb1 to measure RNA Polymerase II (Pol II) occupancies averaged across the CDS of every gene, obtaining highly reproducible results across replicates (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). To quantify absolute changes in Pol II occupancies, <italic>S. pombe</italic> chromatin was added to each <italic>S. cerevisiae</italic> chromatin sample prior to immunoprecipitation. To measure absolute changes in mRNA abundance, we re-analyzed the RNA-Seq data taking into account the recovery of External RNA Controls Consortium (ERCC) transcripts that were added to each total RNA sample prior to preparation of cDNA libraries, yielding highly reproducible normalized values among replicates (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>). Interrogating the non-ESR mRNAs up- or down-regulated by <italic>scd6Δedc3</italic> revealed a 2.79-fold increase in median normalized mRNA abundance for the non-iESR mRNA_up_s6,e3 group that was associated with only a 1.2-fold increase in normalized Rpb1 occupancies (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, cols. 1 &amp; 4). The down-regulated non-rESR mRNA_dn_s6,e3 transcripts showed 12% and 7% decreases in spike-in normalized median mRNA abundance and Rpb1 occupancies, respectively (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, cols. 2 &amp; 5). Because the majority of total RNA is rRNA, the ERCC normalization effectively yields the abundance of each mRNA relative to rRNA, and the ribosome content per cell is expected to be reduced in the <italic>scd6∆edc3∆</italic> mutant owing to repression of rESR mRNAs encoding ribosomal proteins and biogenesis factors (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). We showed previously that the isogenic <italic>dcp2∆</italic> mutant displays an ESR response of similar magnitude and a 30% reduction in ribosomal subunits per cell compared to the same WT examined here (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). Assuming a similar reduction in ribosome abundance in <italic>scd6∆edc3∆</italic> cells, the absolute changes in mRNA per cell conferred by <italic>scd6∆edc3∆</italic> are expected to be 0.7-fold of the ERCC-normalized values given in <xref ref-type="fig" rid="fig3">Figure 3E</xref>, yielding fold changes of 2.0 and 0.62 for the mRNA_up_s6,e3 and mRNA_dn_s6,e3 groups, respectively. Because these predicted changes in mRNA per cell still differ substantially from the corresponding changes in normalized Rpb1 occupancies of 1.2 and 0.93, respectively, there is only a small contribution of altered transcription to the altered abundance of transcripts dysregulated in the double mutant.</p><p>Our findings above that the <italic>scd6∆edc3∆</italic> and <italic>dhh1∆</italic> mutations up-regulate highly similar sets of mRNAs (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) is consistent with a previous proposal that recruitment of Dhh1 to Dcp2 can be mediated interchangeably by Edc3 or Scd6 bound to the same site in the Dcp2 CTT (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>). To test this model, we asked whether the association of Dhh1 with Dcp2 in cell extracts is impaired only when both Edc3 and Scd6 are eliminated. Indeed, co-immunoprecipitation of HA-tagged Dcp2 with TAP-tagged Dhh1 was reduced in <italic>scd6∆edc3∆</italic> cells but not in either single mutant in replicate experiments (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, lanes 2–4; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2(i-ii)</xref>). The residual association in the double mutant suggests that Dhh1 can interact with Dcp2 either directly or via Pat1 in addition to the interaction mediated by Scd6/Edc3, which might explain why a small fraction of mRNAs are up-regulated by <italic>dhh1∆</italic> but not by <italic>scd6∆edc3∆</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p></sec><sec id="s2-4"><title>Slow rates of translation initiation or elongation generally do not dictate preferential decapping/decay by the decapping activators</title><p>Codon non-optimality has been linked with Dhh1-mediated mRNA decay partly by demonstrating that the sTAI values of mRNAs, which quantify their overall codon optimality (<xref ref-type="bibr" rid="bib43">Sabi and Tuller, 2014</xref>), are inversely correlated with the changes in mRNA abundance observed in <italic>dhh1Δ</italic> versus WT cells (<xref ref-type="bibr" rid="bib40">Radhakrishnan et al., 2016</xref>). Similarly, analyzing the mRNA changes conferred by the <italic>scd6Δedc3Δ</italic> mutation for all non-ESR transcripts reveals a small but statistically significant negative correlation with sTAI values (Pearson r of –0.085, <italic>p</italic>=2 ×10<sup>–9</sup>) similar to that observed for the <italic>dhh1Δ</italic> mutation (<italic>r</italic>=–0.071, <italic>p</italic>=6 ×10<sup>–6</sup>) (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>, cyan vs. orange), indicating a tendency for mRNAs with lower codon optimality/sTAI scores to show greater increases in relative abundance in response to <italic>scd6Δedc3Δ</italic> or <italic>dhh1Δ</italic>. However, the 591 non-iESR mRNAs up-regulated by the <italic>scd6Δ/edc3Δ</italic> mutations (from <xref ref-type="fig" rid="fig1">Figure 1B</xref>) have a median sTAI value (0.35) nearly identical to that of all nonESR mRNAs, which is also the case for the group of 1018 mRNAs up-regulated by the <italic>pat1Δ</italic> or <italic>dhh1</italic> mutations (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>). Similar results were obtained for other metrics of codon optimality, tAI and average CSC (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>), suggesting that poor codon optimality is not a key property defining the mRNAs repressed most extensively by these decapping activators. It has also been proposed that competition between translation initiation and mRNA decay, rather than codon optimality and elongation, is a major determinant of mRNA stability in yeast (<xref ref-type="bibr" rid="bib31">Muhlrad et al., 1995</xref>; <xref ref-type="bibr" rid="bib27">LaGrandeur and Parker, 1999</xref>; <xref ref-type="bibr" rid="bib44">Schwartz and Parker, 1999</xref>; <xref ref-type="bibr" rid="bib7">Chan et al., 2018</xref>). However, the mRNAs up-regulated in the <italic>scd6Δ/edc3Δ</italic> or <italic>pat1Δ/dhh1</italic> mutants have slightly greater than average median translational efficiencies (TEs) in WT cells (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>), as determined by ribosome profiling experiments described below. Thus, neither slow rates of translation initiation nor pausing during elongation at non-optimal codons appears to dictate preferential targeting of the mRNAs most strongly repressed by these four decapping activators.</p></sec><sec id="s2-5"><title>Scd6 and Edc3 act redundantly and cooperate more extensively with Dhh1 than Pat1 in controlling translation of individual mRNAs</title><p>The changes in mRNA abundance described above were highly correlated with changes in RPF abundance determined by Ribo-Seq analysis for the <italic>scd6Δedc3Δ</italic> mutant compared to WT for all expressed transcripts, with an r value of 0.81 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>), providing strong mutual validation of the RNA-Seq and Ribo-Seq data for these strains. Nevertheless, the fact that this correlation is weaker than that observed between biological replicates of RNA-Seq or Ribo-Seq data (r values &gt;0.95, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–B</xref>) suggests that certain mRNAs exhibit altered translational efficiencies in the double mutant. Indeed, DESeq2 analysis of the Ribo-Seq data identified 184 mRNAs showing TE increases of &gt;1.41 fold at FDR &lt;0.10 in the <italic>scd6Δedc3Δ</italic> strain (dubbed TE_up_s6,e3) but only 42, or a single mRNA, in the <italic>scd6∆</italic> and <italic>edc3Δ</italic> single mutants, respectively (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), suggesting that Scd6 and Edc3 have overlapping functions in repressing the translation of particular mRNAs. Supporting this, a group of 169 mRNAs translationally up-regulated exclusively in the <italic>scd6Δedc3Δ</italic> double mutant exhibits only modest TE increases in the two single mutants (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>, sectors (iii)). <italic>SPI1,</italic> encoding a cell wall protein, is a representative transcript displaying increased mRNA abundance coupled with an even greater increase in RPF abundance that confers a TE increase of ~ threefold only in the double mutant (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). As expected, the 28 mRNAs showing substantial TE increases only in <italic>scd6Δ</italic> cells show no increase in median TE in the <italic>edc3Δ</italic> strain (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>, sectors (i)) and thus appear to be translationally repressed by Scd6 alone.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Most mRNAs translationally up-regulated in <italic>scd6∆edc3∆</italic> cells exhibit Scd6/Edc3 functional redundancy for repressing translational efficiency (TE) and show correlated changes in TE and protein abundance.</title><p>(<bold>A</bold>) Venn diagram of overlap between the 184 and 42 mRNAs in the TE_up groups identified in the <italic>scd6Δedc3Δ</italic> vs. wild-type (WT) or <italic>scd6Δ</italic> vs. WT comparisons, respectively. Fold-enrichment and p value from the hypergeometric distribution are indicated for the overlap. (<bold>B</bold>) Notched box-plots of log<sub>2</sub>∆TE values between the indicated mutants vs. WT for the mRNAs belonging to sectors (i) or (iii) of the diagram in (<bold>A</bold>). (<bold>C</bold>) Gene browser image for <italic>SPI1</italic> presented as in <xref ref-type="fig" rid="fig1">Figure 1D</xref>, except also giving the TE changes for each mutant vs. WT on the lower right. (<bold>D</bold>) Density scatterplot of log<sub>2</sub>∆RPF values measured by ribosome profiling vs. log<sub>2</sub>∆protein values measured by TMT mass spectrometry (TMT-MS) for 4339 mRNAs for which data were obtained in both analyses, indicating the Pearson correlation coefficient (r) and p-value of the correlation. (<bold>E–F</bold>) Notched box-plots of log<sub>2</sub>∆protein values from TMT-MS analysis between the <italic>scd6Δedc3Δ</italic> mutant vs. WT for the 843 and 839 mRNAs belonging to the Ribo_up or Ribo_down groups, respectively (<bold>D</bold>), or the 184 and 152 TE_up or TE_down mRNA groups (<bold>E</bold>) determined for the <italic>scd6Δedc3Δ</italic> mutant vs. WT, or for all mRNAs, for which TMT-MS data was obtained.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig4-v1.tif"/></fig><p>We explored next whether the increased ribosome occupancies observed in the <italic>scd6Δedc3Δ</italic> mutant are associated with increased protein synthesis by conducting TMT mass spectrometry (TMT-MS) of total cell proteins to obtain ratios of peptide abundance in the <italic>scd6Δedc3Δ</italic> strain vs. WT for &gt;4000 different proteins (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>). Importantly, significant correlations exist between changes in protein abundance and RPFs across the translatome (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Moreover, mRNAs showing increased or decreased RPFs in <italic>scd6Δedc3Δ</italic> vs. WT cells (&gt;1.5 fold, FDR &lt;0.05, Ribo_up and Ribo_dn) likewise exhibit increased or decreased median protein abundances determined by TMT-MS (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). These results suggest that increased ribosome occupancies measured by Ribo-Seq, which could occur by increases in mRNA, TE, or both, are generally associated with increased synthesis of the encoded proteins in <italic>scd6Δedc3Δ</italic> cells.</p><p>It was possible that translational repression by Edc3/Scd6 generally occurs by slowing elongation, leading to increased ribosome densities (RPF/mRNA ratios, i.e. calculated TEs) in WT cells and decreased TE values in <italic>scd6Δedc3Δ</italic> cells that would be associated with increased protein expression. In this scenario, changes in TEs would be inversely associated with changes in protein expression. Instead, mRNAs showing increased or decreased TEs in the double mutant (TE_up_s6,e3 and TE_dn_s6,e3 transcripts defined above) also exhibit increased or decreased protein expression in <italic>scd6Δedc3Δ</italic> vs. WT cells (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), implying that Scd6/Edc3 generally influence translation at the initiation step.</p><p>We previously identified 274 mRNAs whose TEs are up-regulated in the <italic>pat1Δ, dhh1Δ,</italic> or <italic>pat1Δdhh1Δ</italic> mutants by the same criteria employed here (&gt;1.41 fold at FDR &lt;0.10) (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). Interestingly, these mRNAs overlap significantly with those translationally up-regulated in the single or double <italic>scd6Δ/edc3Δ</italic> mutants (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The 76 mRNAs common to both groups show larger TE increases in the <italic>scd6Δedc3Δ</italic> mutant compared to the 136 transcripts up-regulated exclusively in the <italic>scd6Δ/edc3Δ</italic> mutants (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>, sectors (ii) vs. sectors (i), cyan data). These 76 mRNAs also show marked TE increases in the <italic>dhh1Δ, pat1Δ</italic>, and <italic>pat1Δdhh1Δ</italic> mutants (<xref ref-type="fig" rid="fig5">Figure 5B(ii)</xref>), indicating that all four decapping activators are required for efficient translational repression of these mRNAs in WT cells. The 136 mRNAs significantly up-regulated only in the <italic>scd6Δ/edc3Δ</italic> mutants show a moderate increase in median TE in <italic>dhh1∆</italic> cells, but little response to <italic>pat1∆</italic> (<xref ref-type="fig" rid="fig5">Figure 5B(i)</xref>). The 198 mRNAs up-regulated only in the <italic>pat1Δ/dhh1Δ</italic> mutants show only a small TE increase in the <italic>scd6Δedc3Δ</italic> strain and cumulative TE increases in the <italic>pat1Δdhh1Δ</italic> double mutant (<xref ref-type="fig" rid="fig5">Figure 5B(iii)</xref>). In summary, similar to our findings for repression of mRNA abundance, efficient translational repression of certain mRNAs requires the combined functions of Pat1, Dhh1, and either Scd6 or Edc3, whereas other mRNAs are translationally repressed by either Edc3/Scd6 or Pat1 with appreciable contributions from Dhh1.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Most mRNAs translationally up-regulated in the <italic>scd6∆edc3∆</italic> mutant are also translationally up-regulated by <italic>dhh1Δ</italic> or <italic>pat1Δ</italic>.</title><p>(<bold>A</bold>) Venn diagram of overlap between all 212 mRNAs translationally up-regulated by <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> (defined in <xref ref-type="fig" rid="fig4">Figure 4</xref>) or all 274 mRNAs translationally up-regulated by <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> vs. wild-type (WT) identified previously (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). Fold-enrichment and p value from the hypergeometric distribution are indicated for the overlap. (<bold>B</bold>) Notched box plots of log<sub>2</sub>∆TE values between the indicated mutants vs. WT for the mRNAs belonging to the specified sectors of the diagram in (<bold>A</bold>). (<bold>C</bold>) Hierarchical clustering analysis of log<sub>2</sub>∆TE values conferred by the indicated mutations vs. WT for 222 of the 336 mRNAs translationally up- or down-regulated in <italic>scd6Δedc3Δ</italic> vs. WT cells for which RNA-Seq and Ribo-Seq data were obtained in all five strains and with log<sub>2</sub>∆TE values &gt;-5 and &lt;5 conducted as in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, including the Spearman coefficients (ρ) and p values for the indicated correlations. (<bold>D</bold>) Notched box-plots of log<sub>2</sub>∆TE values between the indicated mutants vs. WT for the 54 mRNAs showing &gt;2 fold translational efficiency (TE) increases conferred by both <italic>scd6Δedc3Δ</italic> and <italic>pat1Δdhh1Δ</italic> mutations vs. WT. (<bold>E</bold>) Relative Dhh1 occupancies from the Dhh1 RIP-seq experiments of <xref ref-type="bibr" rid="bib30">Miller et al., 2018</xref> for the 212 and 274 mRNAs identified as TE_up in the <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> mutants, or the <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> mutants, vs. WT, respectively (cols 1–2), or for the 591 and 1018 mRNAs identified as mRNA_up in either the <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> mutants, or the <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> mutants, vs. WT, respectively (cols. 3–4).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Properties of mRNAs translationally repressed by Scd6/Edc3 or Dhh1/Pat1.</title><p>(<bold>A</bold>) Notched box-plots of log<sub>2</sub>∆mRNA values between the indicated mutants vs. wild-type (WT) for the translationally up-regulated mRNAs belonging to the specified sectors of the diagram in <xref ref-type="fig" rid="fig5">Figure 5A</xref>. (<bold>B</bold>) Notched box plots of log<sub>2</sub>∆TE values between the indicated mutants vs. WT for the mRNAs belonging to the 591 non-iESR mRNAs derepressed in abundance by <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> vs. WT (cols. 1–4) or the 1018 non-ESR mRNAs up-regulated by <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> vs. WT (cols. 5–8). (<bold>C</bold>) Box plot of log<sub>2</sub> values of TE determined in WT cells for the translationally up-regulated mRNAs belonging to the specified sectors of the diagram in <xref ref-type="fig" rid="fig5">Figure 5A</xref>, the 54 mRNAs showing &gt; twofold translational efficiency (TE) increases conferred by both <italic>scd6Δedc3Δ</italic> and <italic>pat1Δdhh1Δ</italic> mutations vs. WT, or for all mRNAs. (<bold>D</bold>) Box-plot of ratios of capped to total mRNA abundance in transcript numbers per million reads (TPMs) (Relative C/T) in WT cells for the translationally up-regulated mRNAs belonging to the specified sectors of the diagram in <xref ref-type="fig" rid="fig5">Figure 5A</xref>, or for all mRNAs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Greater cooperation of Scd6/Edc3 with Dhh1 vs. Pat1 in controlling translation was again revealed by clustering analysis of TE changes in different mutants for the mRNAs exhibiting altered TEs in the <italic>scd6Δ/edc3Δ</italic> mutants, with greater similarity between TE changes conferred by <italic>scd6Δedc3Δ</italic> vs. <italic>dhh1Δ</italic> (ρ=0.82) compared to <italic>scd6Δedc3Δ</italic> vs. <italic>pat1Δ</italic> (ρ=0.68) or <italic>scd6Δedc3Δ</italic> vs. <italic>pat1Δdhh1Δ</italic> (ρ=0.69) cells (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). However, as noted above, the group showing the strongest up-regulation of TEs in the <italic>scd6Δedc3Δ</italic> double mutant tends to be highly up-regulated in all three of the other mutants lacking Dhh1 or Pat1 (bracketed mRNAs at the top of <xref ref-type="fig" rid="fig5">Figure 5C</xref>), as shown in <xref ref-type="fig" rid="fig5">Figure 5D</xref> for a group of 54 mRNAs whose TEs are up-regulated by 2.0-fold or more in both the <italic>scd6Δedc3Δ</italic> and <italic>pat1Δdhh1Δ</italic> double mutants. Thus, although Scd6/Edc3 appear to cooperate more extensively with Dhh1 than Pat1 in translational control, the subset of 50–60 mRNAs exhibiting the strongest repression by Scd6/Edc3 or Pat1/Dhh1 requires the concerted functions of Pat1, Dhh1, and either Scd6 or Edc3 to achieve their strong translational repression in WT cells.</p><p>To assess whether mRNAs translationally repressed by the decapping activators are also targeted for degradation by these factors, we examined mRNA changes for the groups of mRNAs exhibiting TE up-regulation in the <italic>scd6Δ/edc3Δ</italic> or <italic>pat1Δ/dhh1Δ</italic> mutants (sectors (i) to (iii) of <xref ref-type="fig" rid="fig5">Figure 5A</xref>). The mRNAs showing increased TEs only in the <italic>pat1∆/dhh1Δ</italic> strains show little change in mRNA abundance in these mutants (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A(iii)</xref>), indicating selective repression of translation vs degradation. Similarly, mRNAs translationally up-regulated only in the <italic>scd6∆/edc3Δ</italic> mutants show little change in mRNA abundance in the <italic>scd6∆edc3Δ</italic> strain and only a modest up-regulation in the <italic>pat1∆/dhh1Δ</italic> mutants (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A(i)</xref>). In contrast, the transcripts showing increased TEs in all of the mutants also show markedly increased abundance in the same mutants (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A(ii)</xref>). Thus, coupled repression of translation and abundance by the decapping factors occurs only for the subset of transcripts exhibiting concerted translational repression by all four factors. In contrast, the much larger groups of transcripts defined above showing increased mRNA abundance in the mutants (described in <xref ref-type="fig" rid="fig2">Figure 2A</xref>) exhibit little change in median TE in all four mutants (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>), suggesting that most mRNAs targeted for enhanced turnover do not exhibit translational repression of the undegraded transcripts remaining in WT cells.</p><p>We next examined the native translational efficiencies of mRNAs translationally repressed by Scd6/Edc3 by interrogating the Ribo-Seq data for WT cells on rich medium. The mRNAs translationally repressed by Scd6/Edc3 in concert with Pat1/Dhh1 tend to be poorly translated in WT, having a substantially lower median relative TE compared to all mRNAs (0.24 vs 0.95) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>, col. 2), thus resembling the mRNAs translationally repressed exclusively by Dhh1/Pat1 (in col. 3). In contrast, the transcripts translationally repressed exclusively by Edc3/Scd6 are generally well translated, exhibiting a ~2.5 fold greater than average median TE in WT cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>, col. 1). Consistent with this distinction, gene ontology (GO) analysis revealed that products of the 136 mRNAs translationally repressed exclusively by Scd6/Edc3 are enriched for cytoplasmic or mitochondrial ribosomal proteins (<italic>p</italic>=1 ×10<sup>–7</sup>), whereas products of the 76 transcripts repressed interdependently by Scd6/Edc3/Pat1/Dhh1 are enriched for factors involved in fermentation (<italic>p</italic>=2 ×10<sup>–7</sup>), carbohydrate metabolism (<italic>p</italic>=1 ×10<sup>–6</sup>) or metabolism of non-protein amino acids (<italic>p</italic>=3 ×10<sup>–6</sup>). Thus, Scd6/Edc3 translationally repress distinct groups of mRNAs depending on whether Dhh1/Pat1 participate in the repression.</p><p>We showed previously (<xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>) that mRNAs up-regulated by <italic>dhh1∆</italic> are enriched for Dhh1 protein association in vivo, as judged by RIP-Seq analysis of yeast mRNAs using antibodies against Dhh1 (<xref ref-type="bibr" rid="bib30">Miller et al., 2018</xref>), thus providing evidence for a direct role of Dhh1 in decapping/degradation of these transcripts. The same observation was made for the mRNAs up-regulated by <italic>pat1∆,</italic> consistent with widespread cooperation between Dhh1 and Pat1 in repressing mRNA abundance (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). Interestingly, here we observed greater than average Dhh1 occupancies for all four mRNA groups defined above (in <xref ref-type="fig" rid="fig2">Figure 2A</xref> or <xref ref-type="fig" rid="fig5">Figure 5A</xref>) that are up-regulated in transcript abundance or TE by the <italic>scd6∆/edc3∆</italic> or <italic>dhh1∆/pat1∆</italic> mutations (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). This finding is consistent with the fact that Dhh1 contributes to repressing the abundance or TE of the majority of transcripts in these groups (<xref ref-type="fig" rid="fig2">Figures 2B</xref> and <xref ref-type="fig" rid="fig5">5B</xref>, orange data). It is possible that Dhh1 is recruited to most of these mRNAs in a complex with Dcp1:Dcp2 and other decapping activators (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>), but contributes differentially to their degradation or translational repression.</p></sec><sec id="s2-6"><title>Scd6/Edc3 post-transcriptionally repress mRNAs encoding enzymes for respiration and catabolism of non-glucose carbon sources in rich medium</title><p>Recently, we reported that mRNAs up-regulated in abundance or TE in the <italic>dcp2∆, pat1∆,</italic> and <italic>dhh1∆</italic> mutants are enriched for mitochondrial proteins that function in Ox. Phos. (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>; <xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). GO analysis led to the same finding here for the non-iESR mRNAs up-regulated in abundance by the <italic>scd6Δ/edc3Δ</italic> mutations, including many of the same categories of mitochondrial functions enriched among the mRNAs up-regulated by <italic>dhh1Δ/pat1Δ</italic> mutations (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–B</xref>, green type). GO analysis of genes showing increased ribosome occupancies (RPFs), indicating either increased mRNA abundance or TE, confirms that the <italic>scd6Δ/edc3Δ</italic> mutations derepress the translation of Ox. Phos. gene transcripts (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C–D</xref>, green). Examining a collection of Ox. Phos. genes functioning in electron transport, the TCA cycle, or mitochondrial ATP synthase reveals that the <italic>scd6Δedc3Δ</italic> and <italic>pat1Δdhh1Δ</italic> double mutations up-regulate expression of these genes primarily at the level of mRNA abundance, with small additional increases in TE (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Western blot analysis revealed increased expression of four Ox. Phos. proteins (Qcr8, Atp20, Idh1, and Sdh4), two proteins (Cox14 and Cox20) involved in cytochrome c oxidase assembly, and mitochondrial cytochrome b2 (Cyb2) required for lactate utilization in <italic>scd6Δedc3Δ</italic> cells, relative to Gcd6 examined as loading control (<xref ref-type="fig" rid="fig6">Figure 6B–C</xref>). Results similar to these were obtained for the same mitochondrial proteins in the <italic>dhh1∆</italic> and <italic>pat1∆</italic> mutants (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>) and for a subset in <italic>dcp2∆</italic> cells (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). Importantly, we also observed increased expression of Cox2, a mitochondrially encoded subunit of cytochrome <italic>c</italic> oxidase, terminal enzyme of the mitochondrial ETC, whose expression correlates with mitochondrial activity (<xref ref-type="bibr" rid="bib52">Vengayil et al., 2024</xref>). Except for <italic>dcp2∆</italic>, all the decapping mutants had significantly increased Cox2 protein (<xref ref-type="fig" rid="fig6">Figure 6D</xref>), suggesting an increase in ETC activity in these mutants. Up-regulation of mRNA and RPF abundance in <italic>scd6Δedc3Δ</italic> and <italic>pat1Δdhh1Δ</italic> double mutants also occurred for enzymes of the glyoxylate cycle (<xref ref-type="fig" rid="fig6">Figure 6E</xref>), which catalyze certain reactions of the TCA cycle in the cytoplasm to support gluconeogenesis during respiratory growth on two-carbon compounds; and the increased expression of one such enzyme, Cit2, was confirmed by Western analysis (<xref ref-type="fig" rid="fig6">Figure 6B–C</xref>). Both Ox. Phos. and the glyoxylate cycle normally operate at low levels in yeast growing with abundant glucose, as in our experiments, suggesting that Scd6/Edc3 cooperate with Dhh1/Pat1 to help suppress these pathways in glucose-replete cells.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Scd6/Edc3 post-transcriptionally repress proteins involved in respiration and suppress mitochondrial membrane potential in rich medium.</title><p>(<bold>A</bold>) Log<sub>2</sub> changes in mRNA, ribosome-protected fragments (RPFs), or translational efficiency (TE) conferred by the indicated double mutations vs. wild-type (WT) for 53 nuclear genes encoding mitochondrial proteins involved directly in oxidative phosphorylation. (<bold>B–C</bold>) Western blot analysis of nine mitochondrial proteins and Gcd6 (examined as loading control) in WT and <italic>scd6Δedc3Δ</italic> strains, cultured in duplicate in YPD medium to OD<sub>600</sub> of ~0.6–0.8. WCEs were extracted under denaturing conditions and aliquots corresponding to 1 X or 2 X amounts of WCE were loaded in successive lanes for the two biological replicate cultures. Immune complexes were visualized with enhanced chemiluminescence (<bold>B</bold>). Signals for each protein were quantified, normalized to the corresponding signals for Gcd6 in the same extract and expressed relative to the resulting values for WT cells. Mean values and standard errors are plotted (<bold>C</bold>). (<bold>D</bold>) Western blot analysis of Cox2 in strains of the indicated genotypes in cells cultured as in (<bold>B</bold>). Cox2 signal intensity was normalized to total Coomassie-stained protein and the resulting relative Cox2 protein levels from three biological replicates were averaged and plotted. P-values from student’s t-test indicated as **,&lt;0.01; *,&lt;0.05; ns, not significant. (<bold>E</bold>) Log<sub>2</sub> changes in mRNA, RPFs, or TE conferred by the indicated double mutations vs. WT for 22 genes encoding enzymes of the glyoxylate cycle or fatty acid metabolism. (<bold>F</bold>) Expression of the <italic>CYC1-lacZ</italic> reporter on plasmid pLG265, lacking UAS1 and containing the optimized version of UAS2, UAS2UP1, in the WT strain grown on SC-Ura medium containing either 2% glucose or 3% glycerol/2% ethanol as carbon sources (i), or in WT and the indicated mutant strains on SC-Ura with 2% glucose (ii). β-galactosidase activity (nmoles of o-nitrophenyl-β-D-galactopyranoside (ONPG) cleaved per min per mg of total protein) was measured in whole cell extracts for three biological replicates of each strain and the mean values were normalized to the mean activity measured in WT grown with glucose as carbon source. **<italic>p</italic>-value &lt;0.01 from student’s t-test; ns, not significant. (<bold>G</bold>) Measurements of mitochondrial membrane potential. WT cells or transformants of the <italic>scd6Δedc3Δ</italic> mutant containing the <italic>EDC3</italic> plasmid pLfz614-7 or empty vector were cultured in SC-Ura to mid-log phase. Tetramethylrhodamine (TMRM) (500 nM) was added and incubated for 30 min before samples were collected and washed once with deionized water. ∆Ψ<sub>m</sub> was determined by measuring TMRM fluorescence intensity using flow cytometry. Data are presented in arbitrary fluorescence intensity units per OD<sub>600</sub>. Two-way ANOVA was used for statistical analysis and data are given as mean values ± SD (n=3) (****<italic>p</italic>&lt;0.0001).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Western blot analysis and <italic>lacZ</italic> reporter analysis of <italic>scd6∆edc3∆</italic> vs. wild-type (WT) strains.</title><p>Sheet ‘<xref ref-type="fig" rid="fig6">Figure 6B–C</xref> Western analysis’ lists averages of band intensities normalized to the loading control (Gcd6) on the same blots and the corresponding S.E.M. values calculated from the replicates for each protein analyzed in <xref ref-type="fig" rid="fig6">Figure 6B–C</xref>. Sheet ‘<xref ref-type="fig" rid="fig6">Figure 6D</xref> Western analysis’ lists the Cox2 band intensities normalized to total stained proteins and the ratios of normalized Cox2 for each mutant vs. WT. Sheet ‘<xref ref-type="fig" rid="fig6">Figure 6F</xref>’ lists the specific activities of β-galactosidase determined from three biological replicates of each strain harboring the <italic>CYC1-lacZ</italic> reporter analyzed in <xref ref-type="fig" rid="fig6">Figure 6F</xref>. Sheet ‘<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>’ lists the specific activities of β-galactosidase determined from three biological replicates of each strain harboring the <italic>ADH2-lacZ</italic> reporter analyzed in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig6-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Figures of the uncropped blots with the relevant bands labelled used to prepare <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig6-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Original images of the full uncropped, unedited blots used to prepare <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig6-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Figures of the uncropped blots with the relevant bands labelled used to prepare <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig6-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata5"><label>Figure 6—source data 5.</label><caption><title>Original images of the full uncropped, unedited blots used to prepare <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102287-fig6-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>mRNAs repressed in abundance or translation by Scd6/Edc3 or Dhh1/Pat1 are enriched for common functional categories, including Ox. Phos. proteins and cell wall components.</title><p>(<bold>A–B</bold>) Functional categories showing enrichment for genes encoding the 591 non-iESR mRNAs derepressed in abundance by <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> vs. wild-type (WT) or the 1018 non-ESR mRNAs up-regulated by <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> vs. WT, using color-coding to indicate related functions or cellular components, conducted using the Web-based tool FunSpec and applying the Bonferroni correction and <italic>p</italic>&lt;0.05 cutoff. (<bold>C–D</bold>) Functional categories showing enrichment for genes encoding the 853 mRNAs with RPFs up-regulated by <italic>scd6Δ, edc3Δ</italic>, or <italic>scd6Δedc3Δ</italic> vs. WT or the 1350 mRNAs with ribosome-protected fragments (RPFs) up-regulated by <italic>dhh1Δ, pat1Δ</italic>, or <italic>pat1Δdhh1Δ</italic> vs. WT, analyzed as in (A-B).</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Source table for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig6-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Scd6/Edc3 post-transcriptionally repress carbon-catabolite-repressed (CCR) genes in rich medium.</title><p>(<bold>A</bold>) Log<sub>2</sub> changes in mRNA, ribosome-protected fragments (RPFs), or translational efficiency (TE) conferred by the indicated double mutations vs. wild-type (WT) for 106 genes subject to carbon catabolite repression or activated by transcription factors Adr1 or Cat8. (<bold>B</bold>) Notched box-plots showing log<sub>2</sub>∆RPFs or log<sub>2</sub>∆Rpb1 relative occupancies averaged over the coding sequences (CDSs) in <italic>scd6Δedc3Δ</italic> vs. WT cells for the same Ox-Phos (left) or CCR genes (right) analyzed in <xref ref-type="fig" rid="fig6">Figures 6A</xref> and <xref ref-type="fig" rid="fig7">7A</xref>, respectively. (<bold>C</bold>) Expression of the <italic>ADH2-lacZ</italic> reporter on plasmid pLGADH2, containing the entire <italic>ADH2</italic> 5’ non-coding region, in the WT strain grown on SC-Ura medium containing either 2% glucose or 3% glycerol/2% ethanol as carbon sources (i), or in WT and the indicated mutant strains on SC-Ura cultured with 2% glucose (ii). For (ii), mean values of β-galactosidase activity measured for three biological replicates of each strain were normalized to the mean value measured for WT cells. **<italic>p</italic>-value &lt;0.01 from student’s t-test; ns, not significant. (<bold>D</bold>) Log<sub>2</sub> changes in RPFs for 93 genes encoding amino acid biosynthetic enzymes in the indicated mutants vs. WT.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Synthetic genetic up-regulation of four Dhh1 target mRNAs on combining <italic>scd6∆</italic> and <italic>edc3∆</italic> mutations.</title><p>RNA-seq results obtained here for the four Dhh1 target mRNAs, two of which were designated as Pat1 targets as well (last column), identified by <xref ref-type="bibr" rid="bib21">He et al., 2022</xref>, in the <italic>scd6∆, edc3∆,</italic> and <italic>scd6∆edc3∆</italic> mutants vs. wild-type (WT). The log<sub>2</sub>∆mRNA values for each of the three mutants vs. WTs are listed together with the false discovery rate (FDR) values and color-coded according to derepression ratios.</p><p><supplementary-material id="fig6s3sdata1"><label>Figure 6—figure supplement 3—source data 1.</label><caption><title>Source table for <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig6-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig6-figsupp3-v1.tif"/></fig></fig-group><p>Consistent with post-transcriptional control of Ox. Phos. genes, the median relative RPF levels were up-regulated in the <italic>scd6Δedc3Δ</italic> mutant substantially more than the increases in relative Pol II occupancies observed at the cognate genes by ChIP-Seq analysis of Rpb1 (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>, cols. 1–2). Moreover, the transcription factors responsible for induction of Ox. Phos. genes, the Hap2/Hap3/Hap4/Hap5 complex, were not activated in <italic>scd6Δedc3Δ</italic> cells: expression of a <italic>CYC1-lacZ</italic> reporter activated by this complex (<xref ref-type="bibr" rid="bib12">Forsburg and Guarente, 1989</xref>) was not elevated in the <italic>scd6Δ/edc3Δ</italic> mutants in glucose-containing medium (<xref ref-type="fig" rid="fig6">Figure 6F(ii)</xref>) but showed the expected induction in WT cells grown with glycerol/ethanol versus glucose (<xref ref-type="fig" rid="fig6">Figure 6F(i)</xref>; <xref ref-type="bibr" rid="bib3">Broach, 2012</xref>). These findings support the notion that reduced decapping stabilizes Ox. Phos. gene transcripts in <italic>scd6Δedc3Δ</italic> cells.</p><p>In addition to Ox. Phos., GO analysis of genes up-regulated in RPF abundance in the <italic>scd6Δ/edc3Δ</italic> mutants revealed enrichment for utilization of alternative carbon sources (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>), as observed recently for <italic>dhh1Δ/pat1Δ</italic> mutants (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). Consistent with this, 83 carbon catabolite down-regulated (CCR) genes, known to be glucose-repressed or activated by transcription factors Adr1 or Cat8 (<xref ref-type="bibr" rid="bib59">Young et al., 2003</xref>; <xref ref-type="bibr" rid="bib49">Tachibana et al., 2005</xref>), exhibit increased translation (RPFs) largely through increased mRNA abundance in both <italic>scd6Δedc3Δ</italic> and <italic>pat1Δdhh1Δ</italic> double mutants (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). These genes encode enzymes for β-oxidation of fatty acids in addition to the glyoxylate cycle, which allows cells to synthesize precursors that feed into gluconeogenesis or amino acid biosynthesis, or produce acetyl-CoA and generate NADH by respiration on non-fermentable carbon sources (<xref ref-type="bibr" rid="bib59">Young et al., 2003</xref>). The CCR genes exhibit larger increases in RPFs compared to Pol II occupancies at the cognate genes in <italic>scd6Δedc3Δ</italic> vs. WT cells (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>, cols. 3–4), consistent with post-transcriptional repression by Scd6/Edc3. Supporting this, an <italic>ADH2-lacZ</italic> reporter transcriptionally induced by activated Adr1 (<xref ref-type="bibr" rid="bib46">Sloan et al., 1999</xref>) displayed the expected large induction in our WT strain cultured with glycerol/ethanol versus glucose as carbon source (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C(i)</xref>), but was down-regulated by <italic>scd6Δedc3Δ</italic> in glucose-grown cells (panel (ii)).</p></sec><sec id="s2-7"><title>Functional evidence that Scd6/Edc3 repress oxidative phosphorylation</title><p>We examined the effects of eliminating Scd6/Edc3 on mitochondrial electron transport by measuring mitochondrial membrane potential (∆Ψ<sub>m</sub>) generated by the ETC using the probe tetramethylrhodamine (TMRM)—a cationic fluorescent dye that accumulates in mitochondria as a function of ΔΨ<sub>m</sub>. Quantifying dye fluorescence by flow cytometry revealed increased TMRM fluorescence in the <italic>scd6Δedc3Δ</italic> mutant containing an empty vector compared to both the isogenic WT strain and the mutant complemented by WT <italic>EDC3</italic> (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). These results are consistent with increased mitochondrial ETC activity in glucose-grown <italic>scd6Δedc3Δ</italic> cells.</p><p>To determine whether up-regulation of Ox. Phos. and other glucose-repressed genes in the decapping activator mutants alters cellular metabolites, we used targeted, quantitative LC-MS/MS-based approaches (see Methods) to quantify levels of 147 polar metabolites in the isogenic <italic>scd6Δedc3Δ</italic>, <italic>dhh1Δ, pat1Δ, dcp2Δ,</italic> and WT strains described above, cultured in YPD medium. Principal component analysis revealed clustering of results from biological replicates in the manner expected for reproducible differences in metabolite levels among different strains, with results for the <italic>scd6Δedc3Δ</italic> mutant most closely resembling those for <italic>dhh1Δ,</italic> which in turn were more similar to the results for <italic>pat1Δ</italic> vs. the <italic>dcp2Δ</italic> mutant or WT strains (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). This conclusion was borne out by cluster and correlation analyses of changes in metabolites between each mutant compared to WT, with the strongest correlation observed for <italic>scd6Δedc3Δ</italic> vs. <italic>dhh1Δ</italic>, followed by <italic>dhh1Δ</italic> vs. <italic>pat1Δ</italic> (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Considering the subset of 46 metabolites up-regulated in any two of the four mutants again showed greatest similarity between changes conferred by <italic>scd6Δedc3Δ</italic> vs. <italic>dhh1Δ</italic> followed by <italic>dhh1Δ</italic> vs. <italic>pat1Δ</italic> (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). These findings mirror the results from RNA-seq and ribosome profiling, in which the up-regulation of mRNA levels or translation was most similar between the <italic>scd6Δedc3Δ</italic> and <italic>dhh1Δ</italic> mutants. Pathway analysis of the 46 up-regulated metabolites (at <ext-link ext-link-type="uri" xlink:href="https://www.metaboanalyst.ca/MetaboAnalyst/">https://www.metaboanalyst.ca/MetaboAnalyst/</ext-link>) revealed a significant enrichment for metabolites of both the TCA and glyoxylate cycles (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), with five of the six TCA cycle intermediates detected (fumarate, malate, α-ketoglutarate, cis-aconitate and citrate) being elevated in the decapping mutants (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). These results are consistent with the possibility that up-regulation of Ox. Phos. proteins (<xref ref-type="fig" rid="fig6">Figure 6A–D</xref>) and ETC function (<xref ref-type="fig" rid="fig6">Figure 6G</xref>) in the decapping mutants leads to increased flux from glucose towards the TCA cycle.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Eliminating decapping activators or decapping enzyme confers similar changes in polar metabolites.</title><p>(<bold>A</bold>) Principal component analysis of the levels of 147 metabolites in biological replicates of each strain. (<bold>B–C</bold>) Hierarchical clustering analysis of log<sub>2</sub> changes in all 147 metabolites analyzed (<bold>B</bold>) or the 46 metabolites up-regulated in any two of the four mutants (<bold>C</bold>) conferred by the indicated mutations vs. wild-type (WT), including the Spearman coefficients (ρ) and p values for the indicated correlations. (<bold>D</bold>) Results of pathway analysis of the 46 up-regulated metabolites described in (<bold>C</bold>), conducted at <ext-link ext-link-type="uri" xlink:href="https://www.metaboanalyst.ca/MetaboAnalyst/">https://www.metaboanalyst.ca/MetaboAnalyst/</ext-link>. Red ovals depict groups of metabolites significantly enriched among the set of 46 compounds, with <italic>p</italic>-value &lt;0.05. (<bold>E–F</bold>) Log<sub>2</sub> changes in levels of tricarboxylic acid (TCA) cycle intermediates (<bold>E</bold>) or amino acids (<bold>F</bold>) conferred by the indicated mutations vs. WT.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Metabolomics of polar compounds of intermediary metabolism.</title><p>Sheets 1–4 list the statistical analyses of changes in metabolite concentrations in four biological replicates of the indicated four mutants vs. the wild-type (WT) determined in parallel for all 20 samples of metabolite extracts. Sheet 5 summarizes the log<sub>2</sub> fold changes in metabolite levels and corresponding p-values for all 147 metabolites detected in for each of the four mutants. Sheet 6 lists the 46 metabolites up-regulated in any two of the four mutants (analyzed in <xref ref-type="fig" rid="fig7">Figure 7C</xref>), TCA cycle intermediates, and amino acids. Sheet 7 lists 93 amino acid biosynthetic genes interrogated in <xref ref-type="fig" rid="fig8">Figure 8D</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig7-v1.tif"/></fig><p>To confirm increased flux through the TCA cycle coming from glucose breakdown, WT and mutant cells were grown in high glucose, pulsed with <sup>13</sup>C<sub>6</sub> glucose, and relative <sup>13</sup>C label incorporation into TCA cycle intermediates was estimated for each carbon molecule derived from glucose (as indicated schematically in <xref ref-type="fig" rid="fig8">Figure 8A</xref>) 8 min following the pulse. In all mutants, <sup>13</sup>C label incorporation in all TCA cycle intermediates was significantly higher than in WT cells (<xref ref-type="fig" rid="fig8">Figure 8A</xref>), demonstrating increased carbon flux from glucose into the TCA cycle. These results, along with increased ETC activity (<xref ref-type="fig" rid="fig6">Figure 6G</xref>), indicate that mitochondrial function is up-regulated in these mutants on glucose. If so, we might expect them to show increased ATP production from respiration versus glycolysis. Measuring total ATP levels in glucose-grown cells revealed that, while all decapping mutants except <italic>pat1∆</italic> showed reduced ATP per cell (<xref ref-type="fig" rid="fig8">Figure 8B</xref>), the proportion of ATP produced from respiration, and thus eliminated by sodium azide treatment (by inhibiting the ETC), was elevated in all of the mutants (<xref ref-type="fig" rid="fig8">Figure 8C</xref>).</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Elimination of decapping activators or decapping enzyme up-regulates respiration, increasing flux from glucose into TCA cycle intermediates and proportion of ATP produced by Ox. Phos.</title><p>(<bold>A</bold>) Three biological replicates of cells of each indicated genotype were cultured in YP with 2% unlabeled glucose, shifted to YP with 1% unlabeled glucose for 20 min, and pulsed with <sup>13</sup>C<sub>6</sub> labeled glucose (at final concentration of 1%) for 8 min, followed by extraction of metabolites and quantification of the indicated TCA cycle intermediates by mass spectrometry. In the diagrams, green circles signify the labeled carbon atom and the notation M+1, M+2, etc., indicates the mass increase in the molecules due to the labeled carbon. The depicted labeling pattern of metabolites reflects one cycle of the TCA cycle, resulting in mass additions of M+1 and M+2; however, across multiple cycles, a broader range of metabolite species with different mass additions will emerge. The metabolite signal intensities in all samples are expressed relative to that determined for the first replicate of the wild-type (WT) strain. (<bold>B–C</bold>) Measurements of ATP levels and proportions of total ATP impaired by azide inhibition of ETC activity. Cells cultured in YPD were treated or untreated with sodium azide for 30 min prior to harvesting. ATP levels were determined in extracts and normalized to OD<sub>600</sub> units of cells for three biological replicates each of treated and untreated cell aliquots. Mean values for each strain are plotted in (<bold>B</bold>) and relative fractions of ATP in untreated samples retained following azide treatment (ATP_untreated)-(ATP_Azide)/(ATP_untreated), normalized to the values determined for WT are plotted in (<bold>C</bold>) with results from a student’s t-test indicated with asterisks: **<italic>p</italic>&lt;0.005; *<italic>p</italic>&lt;0.05.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Glucose flux analysis.</title><p>In Sheet 2 ‘raw intensity,’ the numbers indicate the signal intensities (areas under the peaks from mass spectrometry) of the metabolite listed in column A in the three biological replicates of the indicated mutant or wild-type (WT) strains. In the subsequent sheets, raw data from Sheet 2 is collated for the different labeled isoforms of the indicated metabolite in the upper eight rows, and the proportion of the metabolite comprised of each isoform is given in the lower rows for the different samples. The ‘_N’ labeling indicates the label addition in the metabolite, i.e., _1 indicates mass addition of 1 labeled carbon, _2 indicates mass addition of 2 labeled carbons. Please let me know if you have any doubts regarding this.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig8-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Measurements of cellular ATP content.</title><p>Sheets 2–3 provide source data for measurements of ATP content in three biological replicates of the indicated five mutants vs. wild-type (WT) and the fraction of total ATP content that is eliminated by inhibiting respiration by sodium azide treatment. Sheet 4 shows the standard curve produced using pure ATP employed to determine the ATP content in cell extracts.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102287-fig8-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Hypothetical model to explain concerted repression of mRNA abundance or translation of particular mRNAs by decapping activators Scd6, Edc3, Dhh1, and Pat1.</title><p>A complex of Dcp1:Dcp2 containing Scd6/Edc3, Pat1/Dhh1, or different combinations of these factors is recruited to target mRNAs, possibly by a sequence-specific RNA-binding protein (RBP) binding to the 3’UTR. In agreement with a recent proposal (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>), the recruitment of Dhh1 is enhanced by its redundant interactions with Scd6 or Edc3, which interact with the same segment of the Dcp2 CTT, whereas Pat1 is recruited independently to a distinct region of the C-terminal tail (CTT). One outcome of association of the decapping complex with an mRNA is activation of decapping with attendant 5’–3’ degradation by Xrn1 occurring without detectable repression of translation (i). A different outcome is translational repression by decapping wherein degradation by Xrn1 is inefficient and decapped intermediates accumulate that cannot bind the cap-binding initiation factors eIF4E and eIF4G (depicted as subunits of eIF4F excluded from the m<sup>7</sup>G mRNA cap) and thus persist as translationally inert isoforms (ii). Alternatively, decapping may not occur and the decapping complex competes with the cap-binding initiation factors to selectively inhibit translation initiation (iii), a fate that could be favored by sequestration of the transcript in RNA granules in a manner facilitated by the decapping activator proteins (iv).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102287-fig8-figsupp1-v1.tif"/></fig></fig-group><p>Interestingly, amino acids are also up-regulated in the decapping mutants (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), particularly in <italic>pat1Δ</italic> cells (<xref ref-type="fig" rid="fig7">Figure 7F</xref>), as well as intermediates in amino acid biosynthesis and amino acid derivatives (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). The expression of amino acid biosynthetic enzymes is unaffected or reduced in the mutants however (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D</xref>), suggesting that increased amino acid abundance results from metabolic reprogramming rather than increased biosynthetic capacity. One possibility is that accumulation of the TCA cycle intermediate α-ketoglutarate leads to increased production of glutamate and glutamine, precursors in all amino acid biosynthetic pathways (<xref ref-type="bibr" rid="bib28">Ljungdahl and Daignan-Fornier, 2012</xref>). The two 3-phosphotrioses generated in glycolysis (glyceraldehyde 3-phosphate and dihydroxyacetone phosphate) are also elevated in the mutants, possibly owing to increased glyoxylate shunt function, which might stimulate the synthesis of amino acids serine and glycine (<xref ref-type="bibr" rid="bib28">Ljungdahl and Daignan-Fornier, 2012</xref>; <xref ref-type="fig" rid="fig7">Figure 7D</xref>, Methane metabolism category). The increases in fructose 1,6-bisphosphate, fructose 6-phosphate, glucose 6-phosphate, and UDP-glucose in all four mutants (<xref ref-type="fig" rid="fig7">Figure 7D</xref>, Starch/Sucrose metabolism category) all suggest substantial metabolic rewiring indicative of glucose up-regulation and usage of alternative carbon sources. In addition to amino acids, pyrimidine nucleotides are up-regulated in the mutants (<xref ref-type="fig" rid="fig7">Figure 7D</xref>, Pyrimidine metab.), which might be driven by the elevated glutamine levels or increased glycolytic flux towards the pentose phosphate pathway (<xref ref-type="bibr" rid="bib28">Ljungdahl and Daignan-Fornier, 2012</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>RNA-seq analysis of single and double <italic>scd6Δ</italic> and <italic>edc3Δ</italic> mutants has revealed that Scd6 and Edc3 have largely overlapping functions in repressing mRNA abundance, as the presence of either protein alone is sufficient for nearly WT levels of most mRNAs found up-regulated in the double mutant (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref> and <xref ref-type="fig" rid="fig1">Figure 1B–C(ii–iii)</xref>). Although the mRNAs dysregulated in the <italic>scd6Δedc3Δ</italic> mutant are enriched for ESR mRNAs; the majority are not ESR transcripts (<xref ref-type="fig" rid="fig1">Figure 1A–B</xref>) and are most likely repressed more directly by Scd6/Edc3. Functional redundancy of Scd6/Edc3 is consistent with their similarities in sequence and domain structure, including shared FDF motifs that interact competitively with Dhh1 in animals (<xref ref-type="bibr" rid="bib50">Tritschler et al., 2008</xref>; <xref ref-type="bibr" rid="bib51">Tritschler et al., 2009</xref>) and N-terminal LSm domains that compete for binding motifs in the Dcp2 CTT of <italic>S. pombe</italic> (<xref ref-type="bibr" rid="bib13">Fromm et al., 2012</xref>), as well as the synthetic growth defect produced by deleting both genes simultaneously (<xref ref-type="bibr" rid="bib10">Decourty et al., 2008</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Interestingly, a set of 37 mRNAs appears to be repressed by Edc3 exclusively (<xref ref-type="fig" rid="fig1">Figure 1B–C(i)</xref>), including the canonical Edc3 targets identified previously, <italic>YRA1</italic> and <italic>RPS28B</italic> (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>), and is enriched for genes belonging to the GO category ‘mitochondrion’ (22/37 genes) and the Ox. Phos. categories of electron transport and mitochondrial ATP synthesis (11/37 genes: <italic>ATP3 ATP16 ATP5 TIM11 ATP17 COX4 QCR9 CYC1 COX12 ATP18 COX5A</italic>). The fact that deleting <italic>SCD6</italic> in the double mutant frequently diminishes the up-regulation of these transcripts conferred by deleting <italic>EDC3</italic> alone (<xref ref-type="fig" rid="fig1">Figure 1C(i)</xref>) might indicate that eliminating both Scd6 and Edc3 together enables a distinct degradation pathway that compensates for loss of Edc3-stimulated decapping/decay.</p><p>Several lines of evidence support the conclusion that most of the changes in mRNA abundance in the <italic>scd6Δedc3Δ</italic> double mutant result from impaired decapping and attendant 5’–3’ degradation by Xrn1. ChIP-seq analysis of Rpb1 shows that Pol II occupancies in the coding sequences increase by much smaller amounts compared to the increased transcript levels for non-iESR mRNAs up-regulated in <italic>scd6Δ/edc3Δ</italic> cells (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), indicating a minor contribution of increased transcription to their up-regulation. The transcriptional activators of Ox-Phos. and CCR genes, many of whose transcripts are up-regulated by <italic>scd6Δ/edc3Δ</italic>, remain largely inert in this mutant, ruling out inappropriate transcriptional induction of their target genes in glucose-replete <italic>scd6Δ/edc3Δ</italic> cells. Consistent with mRNA turnover via decapping, most of these transcripts are up-regulated similarly by <italic>scd6Δedc3Δ</italic> and deletion of <italic>DCP2</italic> (<xref ref-type="fig" rid="fig3">Figure 3A–B</xref>), exhibit a heightened proportion of decapped isoforms in WT cells that is diminished by deleting <italic>SCD6/EDC3</italic> or <italic>DHH1</italic> (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E</xref>), and show evidence of co-translational 5’–3’ decay of decapped intermediates by Xrn1 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>); none of which was observed for the mRNAs down-regulated in <italic>scd6Δ/edc3Δ</italic> cells. Similar findings were reported previously for sets of mRNAs up-regulated by <italic>dhh1Δ</italic> or <italic>pat1Δ</italic> (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>), consistent with the widespread involvement of Dhh1 and Pat1 in controlling the levels of mRNAs preferentially targeted by Scd6/Edc3.</p><p>Supporting this last assertion, most (~70%) of the mRNAs repressed in abundance by Edc3/Scd6 are also repressed by Dhh1 and Pat1, and their efficient repression in WT cells involves independent contributions of similar magnitude by Pat1, Dhh1, and either Edc3 or Scd6 (<xref ref-type="fig" rid="fig2">Figure 2A–B(ii)</xref>). Another large set of mRNAs is repressed predominantly by Pat1 with lesser contributions by Dhh1 and Scd6/Edc3 (<xref ref-type="fig" rid="fig2">Figure 2A–B(iii)</xref>). Our finding of extensive cooperation among these four decapping factors is consistent with our recent finding that ~55% of the mRNAs up-regulated in the <italic>dcp2∆</italic> mutant, and thus targeted by Dcp2 for enhanced degradation, tend to be up-regulated in the <italic>pat1∆dhh1∆</italic> and <italic>scd6∆edc3∆</italic> mutants, whereas the remaining 45% are generally up-regulated by <italic>upf1∆</italic> instead. This finding suggested a major bifurcation of Dcp2 activation by either Pat1/Dhh1/Scd6/Edc3 or the Upf factors responsible for NMD (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>).</p><p>Closer examination of the effects of individual mutations on mRNA levels revealed a greater overlap between the mRNAs dysregulated by <italic>dhh1Δ</italic> and <italic>scd6Δ/edc3Δ</italic> versus those altered by <italic>pat1Δ</italic> (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>), consistent with the aforementioned FDF motifs in Scd6 and Edc3 that interact with Dhh1 in animal systems, and with evidence for distinct complexes of the decapping enzyme containing Dhh1 and Edc3 or Scd6 but lacking Pat1. It also supports the recent suggestion that Edc3 and Scd6 act interchangeably to recruit Dhh1 to the Edc3-interaction site in the Dcp2 CTT to stimulate turnover of several Dhh1 target mRNAs (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>). Our RNA-seq results support this last proposal in showing that all four Dhh1 target mRNAs examined in that study (<italic>EDC1, SDS23, HXT6,</italic> and <italic>HSP12</italic>) are up-regulated in the <italic>scd6∆edc3∆</italic> double mutant while changing little in the single mutants (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>), two of which (<italic>SDS23</italic> and <italic>HXT6</italic>) were shown previously to have longer half-lives in <italic>dhh1∆</italic> vs. WT cells (<xref ref-type="bibr" rid="bib20">He et al., 2018</xref>). Finding that selective up-regulation in the <italic>scd6∆edc3∆</italic> double mutant applies to most mRNAs up-regulated in <italic>dhh1∆</italic> cells (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), we propose that redundant Scd6/Edc3 targeting is a widespread mechanism of Dhh1-enhanced mRNA degradation in the yeast transcriptome (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). Supporting this, our co-immunoprecipitation analysis revealed diminished Dhh1-Dcp2 association in cell extracts of the <italic>scd6Δedc3Δ</italic> double mutant but not for either single mutant (<xref ref-type="fig" rid="fig3">Figure 3F</xref>).</p><p>Examining our Ribo-Seq and TMT-MS data suggests that <italic>DHH1</italic> mRNA translation and steady-state abundance are increased ~ twofold in the <italic>scd6∆edc3∆</italic> strain, indicating that up-regulation of many of the same mRNAs by <italic>scd6∆edc3∆</italic> and <italic>dhh1∆</italic> does not result indirectly from reduced levels of Dhh1 in the <italic>scd6∆edc3∆</italic> mutant. The increased Dhh1 expression might signify a compensatory response to the absence of Scd6/Edc3. We also observed an ~40% reduction in Dcp2 translation and abundance in the <italic>scd6∆edc3∆</italic> strain, which might contribute to the up-regulation of mRNAs dysregulated in this mutant. However, our immunoblot analyses revealed no significant reduction in steady-state Dcp2 levels in <italic>scd6∆edc3∆</italic> cells (Input lanes in <xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2(i–ii)</xref>). Moreover, our previous finding that the majority of mRNAs subject to NMD, up-regulated by both <italic>upf1∆</italic> and <italic>dcp2∆,</italic> are not up-regulated by <italic>scd6∆edc3∆</italic> (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>) implies that Dcp2 abundance in <italic>scd6∆edc3∆</italic> cells is adequate for normal levels of NMD. Accordingly, we favor a direct role for Scd6/Edc3 in accelerating degradation of most transcripts up-regulated in the <italic>scd6∆edc3∆</italic> mutant.</p><p>Despite strong evidence for the involvement of decapping in mRNA turnover directed by either Scd6/Edc3 or Pat1/Dhh1, it appears that neither enrichment for non-optimal codons nor low translational efficiencies are principal determinants of preferential targeting of mRNAs by these proteins (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A–C</xref>). There are probably exceptions to these generalizations among the hundreds of transcripts repressed by these factors; nor can we rule out the involvement of clusters of non-optimal codons in transcripts of average overall codon optimality that generate a queue of slowly elongating ribosomes that triggers decapping. Nevertheless, it seems likely that other sequences or properties of the transcripts most strongly repressed by Scd6/Edc3 or Dhh1/Pat1 frequently underlie their preferential targeting by these factors for decapping/decay. Sequence-specific RNA-binding proteins that actively recruit these decapping activators is an attractive potential mechanism (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). For example, there is evidence that Dhh1 is recruited to mRNAs in association with the Ccr4-NOT deadenylase via RNA-binding protein Puf5 (<xref ref-type="bibr" rid="bib17">Goldstrohm et al., 2006</xref>). Involvement of RNA-binding proteins would also be consistent with the observed specific targeting of mRNAs whose expression is repressed in response to nutrient abundance.</p><p>Ribosome profiling of the single and double <italic>scd6Δ</italic> and <italic>edc3Δ</italic> mutants provided evidence that Scd6 and Edc3 also have highly overlapping functions in repressing the translation of ~200 mRNAs, whose TE values are up-regulated substantially only in the double mutant (<xref ref-type="fig" rid="fig4">Figure 4A–B(iii)</xref>). The observation that changes in TE (RPF density) generally correlate with changes in protein abundance conferred by <italic>scd6Δedc3Δ</italic> (<xref ref-type="fig" rid="fig4">Figure 4F</xref>) implies that Scd6/Edc3 generally repress translation at the stage of initiation rather than elongation. Many mRNAs translationally repressed by Scd6/Edc3 additionally require Dhh1, and the subset most strongly repressed also requires Pat1 for efficient translational repression (<xref ref-type="fig" rid="fig5">Figure 5B(ii) and D</xref>). This last group of mRNAs is translated at very low levels in WT cells on rich medium (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>, cols. 2 &amp; 4), which might reflect the concerted action of all four decapping activators in suppressing translation. The transcript abundance of these mRNAs is also up-regulated in each of the mutants (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A(ii)</xref>), indicating enhanced degradation coupled with translational repression by the four decapping activators. One possibility is that a complex of Dcp1:Dcp2 containing Scd6/Edc3, Pat1/Dhh1, or different combinations of these factors (<xref ref-type="bibr" rid="bib21">He et al., 2022</xref>) is recruited to these mRNAs and impedes recruitment of PICs to diminish translation in parallel with stimulating decapping and 5’–3’ degradation by Xrn1 (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>).</p><p>The additional sets of mRNAs identified here that are translationally repressed exclusively by Scd6/Edc3 or Pat1/Dhh1 (<xref ref-type="fig" rid="fig5">Figure 5A(i) and (iii)</xref>) show much less evidence of transcript degradation promoted by these factors (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A(i) and (iii)</xref>), suggesting that inhibition of translation initiation occurs without decapping or involves decapping uncoupled from degradation by Xrn1 (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1(ii–iii)</xref>). In the latter scenario, the decapped mRNAs would be unable to recruit the cap-binding initiation factors necessary for PIC recruitment and hence persist in WT cells as translationally inert degradation intermediates. Eliminating the decapping activators would diminish decapping and eliminate these fractions of poorly translated uncapped isoforms to confer the increased TE values we observed for the cognate genes in the decapping mutants. This hypothetical mechanism of translational repression via decapping is consistent with the lower than average capped to total mRNA (C/T) ratios found in WT cells for the mRNAs translationally repressed by all four decapping activators or by Pat1/Dhh1 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D(ii–iii)</xref>), indicating accumulation of decapped isoforms in WT cells, as observed previously for a subset of mRNAs translationally repressed by Dhh1 (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). In contrast, the mRNAs that are translationally repressed exclusively by Scd6/Edc3 display higher than average C/T ratios in WT (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D(i)</xref>), which is more compatible with an inhibition of PIC recruitment independently of decapping (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1(iii)</xref>). Translational repression without decapping could also occur if transcripts bound by decapping complexes are sequestered from the translation initiation machinery in RNA granules where mRNA decapping occurs inefficiently (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1(iv)</xref>). Finally, it is important to note that mRNA decay occurs apparently without translational control for the much larger groups of ~600 and ~1000 transcripts showing up-regulated mRNA abundance but little evidence of TE changes in the <italic>scd6∆edc3∆</italic> and <italic>pat1∆dhh1∆</italic> mutants, respectively (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). It is unclear whether these mRNAs escape translational repression and are targeted exclusively for decapping/degradation (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1(i)</xref>) or are simply degraded too fast to allow translational repression to be detected by ribosomal profiling of steady-state mRNAs.</p><p>Recently, we reported that Pat1 and Dhh1 functionally collaborate with the decapping enzyme to repress genes and cellular pathways normally repressed in rich medium (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>; <xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). Here, we found evidence that Scd6 and Edc3 broadly cooperate with Pat1/Dhh1 in this control, acting redundantly to repress the abundance, translation, or both, of mRNAs encoding numerous proteins involved in respiration or utilization of alternative carbon sources (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–D</xref>), without affecting transcription of the cognate genes (<xref ref-type="fig" rid="fig6">Figure 6F</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A–C</xref>). Evidence that up-regulation of Ox. Phos. mRNAs/proteins in the <italic>scd6∆edc3∆</italic> mutant is sufficient to increase respiration in glucose-replete cells came from our findings of increased mitochondrially-encoded subunit II of ETC component cytochrome <italic>c</italic> oxidase (<xref ref-type="fig" rid="fig6">Figure 6D</xref>) and elevated mitochondrial membrane potential (<xref ref-type="fig" rid="fig6">Figure 6G</xref>) in the <italic>scd6∆edc3∆</italic> mutant, extending similar findings we made previously for <italic>dcp2∆, dhh1∆,</italic> and <italic>pat1∆</italic> mutants (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>; <xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). Consistent with this, our metabolomics analysis revealed elevated steady-state levels of TCA cycle intermediates in all four decapping mutants (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), and increased <sup>13</sup>C carbon incorporation from <sup>13</sup>C<sub>6</sub>-glucose breakdown into TCA cycle intermediates in the same mutant strains (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Analysis of ATP levels further revealed increased proportions of ATP derived from Ox. Phos. in the decapping mutants (<xref ref-type="fig" rid="fig8">Figure 8C</xref>), which together provide strong evidence that mitochondrial respiration is inappropriately elevated in glucose-replete cells of decapping activator mutants. It is well established that the enzymes involved in respiration and catabolism of non-glucose carbon sources are repressed at the transcriptional level in glucose-replete yeast (<xref ref-type="bibr" rid="bib60">Zaman et al., 2008</xref>). Our findings demonstrate that Scd6/Edc3 collaborate with Dhh1/Pat1 to provide an additional layer of post-transcriptional control of these enzymes through enhanced decapping/decay or translational repression to help ensure their complete suppression when glucose is abundant (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>).</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Cycloheximide</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">Cat # C7698</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">5-fluoro-orotic acid</td><td align="left" valign="top">US Biological</td><td align="left" valign="top">Cat # F5050</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">ONPG (o-nitrophenyl-β-D-galactopyranoside)</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">Cat # N1127</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">TCA (Trichloroacetic acid) solution</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">Cat # T0699</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">G418 Sulfate (Geneticin)</td><td align="left" valign="top">US Biological</td><td align="left" valign="top">Cat # G1000</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">IgG sepharose</td><td align="left" valign="top">Cytiva</td><td align="left" valign="top">Cat # 17-0969-01</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">NEBuilder HiFi DNA assembly</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat # E2621S</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">RNase I</td><td align="left" valign="top">Ambion</td><td align="left" valign="top">Cat # AM2294</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">QIAzol Lysis reagent</td><td align="left" valign="top">Qiagen</td><td align="left" valign="top">Cat. # 79306</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">miRNeasy Mini Kit</td><td align="left" valign="top">Qiagen</td><td align="left" valign="top">Cat. # 217004</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">RNA Clean and Concentrator kit</td><td align="left" valign="top">Zymo Research</td><td align="left" valign="top">Cat # R1018</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">T4 Polynucleotide kinase</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat # M0201L</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">T4 Rnl2(tr) K227Q</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat # M0351S</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">5’ deadenylase/RecJ exonuclease</td><td align="left" valign="top">Epicentre</td><td align="left" valign="top">Cat # RJ411250</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Oligo Clean and Concentrator column</td><td align="left" valign="top">Zymo Research</td><td align="left" valign="top">Cat # D4060</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Protoscript II</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat # M0368L</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">CircLigase ssDNA Ligase</td><td align="left" valign="top">Epicenter</td><td align="left" valign="top">Cat # CL4111K</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Phusion polymerase</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat # M0530S</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">High Sensitivity DNA Kit</td><td align="left" valign="top">Agilent</td><td align="left" valign="top">Cat # 5067–4,626</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Fragmentation Reagent</td><td align="left" valign="top">Ambion</td><td align="left" valign="top">Cat # AM8740</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Stop Solution</td><td align="left" valign="top">Ambion</td><td align="left" valign="top">Cat # AM8740</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Ribo-Zero Gold rRNA Removal Kit</td><td align="left" valign="top">Illumina</td><td align="left" valign="top">Cat # MRZ11124C</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">RNA 6000 Nano kit</td><td align="left" valign="top">Agilent</td><td align="left" valign="top">Cat # 5067–1511</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">ERCC ExFold RNA spike-In Mixes</td><td align="left" valign="top">Ambion</td><td align="left" valign="top">Cat # 4456739</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">DNA Library Prep Kit</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat # E7370L</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">DNase I</td><td align="left" valign="top">Roche</td><td align="left" valign="top">Cat # 4716728001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Luciferase Control RNA</td><td align="left" valign="top">Promega</td><td align="left" valign="top">Cat # L4561</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Superscript III First-Strand synthesis kit</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat # 18080051</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">25 mM triethylammonium-bicarbonate</td><td align="left" valign="top">Thermo Scientific</td><td align="left" valign="top">Cat # 90114</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">GelCode Blue Stain</td><td align="left" valign="top">Thermo Scientific</td><td align="left" valign="top">Cat # 24592</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Pierce BCA Protein Assay Kit</td><td align="left" valign="top">Thermo Scientific</td><td align="left" valign="top">Cat # 23225</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">protease inhibitor cocktail</td><td align="left" valign="top">Roche</td><td align="left" valign="top">Cat # 5056489001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">enhanced chemiluminescence (ECL)</td><td align="left" valign="top">Cytiva</td><td align="left" valign="top">Cat # RPN2109</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Nano-Glo substrate</td><td align="left" valign="top">Promega</td><td align="left" valign="top">Cat # N1120</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Bradford reagent</td><td align="left" valign="top">BioRad</td><td align="left" valign="top">Cat # 5000006</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">ATP Determination Kit</td><td align="left" valign="top">Thermo-Fisher Scientific</td><td align="left" valign="top">Cat # A22066</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">In-Fusion Snap Assembly Master Mix</td><td align="left" valign="top">Takara</td><td align="left" valign="top">Cat # 638949</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Gcd6, rabbit polyclonal</td><td align="left" valign="top">In house; <xref ref-type="bibr" rid="bib4">Bushman et al., 1993</xref></td><td align="left" valign="top"/><td align="left" valign="top">Dilution:<break/>1:2,000 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Pet10, rabbit polyclonal</td><td align="left" valign="top">Dr. Nikolaus Pfanner</td><td align="left" valign="top"/><td align="left" valign="top">Dilution: 1:1,000 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Cyb2, rabbit polyclonal</td><td align="left" valign="top">Dr. Thomas Fox</td><td align="left" valign="top"/><td align="left" valign="top">Dilution: 1:2,000 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">anti-Idh1, goat polyclonal</td><td align="left" valign="top">Abnova</td><td align="left" valign="top">Cat # PAB19472</td><td align="left" valign="top">Dilution: 1:500 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Cox20, rabbit polyclonal</td><td align="left" valign="top">Dr. Thomas Fox</td><td align="left" valign="top"/><td align="left" valign="top">Dilution: 1:500 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Atp20, rabbit polyclonal</td><td align="left" valign="top">Dr. Nikolaus Pfanner</td><td align="left" valign="top"/><td align="left" valign="top">Dilution: 1:500 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Qcr8, rabbit polyclonal</td><td align="left" valign="top">Dr. Nikolaus Pfanner</td><td align="left" valign="top"/><td align="left" valign="top">Dilution: 1:500 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">anti-Cit2, rabbit polyclonal</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.antibodies-online.com/">https://www.antibodies-online.com/</ext-link></td><td align="left" valign="top">Cat # ABIN4889057</td><td align="left" valign="top">Dilution: 1:250 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Cox14, rabbit polyclonal</td><td align="left" valign="top">Dr. Nikolaus Pfanner</td><td align="left" valign="top"/><td align="left" valign="top">Dilution: 1:500 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Sdh4, rabbit polyclonal</td><td align="left" valign="top">Dr. Nikolaus Pfanner</td><td align="left" valign="top"/><td align="left" valign="top">Dilution: 1:500 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">anti-TAP, rabbit polyclonal</td><td align="left" valign="top">Thermo-Fisher Scientific</td><td align="left" valign="top">Cat # CAB1001</td><td align="left" valign="top">Dilution: 1:2000 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">anti-HA (12CA5) mouse monoclonal</td><td align="left" valign="top">Roche</td><td align="left" valign="top">Cat # 10522600</td><td align="left" valign="top">Dilution: 1:4000 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">anti-mouse IgG (HRP-conjugated), mouse polyclonal</td><td align="left" valign="top">GE HealthCare</td><td align="left" valign="top">Cat # NA931V</td><td align="left" valign="top">Dilution: 1:10000 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">anti-goat IgG (HRP-conjugated), chicken polyclonal</td><td align="left" valign="top">Abnova</td><td align="left" valign="top">Cat # PAB29101</td><td align="left" valign="top">Dilution: 1:10000 (WB)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">anti-Rpb1 8WG16, mouse monoclonal</td><td align="left" valign="top">Biolegend</td><td align="left" valign="top">Cat # 664906; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2565554">AB_2565554</ext-link></td><td align="left" valign="top">4 µl used in Rpb1-ChIP</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="top">Yeast strains used</td><td align="left" valign="top">This paper</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014477">NCBITaxon_2305205</ext-link></td><td align="left" valign="top"><xref ref-type="table" rid="table1">Table 1</xref><break/></td></tr><tr><td align="left" valign="top">Genetic reagent (plasmid)</td><td align="left" valign="top">Plasmids used</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top"><xref ref-type="table" rid="table2">Table 2</xref><break/></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">Primers used</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top"><xref ref-type="table" rid="table3">Table 3</xref><break/><break/></td></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Notched box-plots</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="http://shiny.chemgrid.org/boxplotr/">http://shiny.chemgrid.org/boxplotr/</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_015629">SCR_015629</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Venn diagrams</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.biovenn.nl/">https://www.biovenn.nl/</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_026853">SCR_026853</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Hypergeometric distribution</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://systems.crump.ucla.edu/hypergeometric/index.php">https://systems.crump.ucla.edu/hypergeometric/index.php</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Volcano plots</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://huygens.science.uva.nl/VolcaNoseR/">https://huygens.science.uva.nl/VolcaNoseR/</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_025419">SCR_025419</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Gene ontology (GO)</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="http://funspec.med.utoronto.ca/">http://funspec.med.utoronto.ca/</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_006952">SCR_006952</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">DESeq2 analysis</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib64">Zhang, 2023</xref></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Integrative Genomics Viewer</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="http://software.broadinstitute.org/software/igv/">http://software.broadinstitute.org/software/igv/</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_011793">SCR_011793</ext-link></td><td align="left" valign="top">IGV 2.4.14</td></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Genome-wide occupancy profiles for Rpb1 (ChIP)</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib63">Zhang, 2022</xref></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Image Lab 6.0.1 program</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.bio-rad.com/en-us/product/image-lab-software?ID=KRE6P5E8Z">https://www.bio-rad.com/en-us/product/image-lab-software?ID=KRE6P5E8Z</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014210">SCR_014210</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">SwissProt Yeast database</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/proteomes/UP000002311">https://www.uniprot.org/proteomes/UP000002311</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Proteome Discoverer 2.4</td><td align="left" valign="top">Thermo <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014477">SCR_014477</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">GraphPad Prism 9</td><td align="left" valign="top">GraphPad Software, San Diego, CA</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="top">9.4.1</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Yeast strains and plasmids</title><p>Unless otherwise indicated, the following strains of yeast <italic>Saccharomyces cerevisiae</italic> were employed for all experiments: WT strain HFY114 (W303: <italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100</italic>) (<xref ref-type="bibr" rid="bib18">He et al., 2003</xref>), <italic>scd6∆</italic> strain SYY2352 (<italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 scd6∆::kanMX6</italic>) (<xref ref-type="bibr" rid="bib19">He and Jacobson, 2015</xref>), <italic>edc3∆</italic> strain FZY862 (<italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 edc3∆::kanMX4</italic>), and <italic>scd6∆edc3∆</italic> strain FZY858 (<italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 scd6∆::hphMX4 edc3∆::kanMX4</italic>).</p><p>Strains FZY858 and FZY862 were generated by replacing chromosomal <italic>EDC3</italic> in strains FZY855 and HFY114, respectively, with the <italic>edc3∆::kanMX4</italic> allele amplified by PCR from the chromosomal DNA of strain 255 (<italic>MATa his3∆1 leu2∆0 met15∆0 ura3∆0 edc3∆::kanMX4</italic>) obtained from Research Genetics. DNA sequences up to 310 bp upstream and 340 bp downstream of the <italic>EDC3</italic> coding sequence were included in the amplified fragment used for transformation of FZY855 and HFY114 to G418-resistance. FZY855 was derived from SYY2352 by transforming with marker-swap plasmid pAG32 (<xref ref-type="bibr" rid="bib16">Goldstein and McCusker, 1999</xref>) to replace <italic>scd6∆::kanMX6</italic> with <italic>scd6∆::hphMX6,</italic> selecting for resistance to hygromycin and screening for loss of G418-resistance. The presence of all deletion alleles was verified by PCR analysis of chromosomal DNA.</p><p>Strains H5695, H5696, H5697, and H5698 strains, employed for co-immunoprecipitation experiments, were generated by PCR amplification of a <italic>DHH1-TAP-HIS3MX</italic> fragment from strain F2262 using primers AKV224 and AKV225, containing 474 bp upstream and 450 bp downstream of the <italic>DHH1</italic> stop codon, that was used to transform strains HFY114, FZY862, SYY2352, and FZY858, respectively, to His<sup>+</sup>. A complete list of yeast strains employed is given in <xref ref-type="table" rid="table1">Table 1</xref> and all strains are available on request.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Yeast strains employed.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Strain</th><th align="left" valign="top">Genotype</th><th align="left" valign="top">Source</th></tr></thead><tbody><tr><td align="char" char="." valign="top">255</td><td align="left" valign="top"><italic>MATa his3∆1 leu2∆0 met15∆0 ura3∆0 edc3∆::kanMX4</italic></td><td align="left" valign="top">Research Genetics</td></tr><tr><td align="left" valign="top">HFY114<break/>(W303)</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3, 112 can1-100</italic></td><td align="char" char="." valign="top"><xref ref-type="bibr" rid="bib18">He et al., 2003</xref></td></tr><tr><td align="left" valign="top">SYY2352</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3, 112 can1-100 scd6∆::kanMX6</italic></td><td align="left" valign="top"><xref ref-type="bibr" rid="bib19">He and Jacobson, 2015</xref></td></tr><tr><td align="left" valign="top">FZY855</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3, 112 can1-100 scd6∆::hphMX4</italic></td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">FZY858</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3, 112 can1-100 scd6∆::hphMX4 edc3∆::kanMX4</italic></td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">FZY862</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3, 112 can1-100 edc3∆::kanMX4</italic></td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">H5217/QZY126</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 dhh1∆::kanMX</italic></td><td align="char" char="." valign="top"><xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref></td></tr><tr><td align="left" valign="top">F2181/BSY3037</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 pat1∆::HIS3</italic></td><td align="left" valign="top"><xref ref-type="bibr" rid="bib8">Charenton et al., 2017</xref></td></tr><tr><td align="left" valign="top">F2182/YFW168</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 pat1∆::HIS3 dhh1∆::kanMX</italic></td><td align="left" valign="top"><xref ref-type="bibr" rid="bib8">Charenton et al., 2017</xref></td></tr><tr><td align="left" valign="top">CFY1016</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 dcp2::HIS3</italic></td><td align="char" char="." valign="top"><xref ref-type="bibr" rid="bib18">He et al., 2003</xref></td></tr><tr><td align="left" valign="top">F2262</td><td align="left" valign="top"><italic>MATa his3-Δ1 leu2-Δ0 met15-Δ0 ura3-Δ0 DHH1::TAP::HIS3MX</italic></td><td align="left" valign="top">GE Healthcare Dharmacon</td></tr><tr><td align="left" valign="top">H5695</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 leu2-3,112 can1-100 DHH1- TAP::HIS3MX</italic></td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">H5696</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 leu2-3,112 can1-100 edc3∆::kanMX4 DHH1-TAP::HIS3MX</italic></td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">H5697</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 leu2-3,112 can1-100 scd6∆::kanMX4 DHH1-TAP::HIS3MX</italic></td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">H5698</td><td align="left" valign="top"><italic>MATa ade2-1 ura3-1 his3-11,15 leu2-3,112 can1-100 scd6∆::hphMX4 edc3∆::kanMX4 DHH1-TAP::HIS3MX</italic></td><td align="left" valign="top">This study</td></tr></tbody></table></table-wrap><p>Plasmids pLfz614-7 and pLfz635-5 contain the <italic>EDC3</italic> CDS with 420 bp upstream and 490 bp downstream, on a ~2.6 kb fragment, and plasmids pL615-5 and pLfz636-1 contain the <italic>SCD6</italic> CDS with 500 bp upstream and 180 bp downstream on a ~1.7 kb fragment, amplified by PCR from yeast genomic DNA and inserted between the XhoI and EcoRI sites of YCplac33 or YCplac111, respectively. Plasmid pAK133 containing <italic>DCP2-3HA</italic> was produced by a multi-step PCR amplification scheme. First, the <italic>DCP2</italic> CDS with 920 nucleotides upstream of the start codon and 587 nucleotides downstream of the stop codon was amplified from genomic DNA of WT strain HFY114. Sequences encoding the 3XHA tag were introduced immediately upstream of the <italic>DCP2</italic> stop codon using primer pairs AKV372/AKV373 and AKV374/AKV375 during the first round of PCR amplification; a second round of PCR followed using primers AKV372 and AKV375 to amplify a complete <italic>DCP2-3HA</italic> fragment also containing sequences homologous to the ends of plasmid YCplac33 linearized by digestion with BamHI. The PCR product was fused into BamHI-digested YCplac33 using the Takara In-Fusion cloning kit (#638956) according to the manufacturer’s instructions. Primers AKV372 and AKV375 were designed using the Takara online primer design tool to ensure optimal homologous recombination during the cloning process. The inserted yeast DNA fragments were verified by sequencing in their entirety. A complete list of plasmids employed is given in <xref ref-type="table" rid="table2">Table 2</xref>, and all plasmids are available on request. The sequences of primers employed is listed in <xref ref-type="table" rid="table3">Table 3</xref>.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Plasmids employed.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Plasmid</th><th align="left" valign="top">Description</th><th align="left" valign="top">Source</th></tr></thead><tbody><tr><td align="left" valign="top">YCplac33</td><td align="left" valign="top">s.c. <italic>URA3</italic> vector</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib15">Gietz and Sugino, 1988</xref></td></tr><tr><td align="left" valign="top">YCplac111</td><td align="left" valign="top">s.c. <italic>LEU2</italic> vector</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib15">Gietz and Sugino, 1988</xref></td></tr><tr><td align="left" valign="top">pLfz614-7</td><td align="left" valign="top"><italic>EDC3</italic> in YCplac33</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">pLfz615-5</td><td align="left" valign="top"><italic>SCD6</italic> in YCplac33</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top">pLfz635-5</td><td align="left" valign="top"><italic>EDC3</italic> in YCplac111</td><td align="left" valign="top">This study (in case used)</td></tr><tr><td align="left" valign="top">pLfz636-1</td><td align="left" valign="top"><italic>SCD6</italic> in YCplac111</td><td align="left" valign="top">This study (in case used)</td></tr><tr><td align="left" valign="top">pLGADH2</td><td align="left" valign="top"><italic>ADH2</italic> 5’ non-coding region fused to <italic>lacZ</italic></td><td align="char" char="." valign="top"><xref ref-type="bibr" rid="bib46">Sloan et al., 1999</xref></td></tr><tr><td align="left" valign="top">pLG265</td><td align="left" valign="top"><italic>CYC1-lacZ</italic> reporter lacking UAS1 and containing the optimized version of UAS2, UAS2UP1</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib12">Forsburg and Guarente, 1989</xref></td></tr><tr><td align="left" valign="top">pRK4</td><td align="left" valign="top"><italic>UAS<sub>GATA</sub>-CYC1-lacZ</italic> reporter containing the UAS from <italic>MEP2</italic> modified to contain additional GATA sequences</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref></td></tr><tr><td align="left" valign="top">pAK133</td><td align="left" valign="top"><italic>DCP2-3XHA</italic> cloned in YCplac33 under its native promoter.</td><td align="left" valign="top">This study</td></tr></tbody></table></table-wrap><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Primers employed.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Primer</th><th align="left" valign="top">Sequence (5’ to 3’)</th></tr></thead><tbody><tr><td align="left" valign="top">AKV224</td><td align="left" valign="top"><named-content content-type="sequence">CAAGCCGTTAATGTCGTTATCAATTTCGAT</named-content></td></tr><tr><td align="left" valign="top">AKV225</td><td align="left" valign="top"><named-content content-type="sequence">TTCATCTTGTCAGTTGAAATGAATAGTTTA</named-content></td></tr><tr><td align="left" valign="top">AKV372</td><td align="left" valign="top"><named-content content-type="sequence">CGACTCTAGAGGATCAAAGAACAATGAACTCTAGAGCATC</named-content></td></tr><tr><td align="left" valign="top">AKV373</td><td align="left" valign="top"><named-content content-type="sequence">TCCTGCATAGTCCGGGACGTCATAGGGATAGCCCGCATAGTC</named-content><named-content content-type="sequence">AG</named-content><named-content content-type="sequence">GA</named-content><named-content content-type="sequence">ACATCGTATGGGTAAACGGCCGCCTTCCTATGCAAAATGCTTAATAATT</named-content></td></tr><tr><td align="left" valign="top">AKV374</td><td align="left" valign="top"><named-content content-type="sequence">TATCCCTATGACGTCCCGGACTATGCAGGATCCTATCCATATGACGTT</named-content><named-content content-type="sequence">CCAGATTACGCTCCGGCCGCCTGAAAGAATAAGTGTTATACGTTTTA</named-content></td></tr><tr><td align="left" valign="top">AKV375</td><td align="left" valign="top"><named-content content-type="sequence">CGGTACCCGGGGATCAATATCGACAGTTTTAAGAACCGC</named-content></td></tr></tbody></table></table-wrap></sec><sec id="s4-2"><title>Cell spotting growth assays</title><p>Yeast transformants harboring plasmids containing <italic>EDC3</italic>, <italic>SCD6,</italic> or empty vector were grown to mid-logarithmic phase at 30°C in liquid synthetic complete medium (SC) without uracil (SC-U). Cultures were diluted to OD<sub>600</sub> of 1.0 and 10-fold serial dilutions were spotted on agar medium of the same composition and incubated at 30°C or 37°C for 2 days.</p></sec><sec id="s4-3"><title>Polysome profiling</title><p>Polysome profiling was conducted as described previously (<xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>). In brief, strains were cultured in YPD medium at 30°C to mid-logarithmic phase (OD<sub>600</sub> of ~0.5–0.6). Fifteen A<sub>260</sub> units of WCEs were resolved on a 10–50% sucrose gradient by centrifugation at 35,000 rpm. Gradients were fractionated with continuous scanning at 260 nm. Areas under the A<sub>260</sub> tracings of polysome and monosome peaks were calculated using ImageJ software and used to calculate polysome to monosome (P/M) ratios in mutants and WT.</p></sec><sec id="s4-4"><title>Ribosome footprint profiling</title><p>Duplicate cultures of yeast strains HFY114 (WT W303), SYY2352 (<italic>scd6∆</italic>), FZY862 (<italic>edc3∆</italic>), and FZY858 (<italic>scd6∆edc3∆</italic>) were cultured in YPD medium at 30°C to OD<sub>600</sub>~0.6–0.7. Yeast cells were quickly filtered, frozen in liquid nitrogen and stored at –80C. Cells were lysed in a freezer mill and RPFs were isolated and used for cDNA library preparation as described previously (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). Single-end 100 bp Illumina sequencing was performed by the National Heart, Lung, and Blood Institute (NHLBI) DNA Sequencing and Genomics Core facility (Bethesda, MD).</p></sec><sec id="s4-5"><title>RNA sequencing with spike-in normalization and CAGE analysis</title><p>The same lysates used for RPF library preparation were used to prepare RNA-Seq libraries after adding ERCC RNA Spike-In Control Mix 1 (Thermo Fisher Scientific, Cat. # 4456740). Total RNA was extracted from cell lysates using QIAzol Lysis reagent (Qiagen Cat. # 79306) and miRNeasy Mini Kit (Qiagen, Cat. 217004). Twenty µg of total RNA of each sample was subjected to RNase-free DNase I (Roche, Cat. # 04716728001) treatment and then processed with the RNA Clean and Concentrator Kit (Zymo, Cat. R1018). An aliquot of 2.4 µl of 1:100 diluted ERCC RNA Spike-In Control Mix 1 was added to 1.2 µg of each RNA sample and submitted to the NHLBI DNA Sequencing and Genomics Core facility (Bethesda, MD) for cDNA library preparation and Illumina sequencing. CAGE sequencing and RNA-Seq were conducted in parallel on two biological replicates of total RNA isolated from the same WT and <italic>scd6∆edc3∆</italic> strains, cultured under the same conditions as employed for ribosomal profiling, exactly as described previously (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>).</p></sec><sec id="s4-6"><title>Rpb1 ChIP-Seq with spike-in normalization</title><p>Triplicates of wild-type and <italic>scd6∆edc3∆</italic> yeast strains were cultured in rich YPD medium at 30°C to OD600=0.6–0.8. Chromatin extracts were prepared from formaldehyde cross-linked cells as described previously (<xref ref-type="bibr" rid="bib39">Qiu et al., 2016</xref>). <italic>S. pombe</italic> chromatin was added to each chromatin sample as a spike-in control prior to immunoprecipitation with Rpb1 antibodies, and ChIP-Seq DNA libraries were prepared as described previously (<xref ref-type="bibr" rid="bib65">Zheng et al., 2023</xref>) subjected to 50 bp paired-end Illumina sequencing by the NHLBI DNA Sequencing and Genomics Core facility (Bethesda, MD) and analyzed as previously described (<xref ref-type="bibr" rid="bib65">Zheng et al., 2023</xref>).</p></sec><sec id="s4-7"><title>Western blot analysis</title><p>For the results in <xref ref-type="fig" rid="fig6">Figure 6B–C</xref>, WCEs were prepared by trichloroacetic acid (TCA) extraction as previously described (<xref ref-type="bibr" rid="bib42">Reid and Schatz, 1982</xref>) and immunoblot analysis was conducted as described previously (<xref ref-type="bibr" rid="bib32">Nanda et al., 2009</xref>). After electroblotting to nitrocellulose membranes (Bio-Rad 1620094), membranes were probed with antibodies against Atp20, Cox14, Pet10, Qcr8, Sdh4 (kindly provided by Dr. Nikolaus Pfanner), Cyb2 (kindly provided by Dr. Thomas Fox), Idh1 (Abnova, PAB19472), Cit2 (<ext-link ext-link-type="uri" xlink:href="https://www.antibodies-online.com/">https://www.antibodies-online.com/</ext-link>, ABIN4889057), and Gcd6 (<xref ref-type="bibr" rid="bib4">Bushman et al., 1993</xref>). Secondary antibodies employed were HRP-conjugated anti-rabbit (Cytiva, NA9340V), anti-mouse IgG (Cytiva, NA931V), and anti-goat IgG (Abnova, PAB29101). Detection was performed using enhanced chemiluminescence (ECL) Western Blotting Detection Reagent (Cytiva, RPN2016) and the Azure 200 gel imaging biosystem. NIH ImageJ was employed to analyze images for quantification. For analysis of Cox2 levels in <xref ref-type="fig" rid="fig6">Figure 6D</xref>, total proteins were TCA-extracted as described previously (<xref ref-type="bibr" rid="bib41">Rashida et al., 2021</xref>) and subjected to Western blot analysis as recently described (<xref ref-type="bibr" rid="bib33">Niphadkar et al., 2024</xref>) using mouse monoclonal antibody MTCO2 (4B12A5) from Invitrogen.</p></sec><sec id="s4-8"><title>TMT-MS analysis of global protein abundance</title><p>TMT-MS analysis was conducted as described previously (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>) with the following modifications. Replicate cultures of WT, <italic>edc3∆, scd6∆,</italic> and <italic>scd6∆edc3∆</italic> strains were cultured in YPD medium for ~3 doublings to OD<sub>600</sub> of ~0.6, and harvested by centrifugation for 5 min at 3000<italic>×g</italic>. Cells were resuspended in nuclease-free water, collected by centrifugation, and stored at –80°C. WCEs were prepared in freshly prepared 8 M Urea, 25 mM triethylammonium-bicarbonate (TEAB; Thermo Scientific, 90114) by washing the cell pellets once and resuspending again in the extraction buffer, then vortexing with glass beads in the cold room. Lysates were clarified by centrifugation at 13,000<italic>×g</italic> for 30 min and the quality of extracted proteins was assessed following SDS-PAGE using GelCode Blue Stain (Thermo Scientific, 24592) and quantified with the Pierce BCA Protein Assay Kit (Thermo Scientific, 23225). Lysates were stored at –80°C. Sample preparation, TMT-MS/MS (<xref ref-type="bibr" rid="bib61">Zecha et al., 2019</xref>), and data analysis were performed at the IDeA National Resource for Quantitative Proteomics.</p></sec><sec id="s4-9"><title>Co-immunoprecipitation analysis</title><p>Transformants of <italic>DHH1-TAP</italic> strains were cultured in 50 ml YPD at 30°C to OD₆₀₀ ≈ 0.6–0.8, harvested by centrifugation, and washed with 1 ml lysis buffer (LB) containing 0.5 mM PMSF. Cell pellets were resuspended in 500 µl LB supplemented with 0.5 mM PMSF and 1x protease inhibitor cocktail (Roche Cat # 5056489001) and lysed by vortexing in 200 µl glass beads (8 cycles: 30 s on, 45 s off) on ice in a cold room. Lysates were clarified by centrifugation (15,000 rpm, 20 min, 4°C), and protein concentrations determined using the Bradford assay. Approximately 1 µg of lysate was incubated with IgG sepharose beads pre-treated with 5% BSA for 2 h at 4°C. Beads were washed five times with LB containing 0.5 mM DTT. Bound complexes were eluted with 500 µl LB +0.5 mM DTT containing 2 µl TEV protease (1 mg/ml, 10 U/µl; Invitrogen 12575–015) at room temperature for 2 hr. Eluates were precipitated with 10% cold TCA on ice for 10 min, pelleted by centrifugation (13,000 rpm, 10 min, 4°C), washed with cold acetone, air-dried, resuspended in 50 µl 2x SDS PAGE sample buffer, neutralized with 50 µl unadjusted 1 M Tris, and boiled for 5 min. Samples were subjected to immunoblot analysis as described above using rabbit polyclonal TAP antibodies (Thermo Fisher Scientific Cat# CAB1001) and mouse monoclonal antibodies against HA (12CA5) (Roche 10522600) for detecting TAP and HA tags.</p></sec><sec id="s4-10"><title>Measuring mitochondrial membrane potential</title><p>Precultures were grown in SC-Ura (to select for the <italic>URA3</italic> plasmids) to OD<sub>600</sub> of ~3.0 and used to inoculate YPD medium at OD<sub>600</sub> of 0.2. Cells were grown to OD<sub>600</sub> of ~0.6–0.8, incubated with 500 nM TMRM for 1 hr and subjected to flow cytometry to measure dye fluorescence in individual cells as described previously (<xref ref-type="bibr" rid="bib54">Vijjamarri et al., 2023b</xref>). In control samples, 50 µM FCCP was added to dissipate the membrane potential and reveal non-specific background fluorescence. Results are presented in arbitrary fluorescence units normalized to OD<sub>600</sub> of the cultures.</p></sec><sec id="s4-11"><title>Analysis of polar metabolites of intermediary metabolism</title><sec id="s4-11-1"><title>Yeast cell culturing</title><p>Four replicate 15 mL cultures in YEPD medium were prepared for each strain by inoculating with saturated overnight cultures to OD<sub>600</sub> of 0.1, culturing with shaking at 30°C, and harvesting at OD<sub>600</sub> of 0.6 by centrifugation in conical 15 mL tubes for 3 min at 3000 ×g in an Avanti J-HC centrifuge pre-cooled to –10°C. Cell pellets were resuspended in 1.8 mL of ice-cold PBS and centrifuged in 2 mL screw-cap tubes in a refrigerated microfuge for 30 s. Supernatants were decanted, tube rims blotted on tissue paper, and cell pellets frozen in dry ice/ethanol for 5 min and stored at –80°C. Frozen cell pellets were shipped on dry ice to the NYU Metabolomics Core Resource Laboratory, where all subsequent analyses described below were conducted.</p></sec><sec id="s4-11-2"><title>Extraction of metabolites</title><p>Frozen cell pellets were thawed on wet ice. Extraction buffer, consisting of 80% methanol (Fisher Scientific) and 500 nM metabolomics amino acid mix standard (Cambridge Isotope Laboratories, Inc), was prepared and placed on dry ice. Samples were extracted by mixing cell pellets with extraction buffer at 10 mg/mL (determined by sample OD measurements) in 2.0 mL screw-cap vials containing ~100 µL of disruption beads (Research Products International, Mount Prospect, IL). Each sample was homogenized for 10 cycles on a bead blaster homogenizer (Benchmark Scientific, Edison, NJ), with each cycle consisting of 30 s homogenization at 6 m/s followed by a 30 s pause. Samples were centrifuged at 21,000 g for 3 min at 4°C. Aliquots of 450 µL were transferred to 1.5 mL tubes, dried in a Speedvac (Thermo Fisher, Waltham, MA), reconstituted in 50 µL of Optima LC/MS grade water (Fisher Scientific, Waltham, MA), sonicated for 2 min, and centrifuged at 21,000 g for 3 min at 4°C. Aliquots of 20 µL were transferred to LC vials containing glass inserts for analysis, and the remaining samples stored at –80°C.</p></sec><sec id="s4-11-3"><title>LC-MS/MS with the hybrid metabolomics method</title><p>Samples were subjected to an LC-MS analysis to detect and quantify known peaks. Extraction of polar metabolites was carried out on each sample based on a previously described method (<xref ref-type="bibr" rid="bib25">Jones et al., 2014</xref>). LC was conducted using a Millipore ZIC-pHILIC (2.1×150 mm, 5 μm) column coupled to a Dionex Ultimate 3000 system with gradient elution conducted at 25°C with a flow rate of 100 μL/min using the following buffers (A) 10 mM ammonium carbonate in water, pH 9.0, and (B) neat acetonitrile. The gradient profile was as follows: 80–20% B (0–30 min), 20–80% B (30–31 min), 80–80% B (31–42 min). Injection volume was set to 2 μL for all analyses with a 42 min total run time per injection.</p><p>MS was conducted by coupling the LC system to a Thermo Q Exactive HF mass spectrometer operating in heated electrospray ionization mode (HESI). Method duration was 30 min with a polarity switching data-dependent Top five method for both positive and negative modes. Spray voltage for both positive and negative modes was 3.5 kV and capillary temperature was set to 320°C with a sheath gas rate of 35, aux gas of 10, and max spray current of 100 μA. The full MS scan for both polarities utilized 120,000 resolution with an AGC target of 3 x 10<sup>6</sup> and a maximum IT of 100 ms, and the scan range was from 67 to 1000 m/z. Tandem MS spectra for both positive and negative mode used a resolution of 15,000, AGC target of 1 x 10<sup>5</sup>, maximum IT of 50 ms, isolation window of 0.4 m/z, isolation offset of 0.1 m/z, fixed first mass of 50 m/z, and 3-way multiplexed normalized collision energies (nCE) of 10, 35, 80. The minimum AGC target was 1 x 10<sup>4</sup> with an intensity threshold of 2 x 10<sup>5</sup>. All data were acquired in profile mode.</p></sec><sec id="s4-11-4"><title>Relative quantification and statistical analyses of polar metabolites</title><p>The resulting Thermo RAW files were converted to SQLite format using an in-house Python script to enable downstream peak detection and quantification. The available MS/MS spectra were first searched against the NIST17 MS/MS (<xref ref-type="bibr" rid="bib45">Simón-Manso et al., 2013</xref>), METLIN (<xref ref-type="bibr" rid="bib47">Smith et al., 2005</xref>), and respective Decoy spectral library databases using an in-house data analysis Python script adapted from our previously described approach for metabolite identification false discovery rate control (FDR) (<xref ref-type="bibr" rid="bib57">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Wang et al., 2020</xref>). Metabolite peaks were extracted based on the theoretical m/z of the expected ion type, e.g., [M+H]<sup>+</sup>, with a 15 part-per-million (ppm) tolerance and a ± 0.2 min peak apex retention time tolerance within an initial retention time search window of ±0.5 min. For all the group-wise comparisons, t-tests were performed using the Python SciPy (1.5.4) (<xref ref-type="bibr" rid="bib55">Virtanen et al., 2020</xref>) library to test for differences and generate statistics for the downstream analyses. For the pairwise t-tests, any metabolite with a <italic>p</italic>-value &lt;0.01 was considered significantly regulated (up- or down-) for prioritization in the subsequent analyses.</p><p>Coverage of a library of polar metabolites of major pathways of intermediary metabolism allowed detection of 130 of the 147 metabolites examined in at least 4 samples, and 91 detected in all 20 samples after background threshold correction. Instrument performance was assessed using the internal standards added to the samples during metabolite extraction and instrument mass accuracy was within tolerance (–2.0 ppm), LC column performance was stable (0.16 min RT range) and internal standard response variability was 13% across the samples. The resulting data were analyzed by principal components analysis (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), by constructing heatmaps with unsupervised hierarchical clustering of the imputed matrix values utilizing the R library pheatmap (1.0.12). GraphPad Prism 9 (9.4.1, GraphPad Software, San Diego, CA), and volcano plots (generated utilizing R library script Manhattanly (0.2.0)), in addition to the statistical comparisons summarized in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p></sec></sec><sec id="s4-12"><title><sup>13</sup>C<sub>6</sub>-glucose metabolic flux measurements</title><p>Three replicate cultures of each strain were grown in YP medium with 2% unlabeled glucose to OD<sub>600</sub> of 0.6–0.7 and then shifted to YP with 1% unlabeled glucose and cultured for 20 min. <sup>13</sup>C<sub>6</sub>-labeled glucose (1%) was then added and growth was continued for 8 min. Cells were collected, and metabolites were extracted, derivatized, and subjected to mass spectrometry as described previously, with the addition of additional masses for assessing the label incorporation into the specific labeled intermediates that were analyzed (<xref ref-type="bibr" rid="bib56">Walvekar et al., 2018</xref>).</p></sec><sec id="s4-13"><title>ATP measurements</title><p>Cells were cultured in YPD to OD<sub>600</sub> of 0.6–0.7 and treated or untreated with 5 mM sodium azide for 30 min at 30°C. Five OD<sub>600</sub> units of cells were harvested and resuspended in 300 µL ice-cold 5% trichloroacetic acid (TCA), incubated on ice for 15 min, and diluted 50-fold in 20 mM Tris-HCl (pH 7.5)–0.1% TCA, after which 10 µL was mixed with 90 µL of ATP Determination reaction mixture (Cat. # A22066, Thermo Fisher Scientific) and incubated at room temperature for 5 min. Units of Firefly Luciferase were measured in a Berthold Centro XS<sup>3</sup> LB 960 Luminometer, and ATP levels were calculated from an ATP standard curve generated using the same assay.</p></sec><sec id="s4-14"><title>Additional data visualization and statistical analyses</title><p>Notched box-plots were constructed using a web-based tool at <ext-link ext-link-type="uri" xlink:href="http://shiny.chemgrid.org/boxplotr/">http://shiny.chemgrid.org/boxplotr/</ext-link>. In all such plots, the upper and lower boxes contain the second and 3<sup>rd</sup> quartiles and the band gives the median. If the notches in two plots do not overlap, there is roughly 95% confidence that their medians differ. Density scatter plots, Venn diagrams, significance testing of gene set overlaps in Venn diagrams using the hypergeometric distribution, hierarchical clustering analysis, and gene ontology (GO) analysis were all conducted as described previously (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-102287-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Parallel RNA-Seq and Ribo-Seq analysis of decapping mutants, gene groups dysregulated in decapping mutants or belonging to specific functional categories, and capped/total mRNA ratios, codon optimality scores, codon protection indices, and Dhh1 occupancy values for all mRNAs.</title><p>Sheets 1-7 labeled ‘mutant vs WT all comp’ contain the processed data from Ribo-seq and RNA-seq analysis of two or three biological replicates of each strain listing the fold changes in mRNA, ribosome-protected fragments (RPFs), or translational efficiency (TE) between the relevant mutant vs. WT with the p-values and adjusted p-values (FDRs) assigned by DESeq2 analysis. The data for <italic>dhh1∆</italic>, <italic>dcp2∆</italic> (<xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>), <italic>pat1∆</italic>, and <italic>pat1∆dhh1∆</italic> mutants (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>) were reported previously. Sheet ‘Gene groups_mRNA analysis’ contains the lists of mRNAs (identified by systematic gene name) that are up-regulated or down-regulated in abundance by ≥1.5-fold at FDR &lt; 0.05 in the <italic>scd6∆</italic>, <italic>edc3∆</italic>, or <italic>scd6∆edc3∆</italic> mutants vs. WT, either including or excluding iESR mRNAs for up-regulated transcripts or rESR mRNAs for down-regulated transcripts, as indicated. It also lists the transcripts belonging to the three sectors of Figs. 1B-C, the iESR and rESR transcripts defined previously (<xref ref-type="bibr" rid="bib14">Gasch et al., 2000</xref>), and all of the non-iESR mRNAs up-regulated by ≥1.5-fold at FDR &lt; 0.05 in <italic>dhh1∆</italic>, <italic>pat1∆</italic>, or <italic>pat1∆dhh1∆</italic> mutants, as well as those equally up-regulated by the <italic>dcp2∆</italic> mutation. Sheet ‘Gene groups_TE analysis’ contains the lists of mRNAs that are up-regulated or down-regulated in TE by ≥1.41-fold at FDR &lt;0.10 in the different mutants vs. WT. Sheet ‘Gene groups_RPF analysis’ contains the lists of mRNAs that are up-regulated or down-regulated in RPFs by ≥1.5-fold at FDR &lt;0.05 in the different mutants vs. WT. Sheet ‘Pathway gene groups’ lists the genes involved in specific pathways (e.g. Ox. Phos.) analyzed for changes in expression or translation. Sheet ‘Codon Opt Scores nonESR mRNAs’ lists the tRNA adaptation index (tAI), species-specific tRNA adaptation index (stAI), and the average codon stabilization coefficient (AvgCSC) for all non-ESR yeast genes (<xref ref-type="bibr" rid="bib38">Presnyak et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Radhakrishnan et al., 2016</xref>). Sheet ‘Codon Protection Indices’ lists the CPI values for all genes determined previously (<xref ref-type="bibr" rid="bib37">Pelechano et al., 2015</xref>). Sheet ‘Capped to Total RNA ratios_s6,e3’ lists the ratios of transcript numbers per million reads (TPMs) determined by CAGE sequencing of capped mRNAs (C) to TPMs determined by parallel RNA-seq of the same total RNA samples for 5393 genes, determined for <italic>scd6∆edc3∆</italic> and WT cells. Sheet ‘Capped to Total RNA ratios_dhh1’ lists the ratios of transcript numbers per million reads (TPMs) determined by CAGE sequencing of capped mRNAs (C) to TPMs determined by parallel RNA-seq of the same total RNA samples for 5129 genes, determined previously for <italic>dhh1∆</italic> and WT cells (<xref ref-type="bibr" rid="bib53">Vijjamarri et al., 2023a</xref>). Sheet ‘Dhh1 occ enrich scores’ lists the relative Dhh1 occupancies (enrichment scores) determined globally for yeast mRNAs by RIP-seq analysis (<xref ref-type="bibr" rid="bib30">Miller et al., 2018</xref>) for the 3686 transcripts for which both Dhh1 enrichment score and Ribo-seq and RNA-seq data from the dhh1∆ vs. WT comparison (<xref ref-type="bibr" rid="bib62">Zeidan et al., 2018</xref>) are available. Sheet ‘IGV tracks’ lists the results of ribosome profiling of the <italic>scd6∆</italic>, <italic>edc3∆</italic>, and <italic>scd6∆edc3∆</italic> mutants vs. WT for the genes selected for gene-browser depictions.</p></caption><media xlink:href="elife-102287-data1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Ribosome profiling, RNA-Seq, ChIP-Seq and CAGE-Seq data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession numbers GSE270789 and GSE270790. TMT-MS/MS raw proteomics data for all expressed proteins have been deposited in ProteomeXchange with accession number PXD053307. All other data generated or analyzed during this study are included in the manuscript and supporting files; source data files have been provided for all figures.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Decapping activators Edc3 and Scd6 act redundantly with Dhh1 in nutrient-replete cells to post-transcriptionally repress starvation-induced pathways [Ribo and RNA-seq]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270790">GSE270790</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Decapping activators Edc3 and Scd6 act redundantly with Dhh1 in nutrient-replete cells to post-transcriptionally repress starvation-induced pathways</data-title><source>ProteomeXchange</source><pub-id pub-id-type="accession" xlink:href="https://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD053307">PXD053307</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset3"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Decapping activators Edc3 and Scd6 act redundantly with Dhh1 in nutrient-replete cells to post-transcriptionally repress starvation-induced pathways [ChIP-seq]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270789">GSE270789</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Decapping factor Dcp2 controls mRNA abundance and translation to adjust metabolism and filamentation to nutrient availability II</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE220578">GSE220578</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Decapping factor Dcp2 controls mRNA abundance and translation to adjust metabolism and filamentation to nutrient availability</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE216831">GSE216831</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>mRNA decapping activators Pat1 and Dhh1 regulate transcript abundance and translation to tune cellular responses to nutrient availability</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224774">GSE224774</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset7"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zeidan</surname><given-names>Q</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Conserved mRNA-granule component Scd6 targets Dhh1 to repress translation initiation and activates Dcp2-mediated mRNA decay in vivo</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114892">GSE114892</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Drew Jones, Tori Rodrick, and the NYU Langone Medical Metabolomics Lab for valuable advice, metabolomics data acquisition and analysis, Samuel Mackintosh and IDeA National Resource for Quantitative Proteomics for TMT-MS analysis, and the NHLBI DNA Sequencing and Genomics Core for all next-generation DNA sequencing. We thank Feng He and Allan Jacobson and Bertrand Séraphin for gifts of yeast strains, Nikolaus Pfanner and Thomas Fox for gifts of antibodies, and Henry Zhang for help with bioinformatics. We are grateful to Jon Lorsch for financial support of DNA sequencing and invaluable advice, and all other members of our laboratories for helpful comments and suggestions. We thank the NHLBI DNA Sequencing and Genomics Core and NIH HPC Biowulf cluster for computational support. This research was supported [in part] by the Intramural Research Program of the National Institutes of Health (NIH). The contributions of the NIH author(s) are considered Works of the United States Government. The findings and conclusions presented in this paper are those of the author(s) and do not necessarily reflect the views of the NIH or the U.S. Department of Health and Human Services. C.O. and M.L.G. were supported by NIH grants R01 HL117880 and R35 GM149271, and SL acknowledges support from a DBT-Wellcome Trust India Alliance Senior Fellowship IA/S/21/2/505922.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arribere</surname><given-names>JA</given-names></name><name><surname>Doudna</surname><given-names>JA</given-names></name><name><surname>Gilbert</surname><given-names>WV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Reconsidering movement of eukaryotic mRNAs between polysomes and P bodies</article-title><source>Molecular Cell</source><volume>44</volume><fpage>745</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.09.019</pub-id><pub-id pub-id-type="pmid">22152478</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badis</surname><given-names>G</given-names></name><name><surname>Saveanu</surname><given-names>C</given-names></name><name><surname>Fromont-Racine</surname><given-names>M</given-names></name><name><surname>Jacquier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Targeted mRNA degradation by deadenylation-independent decapping</article-title><source>Molecular Cell</source><volume>15</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.06.028</pub-id><pub-id pub-id-type="pmid">15225544</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broach</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nutritional control of growth and development in yeast</article-title><source>Genetics</source><volume>192</volume><fpage>73</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.135731</pub-id><pub-id pub-id-type="pmid">22964838</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bushman</surname><given-names>JL</given-names></name><name><surname>Asuru</surname><given-names>AI</given-names></name><name><surname>Matts</surname><given-names>RL</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Evidence that GCD6 and GCD7, translational regulators of GCN4, are subunits of the guanine nucleotide exchange factor for eIF-2 in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular and Cellular Biology</source><volume>13</volume><fpage>1920</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.1128/mcb.13.3.1920-1932.1993</pub-id><pub-id pub-id-type="pmid">8441423</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>JS</given-names></name><name><surname>Munchel</surname><given-names>SE</given-names></name><name><surname>Weis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The DExD/H box ATPase Dhh1 functions in translational repression, mRNA decay, and processing body dynamics</article-title><source>The Journal of Cell Biology</source><volume>194</volume><fpage>527</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1083/jcb.201007151</pub-id><pub-id pub-id-type="pmid">21844211</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celik</surname><given-names>A</given-names></name><name><surname>Baker</surname><given-names>R</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High-resolution profiling of NMD targets in yeast reveals translational fidelity as a basis for substrate selection</article-title><source>RNA</source><volume>23</volume><fpage>735</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1261/rna.060541.116</pub-id><pub-id pub-id-type="pmid">28209632</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>LY</given-names></name><name><surname>Mugler</surname><given-names>CF</given-names></name><name><surname>Heinrich</surname><given-names>S</given-names></name><name><surname>Vallotton</surname><given-names>P</given-names></name><name><surname>Weis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Non-invasive measurement of mRNA decay reveals translation initiation as the major determinant of mRNA stability</article-title><source>eLife</source><volume>7</volume><elocation-id>e32536</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.32536</pub-id><pub-id pub-id-type="pmid">30192227</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charenton</surname><given-names>C</given-names></name><name><surname>Gaudon-Plesse</surname><given-names>C</given-names></name><name><surname>Fourati</surname><given-names>Z</given-names></name><name><surname>Taverniti</surname><given-names>V</given-names></name><name><surname>Back</surname><given-names>R</given-names></name><name><surname>Kolesnikova</surname><given-names>O</given-names></name><name><surname>Séraphin</surname><given-names>B</given-names></name><name><surname>Graille</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A unique surface on Pat1 C-terminal domain directly interacts with Dcp2 decapping enzyme and Xrn1 5’-3’ mRNA exonuclease in yeast</article-title><source>PNAS</source><volume>114</volume><fpage>E9493</fpage><lpage>E9501</lpage><pub-id pub-id-type="doi">10.1073/pnas.1711680114</pub-id><pub-id pub-id-type="pmid">29078363</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coller</surname><given-names>J</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>General translational repression by activators of mRNA decapping</article-title><source>Cell</source><volume>122</volume><fpage>875</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.07.012</pub-id><pub-id pub-id-type="pmid">16179257</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decourty</surname><given-names>L</given-names></name><name><surname>Saveanu</surname><given-names>C</given-names></name><name><surname>Zemam</surname><given-names>K</given-names></name><name><surname>Hantraye</surname><given-names>F</given-names></name><name><surname>Frachon</surname><given-names>E</given-names></name><name><surname>Rousselle</surname><given-names>JC</given-names></name><name><surname>Fromont-Racine</surname><given-names>M</given-names></name><name><surname>Jacquier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Linking functionally related genes by sensitive and quantitative characterization of genetic interaction profiles</article-title><source>PNAS</source><volume>105</volume><fpage>5821</fpage><lpage>5826</lpage><pub-id pub-id-type="doi">10.1073/pnas.0710533105</pub-id><pub-id pub-id-type="pmid">18408161</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zenklusen</surname><given-names>D</given-names></name><name><surname>Singer</surname><given-names>RH</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>YRA1 autoregulation requires nuclear export and cytoplasmic Edc3p-mediated degradation of its pre-mRNA</article-title><source>Molecular Cell</source><volume>25</volume><fpage>559</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.01.012</pub-id><pub-id pub-id-type="pmid">17317628</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsburg</surname><given-names>SL</given-names></name><name><surname>Guarente</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Identification and characterization of HAP4: a third component of the CCAAT-bound HAP2/HAP3 heteromer</article-title><source>Genes &amp; Development</source><volume>3</volume><fpage>1166</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1101/gad.3.8.1166</pub-id><pub-id pub-id-type="pmid">2676721</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fromm</surname><given-names>SA</given-names></name><name><surname>Truffault</surname><given-names>V</given-names></name><name><surname>Kamenz</surname><given-names>J</given-names></name><name><surname>Braun</surname><given-names>JE</given-names></name><name><surname>Hoffmann</surname><given-names>NA</given-names></name><name><surname>Izaurralde</surname><given-names>E</given-names></name><name><surname>Sprangers</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The structural basis of Edc3- and Scd6-mediated activation of the Dcp1:Dcp2 mRNA decapping complex</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.408</pub-id><pub-id pub-id-type="pmid">22085934</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasch</surname><given-names>AP</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Kao</surname><given-names>CM</given-names></name><name><surname>Carmel-Harel</surname><given-names>O</given-names></name><name><surname>Eisen</surname><given-names>MB</given-names></name><name><surname>Storz</surname><given-names>G</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Genomic expression programs in the response of yeast cells to environmental changes</article-title><source>Molecular Biology of the Cell</source><volume>11</volume><fpage>4241</fpage><lpage>4257</lpage><pub-id pub-id-type="doi">10.1091/mbc.11.12.4241</pub-id><pub-id pub-id-type="pmid">11102521</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gietz</surname><given-names>RD</given-names></name><name><surname>Sugino</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>New yeast-<italic>Escherichia coli</italic> shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites</article-title><source>Gene</source><volume>74</volume><fpage>527</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(88)90185-0</pub-id><pub-id pub-id-type="pmid">3073106</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>AL</given-names></name><name><surname>McCusker</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Three new dominant drug resistance cassettes for gene disruption in <italic>Saccharomyces cerevisiae</italic></article-title><source>Yeast</source><volume>15</volume><fpage>1541</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0061(199910)15:14&lt;1541::AID-YEA476&gt;3.0.CO;2-K</pub-id><pub-id pub-id-type="pmid">10514571</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstrohm</surname><given-names>AC</given-names></name><name><surname>Hook</surname><given-names>BA</given-names></name><name><surname>Seay</surname><given-names>DJ</given-names></name><name><surname>Wickens</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>PUF proteins bind Pop2p to regulate messenger RNAs</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>13</volume><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1038/nsmb1100</pub-id><pub-id pub-id-type="pmid">16715093</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Spatrick</surname><given-names>P</given-names></name><name><surname>Casillo</surname><given-names>R</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genome-wide analysis of mRNAs regulated by the nonsense-mediated and 5’ to 3’ mRNA decay pathways in yeast</article-title><source>Molecular Cell</source><volume>12</volume><fpage>1439</fpage><lpage>1452</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(03)00446-5</pub-id><pub-id pub-id-type="pmid">14690598</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Control of mRNA decapping by positive and negative regulatory elements in the Dcp2 C-terminal domain</article-title><source>RNA</source><volume>21</volume><fpage>1633</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1261/rna.052449.115</pub-id><pub-id pub-id-type="pmid">26184073</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Celik</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>General decapping activators target different subsets of inefficiently translated mRNAs</article-title><source>eLife</source><volume>7</volume><elocation-id>e34409</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.34409</pub-id><pub-id pub-id-type="pmid">30520724</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Dcp2 C-terminal <italic>cis</italic>-binding elements control selective targeting of the decapping enzyme by forming distinct decapping complexes</article-title><source>eLife</source><volume>11</volume><elocation-id>e74410</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.74410</pub-id><pub-id pub-id-type="pmid">35604319</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Eukaryotic mRNA decapping factors: molecular mechanisms and activity</article-title><source>The FEBS Journal</source><volume>290</volume><fpage>5057</fpage><lpage>5085</lpage><pub-id pub-id-type="doi">10.1111/febs.16626</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>LEA</given-names></name><name><surname>Campbell</surname><given-names>SG</given-names></name><name><surname>De Long</surname><given-names>SK</given-names></name><name><surname>Sachs</surname><given-names>AB</given-names></name><name><surname>Ashe</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Loss of translational control in yeast compromised for the major mRNA decay pathway</article-title><source>Molecular and Cellular Biology</source><volume>24</volume><fpage>2998</fpage><lpage>3010</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.7.2998-3010.2004</pub-id><pub-id pub-id-type="pmid">15024087</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingolia</surname><given-names>NT</given-names></name><name><surname>Ghaemmaghami</surname><given-names>S</given-names></name><name><surname>Newman</surname><given-names>JRS</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling</article-title><source>Science</source><volume>324</volume><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1126/science.1168978</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Chauhan</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>KC</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myeloma</article-title><source>Analytical Chemistry</source><volume>86</volume><fpage>3667</fpage><lpage>3675</lpage><pub-id pub-id-type="doi">10.1021/ac500476a</pub-id><pub-id pub-id-type="pmid">24611431</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jungfleisch</surname><given-names>J</given-names></name><name><surname>Nedialkova</surname><given-names>DD</given-names></name><name><surname>Dotu</surname><given-names>I</given-names></name><name><surname>Sloan</surname><given-names>KE</given-names></name><name><surname>Martinez-Bosch</surname><given-names>N</given-names></name><name><surname>Brüning</surname><given-names>L</given-names></name><name><surname>Raineri</surname><given-names>E</given-names></name><name><surname>Navarro</surname><given-names>P</given-names></name><name><surname>Bohnsack</surname><given-names>MT</given-names></name><name><surname>Leidel</surname><given-names>SA</given-names></name><name><surname>Díez</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A novel translational control mechanism involving RNA structures within coding sequences</article-title><source>Genome Research</source><volume>27</volume><fpage>95</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1101/gr.209015.116</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaGrandeur</surname><given-names>T</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The cis acting sequences responsible for the differential decay of the unstable MFA2 and stable PGK1 transcripts in yeast include the context of the translational start codon</article-title><source>RNA</source><volume>5</volume><fpage>420</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1017/s1355838299981748</pub-id><pub-id pub-id-type="pmid">10094310</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ljungdahl</surname><given-names>PO</given-names></name><name><surname>Daignan-Fornier</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of amino acid, nucleotide, and phosphate metabolism in <italic>Saccharomyces cerevisiae</italic></article-title><source>Genetics</source><volume>190</volume><fpage>885</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.133306</pub-id><pub-id pub-id-type="pmid">22419079</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JE</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Pugh</surname><given-names>BF</given-names></name><name><surname>Reese</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome-wide mapping of decay factor–mRNA interactions in yeast identifies nutrient-responsive transcripts as targets of the deadenylase Ccr4</article-title><source>G3: Genes, Genomes, Genetics</source><volume>8</volume><fpage>315</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1534/g3.117.300415</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhlrad</surname><given-names>D</given-names></name><name><surname>Decker</surname><given-names>CJ</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Turnover mechanisms of the stable yeast PGK1 mRNA</article-title><source>Molecular and Cellular Biology</source><volume>15</volume><fpage>2145</fpage><lpage>2156</lpage><pub-id pub-id-type="doi">10.1128/MCB.15.4.2145</pub-id><pub-id pub-id-type="pmid">7891709</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanda</surname><given-names>JS</given-names></name><name><surname>Cheung</surname><given-names>YN</given-names></name><name><surname>Takacs</surname><given-names>JE</given-names></name><name><surname>Martin-Marcos</surname><given-names>P</given-names></name><name><surname>Saini</surname><given-names>AK</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name><name><surname>Lorsch</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>eIF1 controls multiple steps in start codon recognition during eukaryotic translation initiation</article-title><source>Journal of Molecular Biology</source><volume>394</volume><fpage>268</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2009.09.017</pub-id><pub-id pub-id-type="pmid">19751744</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niphadkar</surname><given-names>S</given-names></name><name><surname>Karinje</surname><given-names>L</given-names></name><name><surname>Laxman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The PP2A-like phosphatase Ppg1 mediates assembly of the Far complex to balance gluconeogenic outputs and enables adaptation to glucose depletion</article-title><source>PLOS Genetics</source><volume>20</volume><elocation-id>e1011202</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1011202</pub-id><pub-id pub-id-type="pmid">38452140</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissan</surname><given-names>T</given-names></name><name><surname>Rajyaguru</surname><given-names>P</given-names></name><name><surname>She</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Decapping activators in <italic>Saccharomyces cerevisiae</italic> act by multiple mechanisms</article-title><source>Molecular Cell</source><volume>39</volume><fpage>773</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.08.025</pub-id><pub-id pub-id-type="pmid">20832728</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Duibhir</surname><given-names>E</given-names></name><name><surname>Lijnzaad</surname><given-names>P</given-names></name><name><surname>Benschop</surname><given-names>JJ</given-names></name><name><surname>Lenstra</surname><given-names>TL</given-names></name><name><surname>van Leenen</surname><given-names>D</given-names></name><name><surname>Groot Koerkamp</surname><given-names>MJA</given-names></name><name><surname>Margaritis</surname><given-names>T</given-names></name><name><surname>Brok</surname><given-names>MO</given-names></name><name><surname>Kemmeren</surname><given-names>P</given-names></name><name><surname>Holstege</surname><given-names>FCP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cell cycle population effects in perturbation studies</article-title><source>Molecular Systems Biology</source><volume>10</volume><elocation-id>732</elocation-id><pub-id pub-id-type="doi">10.15252/msb.20145172</pub-id><pub-id pub-id-type="pmid">24952590</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RNA degradation in <italic>Saccharomyces cerevisae</italic></article-title><source>Genetics</source><volume>191</volume><fpage>671</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.137265</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelechano</surname><given-names>V</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Steinmetz</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Widespread co-translational RNA decay reveals ribosome dynamics</article-title><source>Cell</source><volume>161</volume><fpage>1400</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.008</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Presnyak</surname><given-names>V</given-names></name><name><surname>Alhusaini</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>Y-H</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>N</given-names></name><name><surname>Kline</surname><given-names>N</given-names></name><name><surname>Olson</surname><given-names>S</given-names></name><name><surname>Weinberg</surname><given-names>D</given-names></name><name><surname>Baker</surname><given-names>KE</given-names></name><name><surname>Graveley</surname><given-names>BR</given-names></name><name><surname>Coller</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Codon optimality is a major determinant of mRNA stability</article-title><source>Cell</source><volume>160</volume><fpage>1111</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.02.029</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Chereji</surname><given-names>RV</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Cole</surname><given-names>HA</given-names></name><name><surname>Rawal</surname><given-names>Y</given-names></name><name><surname>Clark</surname><given-names>DJ</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genome-wide cooperation by HAT Gcn5, remodeler SWI/SNF, and chaperone Ydj1 in promoter nucleosome eviction and transcriptional activation</article-title><source>Genome Research</source><volume>26</volume><fpage>211</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1101/gr.196337.115</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Alhusaini</surname><given-names>N</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Coller</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The DEAD-Box protein Dhh1p couples mRNA decay and translation by monitoring codon optimality</article-title><source>Cell</source><volume>167</volume><fpage>122</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.08.053</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashida</surname><given-names>Z</given-names></name><name><surname>Srinivasan</surname><given-names>R</given-names></name><name><surname>Cyanam</surname><given-names>M</given-names></name><name><surname>Laxman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Kog1/Raptor mediates metabolic rewiring during nutrient limitation by controlling SNF1/AMPK activity</article-title><source>Science Advances</source><volume>7</volume><elocation-id>eabe5544</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abe5544</pub-id><pub-id pub-id-type="pmid">33853774</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>GA</given-names></name><name><surname>Schatz</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Import of proteins into mitochondria. Yeast cells grown in the presence of carbonyl cyanide m-chlorophenylhydrazone accumulate massive amounts of some mitochondrial precursor polypeptides</article-title><source>The Journal of Biological Chemistry</source><volume>257</volume><fpage>13056</fpage><lpage>13061</lpage><pub-id pub-id-type="pmid">6290491</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabi</surname><given-names>R</given-names></name><name><surname>Tuller</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Modelling the efficiency of codon-tRNA interactions based on codon usage bias</article-title><source>DNA Research</source><volume>21</volume><fpage>511</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1093/dnares/dsu017</pub-id><pub-id pub-id-type="pmid">24906480</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>DC</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular and Cellular Biology</source><volume>19</volume><fpage>5247</fpage><lpage>5256</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.8.5247</pub-id><pub-id pub-id-type="pmid">10409716</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simón-Manso</surname><given-names>Y</given-names></name><name><surname>Lowenthal</surname><given-names>MS</given-names></name><name><surname>Kilpatrick</surname><given-names>LE</given-names></name><name><surname>Sampson</surname><given-names>ML</given-names></name><name><surname>Telu</surname><given-names>KH</given-names></name><name><surname>Rudnick</surname><given-names>PA</given-names></name><name><surname>Mallard</surname><given-names>WG</given-names></name><name><surname>Bearden</surname><given-names>DW</given-names></name><name><surname>Schock</surname><given-names>TB</given-names></name><name><surname>Tchekhovskoi</surname><given-names>DV</given-names></name><name><surname>Blonder</surname><given-names>N</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Wallace</surname><given-names>WE</given-names></name><name><surname>Neta</surname><given-names>P</given-names></name><name><surname>Phinney</surname><given-names>KW</given-names></name><name><surname>Remaley</surname><given-names>AT</given-names></name><name><surname>Stein</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources</article-title><source>Analytical Chemistry</source><volume>85</volume><fpage>11725</fpage><lpage>11731</lpage><pub-id pub-id-type="doi">10.1021/ac402503m</pub-id><pub-id pub-id-type="pmid">24147600</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloan</surname><given-names>JS</given-names></name><name><surname>Dombek</surname><given-names>KM</given-names></name><name><surname>Young</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Post-translational regulation of Adr1 activity is mediated by its DNA binding domain</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>37575</fpage><lpage>37582</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.53.37575</pub-id><pub-id pub-id-type="pmid">10608811</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CA</given-names></name><name><surname>O’Maille</surname><given-names>G</given-names></name><name><surname>Want</surname><given-names>EJ</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Trauger</surname><given-names>SA</given-names></name><name><surname>Brandon</surname><given-names>TR</given-names></name><name><surname>Custodio</surname><given-names>DE</given-names></name><name><surname>Abagyan</surname><given-names>R</given-names></name><name><surname>Siuzdak</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>METLIN: a metabolite mass spectral database</article-title><source>Therapeutic Drug Monitoring</source><volume>27</volume><fpage>747</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1097/01.ftd.0000179845.53213.39</pub-id><pub-id pub-id-type="pmid">16404815</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweet</surname><given-names>T</given-names></name><name><surname>Kovalak</surname><given-names>C</given-names></name><name><surname>Coller</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The DEAD-box protein Dhh1 promotes decapping by slowing ribosome movement</article-title><source>PLOS Biology</source><volume>10</volume><elocation-id>e1001342</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001342</pub-id><pub-id pub-id-type="pmid">22719226</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>C</given-names></name><name><surname>Yoo</surname><given-names>JY</given-names></name><name><surname>Tagne</surname><given-names>JB</given-names></name><name><surname>Kacherovsky</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Young</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Combined global localization analysis and transcriptome data identify genes that are directly coregulated by Adr1 and Cat8</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>2138</fpage><lpage>2146</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.6.2138-2146.2005</pub-id><pub-id pub-id-type="pmid">15743812</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tritschler</surname><given-names>F</given-names></name><name><surname>Eulalio</surname><given-names>A</given-names></name><name><surname>Helms</surname><given-names>S</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Coles</surname><given-names>M</given-names></name><name><surname>Weichenrieder</surname><given-names>O</given-names></name><name><surname>Izaurralde</surname><given-names>E</given-names></name><name><surname>Truffault</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Similar modes of interaction enable Trailer Hitch and EDC3 to associate with DCP1 and Me31B in distinct protein complexes</article-title><source>Molecular and Cellular Biology</source><volume>28</volume><fpage>6695</fpage><lpage>6708</lpage><pub-id pub-id-type="doi">10.1128/MCB.00759-08</pub-id><pub-id pub-id-type="pmid">18765641</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tritschler</surname><given-names>F</given-names></name><name><surname>Braun</surname><given-names>JE</given-names></name><name><surname>Eulalio</surname><given-names>A</given-names></name><name><surname>Truffault</surname><given-names>V</given-names></name><name><surname>Izaurralde</surname><given-names>E</given-names></name><name><surname>Weichenrieder</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Structural basis for the mutually exclusive anchoring of P body components EDC3 and Tral to the DEAD box protein DDX6/Me31B</article-title><source>Molecular Cell</source><volume>33</volume><fpage>661</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.02.014</pub-id><pub-id pub-id-type="pmid">19285948</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vengayil</surname><given-names>V</given-names></name><name><surname>Niphadkar</surname><given-names>S</given-names></name><name><surname>Adhikary</surname><given-names>S</given-names></name><name><surname>Varahan</surname><given-names>S</given-names></name><name><surname>Laxman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The deubiquitinase Ubp3/Usp10 constrains glucose-mediated mitochondrial repression via phosphate budgeting</article-title><source>eLife</source><volume>12</volume><elocation-id>RP90293</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.90293</pub-id><pub-id pub-id-type="pmid">39324403</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Onu</surname><given-names>C</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Greenberg</surname><given-names>ML</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2023">2023a</year><article-title>mRNA decapping activators Pat1 and Dhh1 regulate transcript abundance and translation to tune cellular responses to nutrient availability</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>9314</fpage><lpage>9336</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad584</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijjamarri</surname><given-names>AK</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Vandermeulen</surname><given-names>MD</given-names></name><name><surname>Onu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Gaikwad</surname><given-names>S</given-names></name><name><surname>Greenberg</surname><given-names>ML</given-names></name><name><surname>Cullen</surname><given-names>PJ</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2023">2023b</year><article-title>Decapping factor Dcp2 controls mRNA abundance and translation to adjust metabolism and filamentation to nutrient availability</article-title><source>eLife</source><volume>12</volume><elocation-id>85545</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.85545</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virtanen</surname><given-names>P</given-names></name><name><surname>Gommers</surname><given-names>R</given-names></name><name><surname>Oliphant</surname><given-names>TE</given-names></name><name><surname>Haberland</surname><given-names>M</given-names></name><name><surname>Reddy</surname><given-names>T</given-names></name><name><surname>Cournapeau</surname><given-names>D</given-names></name><name><surname>Burovski</surname><given-names>E</given-names></name><name><surname>Peterson</surname><given-names>P</given-names></name><name><surname>Weckesser</surname><given-names>W</given-names></name><name><surname>Bright</surname><given-names>J</given-names></name><name><surname>van der Walt</surname><given-names>SJ</given-names></name><name><surname>Brett</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name><name><surname>Millman</surname><given-names>KJ</given-names></name><name><surname>Mayorov</surname><given-names>N</given-names></name><name><surname>Nelson</surname><given-names>ARJ</given-names></name><name><surname>Jones</surname><given-names>E</given-names></name><name><surname>Kern</surname><given-names>R</given-names></name><name><surname>Larson</surname><given-names>E</given-names></name><name><surname>Carey</surname><given-names>CJ</given-names></name><name><surname>Polat</surname><given-names>İ</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Moore</surname><given-names>EW</given-names></name><name><surname>VanderPlas</surname><given-names>J</given-names></name><name><surname>Laxalde</surname><given-names>D</given-names></name><name><surname>Perktold</surname><given-names>J</given-names></name><name><surname>Cimrman</surname><given-names>R</given-names></name><name><surname>Henriksen</surname><given-names>I</given-names></name><name><surname>Quintero</surname><given-names>EA</given-names></name><name><surname>Harris</surname><given-names>CR</given-names></name><name><surname>Archibald</surname><given-names>AM</given-names></name><name><surname>Ribeiro</surname><given-names>AH</given-names></name><name><surname>Pedregosa</surname><given-names>F</given-names></name><name><surname>van Mulbregt</surname><given-names>P</given-names></name><collab>SciPy 1.0 Contributors</collab></person-group><year iso-8601-date="2020">2020</year><article-title>SciPy 1.0: fundamental algorithms for scientific computing in Python</article-title><source>Nature Methods</source><volume>17</volume><fpage>261</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0686-2</pub-id><pub-id pub-id-type="pmid">32015543</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walvekar</surname><given-names>A</given-names></name><name><surname>Rashida</surname><given-names>Z</given-names></name><name><surname>Maddali</surname><given-names>H</given-names></name><name><surname>Laxman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A versatile LC-MS/MS approach for comprehensive, quantitative analysis of central metabolic pathways</article-title><source>Wellcome Open Research</source><volume>3</volume><elocation-id>122</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.14832.1</pub-id><pub-id pub-id-type="pmid">30345389</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Shaw</surname><given-names>TI</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Target-decoy-based false discovery rate estimation for large-scale metabolite identification</article-title><source>Journal of Proteome Research</source><volume>17</volume><fpage>2328</fpage><lpage>2334</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00019</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Poudel</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Shaw</surname><given-names>TI</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>B</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>JUMPm: A tool for large-scale identification of metabolites in untargeted metabolomics</article-title><source>Metabolites</source><volume>10</volume><elocation-id>190</elocation-id><pub-id pub-id-type="doi">10.3390/metabo10050190</pub-id><pub-id pub-id-type="pmid">32408578</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>ET</given-names></name><name><surname>Dombek</surname><given-names>KM</given-names></name><name><surname>Tachibana</surname><given-names>C</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Multiple pathways are co-regulated by the protein kinase Snf1 and the transcription factors Adr1 and Cat8</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>26146</fpage><lpage>26158</lpage><pub-id pub-id-type="doi">10.1074/jbc.M301981200</pub-id><pub-id pub-id-type="pmid">12676948</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>S</given-names></name><name><surname>Lippman</surname><given-names>SI</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Broach</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>How Saccharomyces responds to nutrients</article-title><source>Annual Review of Genetics</source><volume>42</volume><fpage>27</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1146/annurev.genet.41.110306.130206</pub-id><pub-id pub-id-type="pmid">18303986</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zecha</surname><given-names>J</given-names></name><name><surname>Satpathy</surname><given-names>S</given-names></name><name><surname>Kanashova</surname><given-names>T</given-names></name><name><surname>Avanessian</surname><given-names>SC</given-names></name><name><surname>Kane</surname><given-names>MH</given-names></name><name><surname>Clauser</surname><given-names>KR</given-names></name><name><surname>Mertins</surname><given-names>P</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Kuster</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TMT labeling for the masses: a robust and cost-efficient, in-solution labeling approach</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>18</volume><fpage>1468</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1074/mcp.TIR119.001385</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeidan</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Conserved mRNA-granule component Scd6 targets Dhh1 to repress translation initiation and activates Dcp2-mediated mRNA decay in vivo</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007806</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007806</pub-id><pub-id pub-id-type="pmid">30532217</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>OccProR</data-title><version designator="6c68a2b">6c68a2b</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/hzhanghenry/OccProR">https://github.com/hzhanghenry/OccProR</ext-link></element-citation></ref><ref id="bib64"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>RiboProR</data-title><version designator="0f3d38d">0f3d38d</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/hzhanghenry/RiboProR">https://github.com/hzhanghenry/RiboProR</ext-link></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Differential requirements for Gcn5 and NuA4 HAT activities in the starvation-induced versus basal transcriptomes</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>3696</fpage><lpage>3721</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad099</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102287.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Topisirovic</surname><given-names>Ivan</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>McGill University</institution><country>Canada</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study reports on the redundant roles of the decapping activators Edc3 and Scd6 in orchestrating post-transcriptional programs to modulate metabolic responses to nutrients in yeast. The authors employed mutagenesis studies in conjunction with a battery of transcriptome-wide analyses to provide <bold>convincing</bold> evidence supporting their conclusions. Considering the broad implications of post-transcriptional regulation of gene expression, this study will be of interest across a variety of biomedical disciplines ranging from biochemistry and molecular and cellular biology to those specializing in studying various pathologies.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102287.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>mRNA decapping and decay factors play critical roles in post-transcriptionally regulating gene expression. Here, Kumar and colleagues investigate how deleting two yeast decapping enhancer proteins (Edc3 and Scd6), either alone or in tandem, affects the transcriptome. Using RNA-Seq, CAGE-Seq and ribosome profiling, they conclude that these factors generally act in a redundant fashion, with a mutant lacking both proteins showing an increased abundance of select mRNAs. As these upregulated transcripts are also upregulated in mutants lacking the decapping enzyme, Dcp2, and show no increases in transcription of their cognate genes, the authors conclude that this is at the level of mRNA decapping and decay. This was further supported by CAGE-Seq analyses carried out in WT cells and the scd∆6edc3∆ double mutant. Their ribosome profiling data also lead them to conclude that Scd6 and Edc3 display functional redundancy and cooperativity with Dhh1/Pat1 in repressing the translation of specific transcripts. Finally, as their data suggest that Scd6 and Edc3 repress mRNAs coding for proteins involved in cellular respiration, as well as proteins involved in the catabolism of alternative carbon sources, they go on to show that these decapping activators play a role in repressing oxidative phosphorylation.</p><p>Strengths:</p><p>Overall, this manuscript is well-written and contains a large amount of compelling high-quality data and analyses. At its core, it helps to shed light on the overlapping roles Edc3 and Scd6 have in sculpting the yeast transcriptome.</p><p>Weaknesses:</p><p>While not essential, it would be interesting if the authors carried out add-back experiments to determine which domain within Scd6/Edce3 plays a critical role for enforcing the regulation that they see? Their double mutant now puts them in a perfect position to carry out such experiments.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102287.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This manuscript by Kumar and Zhang presents compelling evidence that Edc3 and Scd6 decapping activators, present a high degree of redundancy that can only be overcome by double mutants of both. In addition, the authors provide strong evidence for their role in regulating starvation-induced pathways as evidenced by measurements of mitochondrial membrane potential, metabolomics and analysis of the flux of Krebs cycle intermediates.</p><p>Strengths:</p><p>Kumar, Zhang et al provide multiple source of evidence of the direct mechanism of Edc3 and Scd6, by using and comparing different approaches such as mRNA-seq, ribosome occupancies and translational efficiencies. By extensive analysis the authors show that this complex can also regulate genes outside the Environmental Stress Response (non-iESR) that are significantly up-regulated in all three mutants. Remarkably, the gene ontology analysis of these non-iESR genes identify enrichment for mitochondrial proteins that are implicated in the Krebs cycle. Overall, this study adds novel mechanistic insight into how nutrients control gene expression by modulating decapping and translational repression.</p><p>Weaknesses:</p><p>The authors show very nicely that growth phenotypes from scd6Δedc3∆ can be rescued by transformation of EDC3 (pLfz614-7) or SCD6 (pLfz615-5). Future work could make use of these rescue strategies, for example as a platform to further characterise protein-protein interactions between Edc3, Scd6 and Dhh1.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102287.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this paper, Kumar et al investigated the role of two decapping activators, Edc3 and Scd6, in regulating mRNA decay and translation in yeast. Using a variety of approaches including RNA-seq, ribosome profiling, proteomics, polysome analysis, and metabolomics the authors demonstrate that whereas single deletions of Edc3 or Scd6 have modest effects, the double mutant leads to increased abundance of mRNAs, many of which overlap with those targeted by the decapping activators Dhh1 and Pat1. The data suggest that Edc3 and Scd6 function redundantly to recruit Dhh1 to the Dcp2 decapping complex, thereby promoting mRNA turnover and translational repression. The authors show that these factors cooperate with Dhh1/Pat1 to repress transcripts involved in respiration, mitochondrial function, and alternative carbon source utilization, linking post-transcriptional regulation to nutrient responses. The study establishes Edc3 and Scd6 as important, but redundant regulators that fine-tune gene expression and metabolic adaptation in response to nutrient availability.</p><p>Strengths:</p><p>The paper has several strengths, including the comprehensive approach taken by the authors using multiple experimental techniques (RNA-seq, ribosome profiling, Western blotting, TMT-MS, polysome profiling, and metabolomics) to provide multiple lines of evidence to support their conclusions. The authors demonstrate clear redundancy of the factors by using single and double mutants for Edc3 and Scd6 and their global approach enables an understanding of these factors' roles across the yeast transcriptome. The work connects post-transcriptional processes to nutrient-dependent gene regulation, providing insights into how cells adapt to changes in their environment. The authors demonstrate the redundant roles of Edc3 and Scd6 in mRNA decapping and translation repression. Their RNA-seq and ribosome profiling results convincingly show that many mRNAs are derepressed only in the double mutants, confirming their hypothesis of redundancy. Furthermore, the functional cooperation between Edc3/Scd6 and Dhh1/Pat1 in regulating specific metabolic pathways, including mitochondrial function and carbon source utilization, is supported by the metabolomic data.</p><p>Weaknesses:</p><p>The study uses indirect evidence to support claims about the effect on mRNA stability rather than directly measuring mRNA stability. However, the combination of Pol II occupancy and RNA abundance measurements is consistent with the claims regarding mRNA stability. The addition of new experiments in the revision co-IPing Dhh1 and Dcp2 strengthens the argument that Edc3 and Scd6 recruit these factors.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102287.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Rakesh</given-names></name><role specific-use="author">Author</role><aff><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Fan</given-names></name><role specific-use="author">Author</role><aff><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Niphadkar</surname><given-names>Shreyas</given-names></name><role specific-use="author">Author</role><aff><institution>Institute for Stem Cell Science and Regenerative Medicine</institution><addr-line><named-content content-type="city">Bangalore</named-content></addr-line><country>India</country></aff></contrib><contrib contrib-type="author"><name><surname>Onu</surname><given-names>Chisom</given-names></name><role specific-use="author">Author</role><aff><institution>Wayne State University</institution><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Vijjamarri</surname><given-names>Anil Kumar</given-names></name><role specific-use="author">Author</role><aff><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Greenberg</surname><given-names>Miriam L</given-names></name><role specific-use="author">Author</role><aff><institution>Wayne State University</institution><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Laxman</surname><given-names>Sunil</given-names></name><role specific-use="author">Author</role><aff><institution>Institute for Stem Cell Science and Regenerative Medicine</institution><addr-line><named-content content-type="city">Bangalore</named-content></addr-line><country>India</country></aff></contrib><contrib contrib-type="author"><name><surname>Hinnebusch</surname><given-names>Alan G</given-names></name><role specific-use="author">Author</role><aff><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Strengths:</p><p>Overall, this manuscript is well-written and contains a large amount of high-quality data and analyses. At its core, it helps to shed light on the overlapping roles of Edc3 and Scd6 in sculpting the yeast transcriptome.</p><p>Weaknesses:</p><p>(1) While the data presented makes conclusions about mRNA stability based on corresponding ChIP-Seq analyses and analyzing other mutants (e.g. Dcp2 knockout), at no point is mRNA stability actually ever directly assessed. This direct assessment, even for select transcripts, would further strengthen their conclusions.</p></disp-quote><p>We appreciate the reviewer’s concern but wish to emphasize that we conducted ChIP-Seq analysis of RNA Polymerase II occupancies in the CDSs of all genes, known to be a reliable indicator of transcription rate, and found only small increases in Pol II occupancies that cannot account for the increased transcript levels of the cohort of mRNAs up-regulated in the scd∆6edc3∆ double mutant (Fig. 3E). This provides strong evidence that increased transcription is not the main driver of increased mRNA abundance in this mutant. Bolstering this conclusion, we showed that the Hap2/Hap3/Hap4/Hap5 complex of transcription factors responsible for induction of Ox. Phos. genes was not activated in scd6Δedc3Δ cells in glucose medium (Fig. 6F(ii)); nor was the Adr1 activator of CCR genes activated (Fig. S9C(i)), ruling out transcriptional induction of their target genes in glucose-replete scd6Δ/edc3Δ cells and instead favoring reduced degradation as the mechanism underlying derepression of Ox. Phos. and CCR gene transcripts in this mutant. In Fig. 3B, we further showed that the majority of mRNAs up-regulated in the scd6Δedc3Δ double mutant are also derepressed by dcp2Δ, and in Fig. 3D that the mRNAs up-regulated in scd∆6edc3∆ cells exhibit a higher than average codon protection index (CPI) indicating a heightened involvement of decapping and co-translational degradation by Xrn1 in their decay. To provide additional support for our conclusion, we have conducted new experiments to measure the abundance of capped mRNAs genome-wide by CAGE sequencing of total mRNA in both WT and scd∆6edc3∆ cells. As established previously, normalizing CAGE TPMs to total mRNA TPMs determined by RNA-Seq, dubbed the C/T ratio, provides a reliable measure of the capped proportion of each transcript. The new data presented in Fig. 3C indicate that the mRNAs up-regulated in the scd∆6edc3∆ mutant have significantly lower than average C/T ratios in WT cells, whereas the C/T ratios for the down-regulated transcripts are higher than average, and that these differences between the two groups and all expressed mRNAs are diminished in the scd∆6edc3∆ double mutant. These are the results expected if the up-regulated mRNAs are selectively targeted for decapping in WT cells dependent on Edc3/Scd6, whereas the downregulated mRNAs are targeted by Edc3/Scd6 less than the average transcript. In the original version of the paper, we came to the same conclusion by analyzing our previous CAGE data for the dhh1∆ mutant for the same transcripts dysregulated scd∆6edc3∆ cells, now presented as supportive data in Fig. S3F. Finally, we added the fact that among all four Dhh1 target mRNAs examined in the previous study of He et al. (2022) and found here to be up-regulated selectively in the scd6∆edc3∆ double mutant (Fig. S10), two of them (SDS23 and HXT6) were shown directly to have longer half-lives in dhh1∆ vs. WT cells by He et al. (2018). Hence, the combined evidence is compelling that selective up-regulation of particular mRNAs in the scd∆6edc3∆ mutant results from diminished decapping/decay rather than enhanced transcription; and we feel that the additional supporting evidence that would be provided by measuring half-lives of a small group of up-regulated transcripts would not justify the considerable effort required to do so. Moreover, the standard approach for such experiments of impairing transcription with an inhibitor of Pol II or a Pol II Ts<sup>-</sup> mutation has been criticized because of the known buffering (suppression) of mRNA decay rates in response to impaired transcription.</p><disp-quote content-type="editor-comment"><p>(2) Scd6 and Edc3 show a high level of functional redundancy, as demonstrated by the double mutant. As these proteins form complexes with other decapping factors/activators, I'm curious if depleting both proteins in the double mutant destabilizes any of these other factors. Have the authors ever assessed the levels of other key decapping factors in the double mutants (i.e. Dhh1, Pat1, Dcp2...etc)? I wonder if depleting both proteins leads to a general destabilization of key complexes. It would also be interesting to see if depleting Edc3 or Scd6 leads to a concomitant increase in the other protein as a compensatory mechanism.</p></disp-quote><p>We thank the reviewer for this insight. Examining our Ribo-Seq and TMT-MS data revealed that Dhh1 expression and steady-state abundance are increased ~2-fold in the scd6∆edc3∆ strain, indicating that the up-regulation of many of the same mRNAs by scd6∆edc3∆ and dhh1∆ does not result indirectly from reduced levels of Dhh1 in the scd6∆edc3∆ mutant. The predicted increased in Dhh1 expression might signify a compensatory response to the absence of Scd6/Edc3. We also observed an ~40% reduction in Dcp2 translation (RPFs) and mRNA abundance in the scd6∆edc3∆ strain, which might contribute to the up-regulation of mRNAs dysregulated in this mutant. However, our new immunoblot analyses revealed no significant reduction in steady-state Dcp2 levels in scd6∆edc3∆ cells (Input lanes in Figs. 3F and S4C(i)-(ii)). Moreover, our previous finding that the majority of mRNAs subject to NMD, up-regulated by both upf1∆ and dcp2∆, are not upregulated by scd6∆edc3∆ implies that Dcp2 abundance in scd6∆edc3∆ cells is adequate for normal levels of NMD and favors a direct role for Scd6/Edc3 in accelerating degradation of most transcripts up-regulated in this mutant. We have added these points to the DISCUSSION.</p><disp-quote content-type="editor-comment"><p>(3) While not essential, it would be interesting if the authors carried out add-back experiments to determine which domain within Scd6/Edce3 plays a critical role in enforcing the regulation that they see. Their double mutant now puts them in a perfect position to carry out such experiments.</p></disp-quote><p>We agree with the reviewer that our scd6∆edc3∆ strain provides an opportunity to dissect the Scd6 and Edc3 proteins to determine which domains and motifs of each protein are most critically required for their functions in activating mRNA decay. However, if conducted thoroughly, this would entail an extensive analysis requiring a combination of genetics, biochemistry and genomics. Considering the large amount of data already presented in 43 and 34 panels of main and supplementary figures, respectively, we feel that these additional experiments would be conducted more appropriately as a stand-alone follow-up study.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Weaknesses:</p><p>The authors show very nicely in Figure S1A that growth phenotypes from scd6Δedc3∆ can be rescued by transformation of EDC3 (pLfz614-7) or SCD6 (pLfz615-5). The manuscript might benefit from using these rescue strategies in the analysis performed (e.g. RNA-seq, ribosome occupancies, and translational efficiencies). Also, these rescue assays could provide a good platform to further characterise the protein-protein interactions between Edc3, Scd6, and Dhh1.</p></disp-quote><p>We responded to this point immediately above in responding to Rev. #1.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Weaknesses:</p><p>The limitations of the study include the use of indirect evidence to support claims that Edc3 and Scd6 recruit Dhh1 to the Dcp2 complex, which is inferred from correlations in mRNA abundance and ribosome profiling data rather than direct biochemical evidence.</p></disp-quote><p>While the reviewer makes a valid point, it is important to note that the greater correlations between effects of scd6∆edc3∆ with those conferred by dhh1∆ vs. pat1∆ also extended to changes in metabolites (Fig. 7A-C). To provide more direct evidence that Edc3 and Scd6 recruit Dhh1 to the Dcp2 complex, we have now conducted co-immunoprecipitation experiments (presented in new Figs. 3F and S5) demonstrating that association of Dhh1 with Dcp2 is diminished in the scd6∆edc3∆ double mutant but not in either scd6∆ or edc3∆ single mutant, thus providing biochemical support for our proposal.</p><disp-quote content-type="editor-comment"><p>Also, there is limited exploration of other signals as the study is focused on glucose availability, and it is unclear whether the findings would apply broadly across different environmental stresses or metabolic pathways. Nonetheless, the study provides new insights into how mRNA decapping and degradation are tightly linked to metabolic regulation and nutrient responses in yeast. The RNA-seq and ribosome profiling datasets are valuable resources for the scientific community, providing quantitative information on the role of decapping activators in mRNA stability and translation control.</p></disp-quote><p>While not disputing the facts of this comment, we think it is unjustified to label as a weakness that our study focused on glucose-grown cells considering the large amount of new data and insights made possible by our multi-omics approach, presented in &gt;70 separate figure panels and nine supplementary datafiles, which the reviewer has characterized as being valuable to the scientific community. Parallel studies in non-preferred carbon or nitrogen sources are underway and represent large-scale investigations in their own right, for which the current dataset in glucose-replete cells provides the critical reference condition.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>The authors made a note that a set of 37 mRNAs is repressed exclusively by Edc3 with little contribution by Scd6, a list that includes the RPS28B mRNA. Edc3 has been previously reported to promote the decay of this mRNA in a deadenylation-independent fashion by binding to an element in its 3'UTR (PMIDs 15225544, 24492965). Can the authors comment on whether Edc3 may be binding to similar elements in the 3'UTRs of these transcripts in their shortlist? This could be an interesting topic matter for discussion as well.</p></disp-quote><p>While an interesting idea, this seems unlikely because the 3’UTR sequence in RPS28B mRNA was shown to bind Rps28 protein itself to confer heightened decapping and decay dependent on Edc3 in a negative autoregulatory loop that exerts tight control over Rps28 protein levels. It would be surprising if Edc3mediated repression of the other 36 mRNAs would involve Rps28 as none of them encode cytoplasmic ribosomal proteins. Nevertheless, we searched for a conserved motif among the 3’UTRs of the 37 mRNAs using the MEME suite and found enrichment for motifs identified for RNA binding proteins Hrp1 and Nab2 and two novel motifs, but none of these motifs could be recognized within in the Rps28 autoregulatory loop. We have chosen not to comment on these findings in the revised manuscript to avoid lengthening it unnecessarily with inconclusive observations.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>The authors show very nicely in Figure S1A that growth phenotypes from scd6Δedc3∆ can be rescued by the transformation of EDC3 (pLfz614-7) or SCD6 (pLfz615-5). The manuscript might benefit from using these rescue strategies on the analysis performed (e.g. RNA-seq, ribosome occupancies, and translational efficiencies); or expressing truncated mutants of EDC3 (pLfz614-7) or SCD6 (pLfz615-5), to show that they can act as dominant negative competitors, either on the binding to Dhh1 and Dcp2.</p></disp-quote><p>We addressed this comment above in our response to this Reviewer.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations for the authors):</bold></p><p>(1) Labels such as &quot;mRNA_up_s6,e3&quot; are not defined in figures or the text. I suggest clearer sample labeling throughout.</p></disp-quote><p>The labels had been defined at first mention in the RESULTS but are now indicated there more explicitly, as well as in the legend to Fig. 1.</p><disp-quote content-type="editor-comment"><p>(2) In Figure 1D it is surprising that the mRNA profile has a peak in the 5' UTR. I would expect to see such a peak in ribosome footprinting data. Is it possible these are incorrectly labeled?</p></disp-quote><p>The figure is correctly labeled. Generally, one does not expect to see RPFs in the 5’UTR region unless there is an efficiently translated uORF, which appears not to be the case for MDH2.</p><disp-quote content-type="editor-comment"><p>In general, the information in this panel and C is inadequate. None of the numbers are clearly explained in the figure legend or in the figure.</p></disp-quote><p>We had cited the legend to Fig. S3C for details of all such gene browser images but have now inserted this information into the Fig. 1D legend, at the first occurrence of such data in the regular figures.</p><disp-quote content-type="editor-comment"><p>(3) Figures 1C and 1D are in the wrong order.</p></disp-quote><p>Corrected.</p><disp-quote content-type="editor-comment"><p>(4) Figure 2D is a very complicated Venn Diagram. I suggest using UpSet plots as an alternative to Venn diagrams to more clearly convey overlaps between sets.</p></disp-quote><p>We provided additional explanatory text in the Fig. 2D legend to facilitate understanding.</p><disp-quote content-type="editor-comment"><p>(5) The use of the same color scheme to represent different sets in panels of the same figure is a source of confusion. E.g. the cyan in Figures 2A, 2D, and 2E indicates unrelated categories, but one would think they are related.</p></disp-quote><p>The use of the same cyan color in these three figure panels actually does designate results for the same set of 591 mRNAs up-regulated in the three mutants. The application of the color schemes is now mentioned explicitly in Figs. 1, 2, and S3.</p><disp-quote content-type="editor-comment"><p>(6) Reporting of p-values = 0 in figures is not useful.</p></disp-quote><p>Corrected.</p><disp-quote content-type="editor-comment"><p>(7) The whole manuscript is extremely long which reduces the overall impact. For example, the introduction is six pages long. I suggest reducing redundant text and being more concise to enhance readability.</p></disp-quote><p>We tried to streamline the text wherever possible, in particular shortening the Introduction by two pages.</p><disp-quote content-type="editor-comment"><p>(8) Many abbreviations are used throughout the text that are not introduced the first time they are used.</p></disp-quote><p>Corrected throughout.</p><disp-quote content-type="editor-comment"><p>(9) The ERCC normalization is unclear. Were the spike-ins added before cell lysis to allow estimation of per-cell RNA counts or to the extracted RNA? If added to extracted RNA rather than cells it is not clear to me how the claim can be made regarding increased mRNA abundance in the mutants.</p></disp-quote><p>We thank the reviewer for this comment. As we explained in the Methods, 2.4 µl of 1:100 diluted ERCC RNA Spike-In Control Mix 1 was added to 1.2 µg of each total RNA sample prior to cDNA library preparation. Because the majority of total mRNA is comprised of rRNA, this normalization yields the abundance of each mRNA relative to rRNA. Owing to repression of rESR mRNAs encoding ribosomal proteins and biogenesis factors in the scd6∆edc3∆ strain (Fig. S3D), the ribosome content per cell is expected to be reduced in this mutant vs. WT. We showed previously that the isogenic dcp2∆ mutant that elicits an ESR response of similar magnitude, showed a 30% reduction in bulk ribosomal subunits per cell compared to same WT strain examined here {Vijjamarri, 2023 #7866}. Assuming a similar reduction in ribosome abundance in the scd6∆edc3∆ mutant, the changes in mRNA per cell conferred by the scd6∆edc3∆ mutation are expected to be 0.7-fold of the ERCCnormalized values given in Fig. 3E, yielding fold-changes of 2.00 and 0.62 for the mRNA_up and mRNA_dn, groups, respectively, which still differ substantially from the corresponding changes in normalized Rpb1 occupancies of 1.2 and 0.93, respectively. We have added this new analysis to the text of RESULTS.</p><disp-quote content-type="editor-comment"><p>(10) The use of the terms &quot;up-regulated&quot; and &quot;derepressed&quot; throughout is confusing. Both refer to observed increased abundance of mRNAs, but they imply different causes which are never clearly defined.</p></disp-quote><p>We changed all occurrences of “derepressed” to “up-regulated”.</p></body></sub-article></article>